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Summary 
Aim of the present PhD thesis is the extraction, purification and 
structural elucidation of lipopolysaccharides (LPS), or endotoxins, 
isolated from human pathogen bacteria. LPSs are amphiphilic 
macromolecules that compose about 75% of the outer membrane of 
Gram-negative bacteria that are indispensable for their growth and 
survival. LPSs have a structural role since increase the strength of 
bacterial cell envelope and mediate the contacts with the external 
environment. The general structure of LPSs is characterised by 
three distinct portions: the lipid A, composed of the typical 
glucosamine disaccharide backbone variously acylated, the core 
oligosaccharide, distinguishable in a inner core and a outer core, 
and the O-chain polysaccharide built up of oligosaccharide 
repeating units. This latter moiety can be absent and in that case 
LPSs are named lipooligosaccharides (LOS). Furthermore, LPS 
elicits host immune response through the TLR4 and MD-2 
receptorial complex expressed on macrophages and neutrophils.
 
Recognition between LPS and its physiological receptor is crucial 
since excessive exposure (or excessive host responses) to LPS can 
lead to an uncontrolled inflammation process in infected patients, 
as in case of individuals affected by Cystic Fibrosis (CF), in which 
premature death occurs after a permanent chronic inflammation 
state. 
The basic genetic defect predisposes CF patients to recurrent 
pulmonary infections that are the major cause of morbidity and 
mortality in CF. Characteristic CF pathogens include Pseudomonas 
aeruginosa, bacteria belonging to the Burkholderia cepacia 
complex (BCC) and the newly identified genus Pandoraea. Since 
LPS is involved in the elicitation of host immune response in a 
structure-dependent mode, the investigation of the LPS structure is 
mandatory to understand the virulence of the abovementioned 
microorganisms and the effect on the host.  
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The endotoxins analysed in the present PhD work are extracted 
from opportunistic Cystic Fibrosis pathogens.  
The first part of the project has been focused on the structural 
characterisation of endotoxins from Burkholderia dolosa, 
Pandoraea pulmonicola and a chronic strain of Pseudomonas 
aeruginosa. Moreover, the biological activity of the LOS isolated 
from B. dolosa and P. aeruginosa has been also assessed.   
Chemical and biological properties of the LOS from Burkholderia 
dolosa IST4208, an isolate recovered from a CF patient in a 
Portuguese CF Center, were analysed. The infected CF patient was 
chronically colonised for 5.5 years with B. dolosa until death, 
following severe pulmonary deterioration. The structural 
determination was attained by a combination of chemical, 
spectrometrical and spectroscopal methods and brought to a novel 
structure; the LOS was also tested for its immunostimulatory 
activity on human HEK 293 cells expressing TLR4, MD-2 and CD-
14, showing a strong pro-inflammatory activity. These findings 
allow to speculate that the novel and heterogeneous structure of the 
core oligosaccharide portion plays a key function in the molecular 
mechanism of the interaction with the TLR4/MD-2 receptorial 
complex, thus demonstrating a notable role in the pathogenicity of 
B. dolosa.  
Pandoraea pulmonicola is a newly identified CF pathogen that 
showed to possess a potent pro-inflammatory activity. Since the O-
chain moiety constitutes the antigenic determinant of the LPS, 
making this latter highly immunogenic, is crucial to know the 
primary structure of this polysaccharide moiety. Thus, it was 
determined for the first time the O-chain structure of the LPS 
isolated from Pandoraea pulmonicola strain LMG 18108, a clinical 
isolate from a US CF patient. Pandoraea pulmonicola revealed to 
possess a LPS composed of a novel polysaccharide, whose 
structure consisted of a trisaccharide repeating unit bearing a
 
very 
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unusual acyl substituent, a five-membered ring acyl residue, the 3-
hydroxy-2,3-dimethyl-5-oxoprolyl group.  
Pseudomonas aeruginosa, considered the key pathogen in CF, 
causes severe acute and chronic infections at the basis of the 
decline of lung functions leading patients to death. The 
establishment of a chronic infection implies that bacteria have to 
adapt themselves to the CF environment and this is possible due to 
their intrinsic plasticity. Indeed, many publications have reported 
that P. aeruginosa can undergo several phenotypic and genotypic 
changes, most of which regard the LPS molecule. Despite these 
studies, very little is known about the molecular mechanism of the 
adaptation process and about other changes that can occur in the 
LPS structure of this CF pathogen. In this scenario, the present 
work reports the elucidation of the structure and the biological 
activity of the LOS isolated from the CF chronic strain P. 
aeruginosa RP73. The complete structural analysis was achieved 
by chemical analyses, NMR spectroscopy and MALDI MS 
spectrometry experiments, while the assessment of the biological 
activity was attained testing the in vivo pro-inflammatory capacity 
of the isolated LOS molecule. P. aeruginosa RP73 LOS showed to 
possess a singular structure since it is composed of the typical core 
moiety found in other CF P. aeruginosa strains but also of an 
under-acylated lipid A found in a non-cystic fibrosis strain. As a 
consequence, the isolated LOS showed to possess a very low 
inflammatory power that could be explained as a bacterial attempt 
to escape from the host immune system. 
Furthermore, it was analysed the structural changes that occur in 
the LPS structure of Burkholderia cenocepacia during the process 
of chronic colonisation in CF patients, by studying the LPS 
extracted from four strains isolated at different stages of 
colonisation. This work demonstrated that, during the colonisation 
process of the body districts, B. cenocepacia loses the O-chain 
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moiety of its LPS molecule leading to a less immunogenic non-
typable strains. 
A second part of this PhD thesis was dedicated to the biological 
aspects of the relationship between the LPS structure and its 
function. Indeed, it was studied the biological role of amino-
arabinoses of Burkholderia cenocepacia LPS. This bacterium is 
well known to possess high antibiotic resistance and capability to 
cause severe inflammation. This resistance is commonly attributed 
to often unknown characteristics of the bacterial outer membrane. 
The work here reported that this high resistance is due to the 
presence of 4-amino-4-deoxy-L-arabinose (L-Ara4N); moreover, 
the L-Ara4N modification of LPS showed to provide a molecular 
signature required for LPS export and proper assembly at the outer 
membrane of B. cenocepacia. These conclusions were achieved by 
isolating and characterising the LPS of three B. cenocepacia 
suppressor mutants that remained viable despite their inability to 
either synthesize L-Ara4N or transfer it to the LPS. In this context, 
it is also reported the fine genetic and molecular biology 
experiments executed to assess the importance of these sugar 
residues on the LPS macromolecule.  
An extensive part of the present thesis has been also dedicated to 
the study of the molecular mechanisms of interaction between B. 
cenocepacia LPS and TLR4/MD-2 receptorial complex. The 
typical paradigm of LPS recognition has the E. coli hexa-acylated 
lipid A species as the typical ligand of the TLR4/MD2 complex 
whereas underacylated LPSs are less or not sensed by the complex. 
Here it has been showed that Burkholderia cenocepacia lipid A 
triggers the innate immune response by binding to the same 
receptor system although it only possesses a penta-acylated or even 
more underacylated lipid A. By using site-directed mutagenesis and 
modeling experiments on Burkholderia cenocepacia, overall results 
led to propose that the increased length of the acyl chains and the 
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presence of amino-arabinoses in the Burkholderia LPS is the key 
feature allowing the lipid A moieties to i) fulfill the binding pocket 
of MD-2 and ii) to be exposed to induce TLR4 dimerization. This 
suggested that B. cenocepacia lipid A possesses a new model of 
TLR4/MD2 activation and opens new trails of discussion that can 
explain the yet unexplained activation of innate immunity by 
different hypoacylated bacterial LPSs. 
Finally, a small section of the current thesis has been focused on 
the structure characterisation of LPSs composing the outer 
membrane of extremophilic Gram-negative bacteria, focusing 
attention on thermophilic bacteria. Bacteria adapted to heat have 
developed peculiar structure for their cell wall components. Since 
the outer membrane of Gram-negative bacteria is constituted 
mainly by LPSs, then it is reasonable to assume that structural 
changes could also be present in these macromolecules isolated 
from thermophilic bacteria. Moreover, it was previously 
demonstrated that lipid A from non-pathogenic bacteria are non 
toxic and, in some cases, can antagonize many effects of 
pathogenic LPSs. Thus, it is of great interest to determine their LPS 
structure and to test the biological activity on human cells. In this 
context, the characterisation of the endotoxin isolated from the 
thermophilic bacterium Thermomonsas hydrothermalis was 
determined. A LOS was found with an unique structure composed 
of a hexa-saccharide skeleton in which a galacturonic acid was 
linked to the core oligosaccharide via phosphodiester linkage. 
Moreover, also lipid A turned out to have a peculiar backbone 
structure characterised by the presence of galacturonic acids linked 
to the phosphate groups. These features render the overall structure 
of T. hydrothermalis LOS highly negatively charged. Interaction 
between LOS-negative charges and cations contribute to the 
rigidity of the outer membrane, resulting in bacterial high 
resistance to external stresses, emphasizing the important role of 
LPS in high resistance of extremophiles to extreme environments. 
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The biological activity assessment showed, moreover, that T. 
hydrothermalis LOS has a low immunopotential and an 
antagonistic activity versus the high immunogenic hexa-acylated E. 
coli LPS at low doses. 
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1.1 The Prokaryotic cell 
     The three-domain system, which classifies organisms on Earth 
into three distinct kingdoms – Archea, Bacteria and Eukarya – was 
designed by the American microbiologist Carl Woese in the 1990. 
Otherwise, an alternative biological classification system currently 
used is known as “the six-kingdoms system of life” and include 
Archaebacteria, Eubacteria, Protista (comprising one-celled 
organisms), Fungi, Plantae and Animalia (Figure 1). While 
Archaebacteria and Eubacteria constitute the Archaea and 
Bacteria domains respectively (both representing the Prokarya 
kingdom), Protista, Fungi, Plantae and Animalia together form the 
Eukarya kingdom of life (Figure 1.1).    
Most prokaryotic cells have diameters in the range of 1-10 μm, 
much smaller than most eukaryotic cells (typically 10-100 μm). 
Despite their small size and structural simplicity, prokaryotes have 
an immense impact on our world; indeed it is enough to mention all 
the known and yet unknown bacterial species that cause serious 
illnesses in humans, animals and plants. On the other hand, of 
enormous importance are also beneficial bacteria as well as all the 
decomposers prokaryotes that live in soil, at the bottom of lakes, 
rivers and oceans, where they return chemical elements to the 
environment in the form of inorganic compounds, that can be used 
by plants, which in turn feed animals. Therefore, it is 
understandable that if decomposers prokaryotes were to disappear, 
the chemical cycle that sustains life on Earth would halt, and all 
forms of eukaryotic life would also die; in contrast, prokaryotic life 
would undoubtedly persists in absence of eukaryotes, as it once did 
for billions of years.  
 
Prokaryotes have a cellular organization different from that of 
eukaryotes; whereas these latter have a membrane-enclosed 
nucleus and numerous membrane-enclosed organelles, prokaryotic 
Chapter 1 
Gram-negative Bacteria 
 
 
4 
 
cells lack these structural features. Typically, Archea domain 
includes all the extremophiles prokaryotic organisms that live and 
thrive in inhospitable, from a human viewpoint, environments such 
as alkaline and acidic waters, boiling hot springs, high pressure 
waters, ultra saline brines, without excluding a combination of 
aforesaid chemical and physical extremes which is typical of 
polyestremophilic microbes (Mesbah and Wiegel, 2008).
 
    
    
                                          
              Figure 1.1 The dogmas of the organisms classification. 
 
Bacteria comprise a wide group of microorganisms characterised 
by a bewildering assortment of size, shapes and arrangements 
reflecting the diverse environments in which they grow and 
reproduce (Pommerville, 2010). Despite the high structural 
variability, Bacteria can be divided on the basis of their basic cell 
morphologies: a bacterial cell with a rod shape is called “bacillus” 
whereas spherical and curved cells are called “cocci” and “spirilli” 
Chapter 1 
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respectively (Raven and Johnson, 2001). Some rod-shaped and 
spherical bacteria form colonies adhering end-to-end after their 
cellular division forming chains, whereas spirilla bacteria generally 
do not form associations with other cells. However, early systems 
for classifying bacteria relied on differential stains such as the 
colorimetric assay developed by the Danish physician Hans Gram, 
in use to date, that allows the distinction of bacteria in Gram-
positive and Gram-negative on the basis of the different response to 
the test. The differences between Gram-positive and Gram-negative 
bacteria are related to diversities in the structure and chemical 
composition of their cell wall: Gram-positive bacteria have the 
thicker cell envelope, nearly uniformly dense layers, and stain the 
purple color of the crystal-violet typically used in the Gram stain, 
whereas Gram-negative bacteria contain just a single or two layers 
and lose the purple-coloured dye (Staley et al., 2007).
 
1.2 Bacterial cell envelope  
     The complex system of layers that surrounds bacterial cells are 
referred collectively as the cell envelope. It consists of a 
cytoplasmic membrane (or plasma membrane), cell wall, and for 
some bacteria, capsule and glycocalyx from inner to outer surface. 
Both Gram-positive and Gram-negative bacteria present the 
cytoplamatic membrane, namely a phospholipid bilayer 
surrounding the cytoplasm representing a physical semi-permeable 
barrier that regulates the transport of nutrients and metabolic 
products in and out the cell. This membrane is, in turn, enclosed by 
the cell wall, an important structure that maintains the cellular 
shape and protects the cell from swelling and rupturing (Raven and 
Johnson, 2001). The bacterial cell wall differs markedly from 
archaeal and eukaryotic cells walls in containing peptidoglycan (or 
murein) which is a network of saccharide molecules connected by 
polypeptide cross-links. In detail, it is composed of β-(1→4)-linked 
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disaccharide chains, alternating N-acetylglucosamine and N-
acetylmuramic acid residues in turn cross linked by short peptide 
stems  composed of alternating L- and D-amino acids (Figure 1.2). 
It is possible to classify peptidoglycan on the basis of the third 
amino acid residue of the stem peptide; indeed, in Gram-negative 
bacteria this residue is the unusual meso-diaminopimelic acid (m-
DAP) while in Gram-positive bacteria is commonly a lysine 
(Figure 1.2).  
 
Figure 1.2 Peptidoglycan structure in Gram-positive (left) and in Gram-negative (right) 
bacteria.  
 
Furthermore, in Gram-negative bacteria the external portion of the 
cell is composed by 95% of rigid peptidoglycan cell wall that may 
be one of the reason why they retain the crystal-violet of Gram 
stain (Figure 1.3); on the contrary, in Gram-negative cells there is a 
thin layer of peptidoglycan, almost 5-10% of the cell wall, 
surrounded by an additional asymmetric phospolipid bilayer, 
termed outer membrane (OM) (Figure 1.3). This external 
membrane is a unique feature of Gram-negative bacteria and 
represents the first barrier that protects bacterial cell from 
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environmental stress factors, thus it is essential for bacterial 
survival. The outer membrane is separated by a gel-like 
compartment, termed periplasm, from the cytoplasmatic membrane 
and shows to have a structure similar to that of the plasma 
membrane, from which nonetheless differs for important physical 
and chemical properties. The inner portion of the OM is mainly 
composed of phospholipids, while the external leaflet is occupied 
for the 75% by glycolipids known as lipopolysaccharides (LPS) 
(Alexander and Rietschel, 2001). Furthermore, the outer membrane 
is also constituted by a large number of proteins, among which 
there is the Braun’s lipoprotein (BLP or murein lipoprotein), that 
acts as a bridge between the outer membrane and the 
peptidoglycan. 
 
 Figure 1.3 Cell-wall structure of Gram-positive (left) and Gram-negative bacteria (right). 
 
1.3 Lipopolysaccharides (LPSs) 
        Lipopolysaccharides are heat-stable amphiphilic molecules 
indispensable for viability and survival of Gram-negative bacteria, 
as they heavily contribute to the structural integrity of the OM and 
to the protection of the bacterial cell envelope (Holst et al., 1996). 
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Being intercalated into the outer membrane, they form hydrophobic 
interactions with the phospholipid bilayer composing the inner 
layer, giving rise to the typical asymmetry of Gram-negative 
bacteria OM (Holst et al., 1996). The highly ordered structure and 
low fluidity of the LPS monolayer, stabilised by electrostatic 
interactions of divalent cations (as Ca
2+
 and Mg
2+
) with negatively 
charged groups present on LPS molecules, is responsible for the 
increase of permeability to hydrophobic compounds and to higher 
molecular weight hydrophilic compounds but also for the bacteria 
resistance to external stress factors. Indeed, most of the common 
used antibiotics directed against Gram-negative bacteria, such as 
polymyxin B, are able to destabilise abovementioned ionic 
interactions leading to the disruption of membrane integrity 
(Cardoso et al., 2007). In addition, since they are exposed toward 
the external environment, LPS molecules participate in crucial 
mechanisms of host-bacterium interactions like colonisation, 
virulence in the case of pathogen and opportunistic bacteria, 
adhesion and symbiosis (Silipo et al., 2010). Among all these 
activities, LPS has been shown to be the most potent 
immunostimulant molecule playing a key role in the pathogenesis 
of Gram-negative infections triggering the immune system in a 
wide range of eukariotic organisms ranging from insects to humans 
(Alexander and Rietschel, 2001). LPSs belonging to different 
bacterial species possess different structures, but also LPS of an 
individual bacterial strain is not a single molecule, possessing a 
specific chemical structure, but rather a blend of various molecules 
characterised by an intrinsic size and structural heterogeneity 
(Raetz, 1990; Raetz and Whitfield, 2002). Furthermore, bacteria of 
the same species producing diverse LPS molecules under different 
growth conditions were also found. Despite the high structural 
heterogeneity, all LPSs  broadly comply with a common basic 
architecture composed of well-conserved domains in which three 
distinct regions encoded by different gene clusters, can be 
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distinguished (Figure 1.4). Indeed, they consist of a polysaccharide 
(also known as O-antigen, O-side chain or O-specific 
polysaccharide) characterised by a highly variable structure which 
constitutes the chemical basis for the serological classification of 
bacterial strains, that is covalently linked to an oligosaccharide part 
(core), in turn, linked to a glycolipid portion (lipid A) that is the 
most conserved region of the entire macromolecule. even among 
different species belonging to the same genus (Holst et al., 1996).  
 
                    Figure 1.4 Schematised structure of Gram-negative LPSs. 
 
The lipid A moiety is embedded in the outer leaflet of the OM 
whereas the sugar chain is oriented outwards (Raetz and Whitfield, 
2002). The O-polysaccharide chain is not ubiquitous, as it can be 
absent or partly truncated in some Gram-negative strains. Bacterial 
colonies can be catalogued by gross colony morphology as rough 
or smooth on the basis of the occurrence of the O-side chain, being 
absent in the former and present in the latter (Lüderitz et al., 1966). 
The terminology currently used to designate the different LPS 
types, namely with or without the O polysaccharide portion, is S-
LPS or R-LPS (or lipooligosaccharide, LOS), respectively (Raetz 
and Whitfield, 2002).  
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1.3.1 The Lipid A moiety: structure and activity 
 Lipid A represents the hydrophobic and endotoxic principle 
of the LPS molecule since it acts as a potent stimulator of the host 
innate immune system (see paragraph 1.4.2). It possesses a high 
conservative structure consisting of a β-(1→6)-linked D-
glucosamine disaccharide backbone substituted with a number of 
amide- and ester-linked 3-hydroxy fatty acids at the positions  2 
and 3 (Figure 1.5), respectively. The acyl groups that are directly 
linked to the sugar backbone are defined primary and some are 
further acylated at the hydroxy groups by secondary acyl chains. 
Furthermore, the sugar backbone is generally α-phosphorylated at 
position O-1 of the reducing glucosamine (GlcpN I) and at position 
O-4' of the non-reducing glucosamine (GlcpN II) (Figure 1.5) 
(Zahringer et al., 1999). The first lipid A characterised were from 
Escherichia coli (Figure 1.5) and Salmonella enterica LPSs in 
1983. E. coli LPS lipid A is built up of the following sugar 
backbone  [P→4-β-D-GlcpN-(1→6)-α-D-GlcpN-1→P] acylated at 
position 2 and 3 of both GlcpNs by four C14:0 (3-OH) (Figure 1.5). 
The primary fatty acids located on the GlcpNII were both esterified 
at their hydroxy group by two secondary acyl chains: the C14:0 (3-
OH) was esterified by a C12:0 while the C14:0 (3-OH) by a C14:0 
(Figure 1.5).  
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                          Figure 1.5 Lipid A from Escherichia coli. 
 
Despite their general architecture, lipid As also present a  
microheterogeneity due to the presence of subtle chemical 
differences depending on a wide number of factors including 
bacterial adaptation, incomplete biosynthesis, changing of 
environment, presence of external stimuli and chemical 
modifications resulting from the procedures used for lipid A 
extraction from bacterial cells. Microheterogeneity has been 
observed in the acylation (number, type and distribution of acyl 
chains) and phosphorylation patterns, and, less commonly, also in 
the disaccharide backbone as in the case of bacterial species  as 
Aquifex pyrophilus (Hellerqvist et al., 1971), Brucella abortus 
(Hellerqvist et al., 1969), whose GlcN residues may be replaced 
with 2,3-diamino-2,3-dideoxy-D-glucopyranose (GlcN3N) 
residues. Moreover, phosphate groups can be substituted by further 
phosphate groups, producing a pyrophosphate, but also by other 
polar substituents such as 4-amino-4-deoxy-L-arabinopyranose 
Chapter 1 
Gram-negative Bacteria 
 
 
12 
 
(amino-arabinose, Ara4N) and 2-amino-ethanol group (EtN), or by 
acid residues such as galacturonic acid (GalA); phosphate groups 
can be absent, as in the case of Bdellovibrio bacteriovorus lipid A, 
characterised by the replacement of phosphate groups with two 
mannose residues generating a totally neutral lipid A. Concerning 
the acylation pattern, fatty acids can be attached to the disaccharide 
backbone either symmetrically (3+3, e.g. Neisseria meningitides) 
or asymmetrically (4+2, e.g. Escherichia coli). Finally, lipid A 
fatty acids present less frequently further structural features such as 
methyl branch, different functional and hydroxyl groups, length of 
the chains up to 28 carbon atoms, odd numbered carbon chains and 
unsaturation (Figure 1.6). Environmental- or growth conditions-
dependent changes in lipid A structure have been found in several 
bacterial species; as example, lipid A from E. coli can undergo 
structural changes as the addition of palmitate residues in presence 
of antimicrobial peptides and low concentration of Mg
2+
. It is 
worth to note that some bacterial species, such as the cystic fibrosis 
opportunistic pathogens Burkholderia, were found to constitutively 
synthesize a lipid A substituted by L-Ara4N residues, that are, in 
physiological conditions, positively charged elements whose 
presence on LPS molecule reduces the net charge surface of the 
outer membrane, thus increasing bacterial resistance against 
cationic antimicrobial compounds as polymyxin B or cationic 
antimicrobial peptides (CAMP) (Hamad et al., 2012) (see chapter 
7). Moreover, a very frequent substitution mainly involving 
bacteria that live in extreme habitats (termed extremophiles), is that 
of galacturonic acid residues that can be attached either on the Kdo 
moiety or on the lipid A glucosamine-backbone (see chapter 9). 
Even the most subtle variation in chemical structure of lipid A can 
affect the LPS molecule bioactivity, since this latter is strictly 
structure-related; indeed, the lipid A intrinsic conformation is 
responsible for its agonistic and antagonistic activity on innate 
immune system (Brandenburg et al., 1993; Rietschel et al., 1994; 
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Seydel et al., 2000; Fukuoka et al., 2001; Oikawa et al., 2004) (see 
details in Section III).  
A plethora of studies aimed to the elucidation of the LPS 
structure-activity relationship have highlighted that the hexa-
acylated bisphosphorylated lipid A with an asymmetric 4:2 fatty 
acid distribution, found in the majority of enterobacteria, as the 
aforesaid E. coli lipid A, is considered to have the highest 
immunostimulatory capacity in mammals cells. In contrast, the 
hypoacylated synthetic precursor of E. coli lipid A, the tetra-
acylated lipid IVA, showed to have weak agonistic effects for some 
species of mammals and is well known to possess a strong 
antagonistic activity on human cells (Golenbock et al., 1991). 
These different biological effects are correlated to two 
interconnected structural parameters:  
            
Figure 1.6 Lipid A chemical structures showing their diversity in Gram-negative bacteria. 
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the molecular shape of the lipid A and the tilt angle between the 
diglucosamine backbone and fatty acid chains that is the inclination 
of lipid A hydrophilic moiety respect to the hydrophobic portion 
(Netea et al., 2002). In details, the molecular shape possessed by 
lipid A influences its ability to be recognised by host immune 
system receptors, indeed it has been shown that at 37°C, in aqueous 
solution and in physiological conditions, the most agonistic lipid A 
has a truncated cone form that drives to a hexagonal supra-
structure, while lipid As presenting an antagonistic activity assume 
a cylindrical shape leading to a lamellar structure (Netea et al., 
2002). Regarding the tilt angle, it has been found that the most 
active form has a conical structure with a tilt angle >50°, while the 
antagonist structures present smaller values of tilt angles (Seydel et 
al., 2000): species with a tilt angle <25°, such as lipid IVA and the 
penta-acylated and symmetrically (3+3) hexaacylated lipid As, act 
as antagonists; species with an angle between 25-50°, as 
monophosphorylated lipid A, have a low bioactivity (Figure 1.7) 
(Seydel et al., 2000).  
 
                   
             Figure 1.7 Tilte angle of lipid A depends from the acylation pattern. 
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These physical parameters are reflected in the different binding-
mode of the LPS molecule to its physiological receptor, the 
TLR4/MD-2 complex, since they regulate the lipid A affinity to the 
MD-2 hydrophobic binding pocket that is pivotal for the innate 
immune receptor activation. 
1.3.2 The core oligosaccharide moiety: structure and activity 
 Core oligosaccharide is a complex component of the LPS 
molecule since it can be characterised by up to fifteen 
monosaccharides which can be organised giving either a linear or a 
branched structure (Holst, 1999). In the core LPS portion two 
different regions can be distinguished on the basis of the 
monosaccharide composition termed: inner core and outer core 
(Holst, 1999). The inner core region is directly linked to the lipid 
A, is well conserved and consists of uncommon sugar residues such 
as heptoses (L-glycero-D-manno-heptose and, less commonly, D-
glycero-D-manno-heptose) (De Soyza et al., 2008) and Kdo (3-
deoxy-D-manno octulosonic acid) (Figure 1.8); this latter is 
considered a diagnostic marker for all Gram-negative bacteria that 
connects the core oligosaccharide to the lipid A backbone with an 
α-configured ketosidic linkage in almost every LPS investigated to 
date.  
                                    
                             Figure 1.8 Structure of the Kdo residue. 
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The only two exceptions in which Kdo is not the first residue of the 
inner core regards Acinetobacter (Vinogradov et al., 1997) and 
Shewanella
  
(Vinogradov et al. 2003): in the former Kdo is replaced 
by its C-3 hydroxy-derivative, the  D-glycero-D-talo-oct-2-ulosonic 
acid (Ko), whereas in the latter it is replaced by its C-8 amino-
derivative, the 8-amino-8-deoxy-manno-oct-2-ul-osonic acid 
(Kdo8N). The L-glycero-D-manno-heptose residues are often 
decorated with charged substituents like phosphate, pyrophosphate, 
Ara4N or uronic acids, as found in bacteria belonging to 
Pseudomonas genus and in many other species. Particularly, Ara4N 
residue is always present as terminal non-reducing monosaccharide 
of the trisaccharide Ara4N-(1→8)-α-Ko-(2→4)-α-Kdo in 
Burkholderia LPS (see chapters 3, 6-8). It is speculated that all the 
substituents bearing a positively charged free amino group, as 
Ara4N residues, might play a role in pathogenesis since they 
reduce the negatively charged surface on the outer membrane 
rendering it positively charged or in an isoelectric state that, in turn, 
confers resistance to antibiotic compounds and antimicrobial 
peptides (Raetz and Whitfield, 2001; Hamad et al., 2012)
 
(see 
chapter 7). The outer core region is the most exposed portion, often 
branched, and is characterised by a higher structural variability than 
the inner core region. It is typically characterised by common 
hexoses such as glucose, galactose, N-acetyl glucosamine and N-
acetyl galactosamine and it may also contain residues as 6-deoxy-
L-mannose (L-Rha) and N-acetyl-2,6-dideoxy-D-glucosamine (D-
QuiNAc). It is possible to find peculiarities also in this region 
although less commonly; as example, in Shewanella LPS a new 
kind of glycosidic linkage has been found that involves an open 
chain acetal linkage of a glucosamine residue that is present as a 
non cyclic carbonyl form (Vinogradov et al., 2003).  
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1.3.3 The O-polysaccharide moiety: structure and activity 
 The O-chain polysaccharide is the most variable portion of 
the LPS also within bacteria belonging to the same genus;  it 
consists of up to 50 identical repeating oligosaccharide units 
composed of two to eight different glycosil residues 
(heteroglycans) or, in some bacteria as L. pneumophila, of identical 
sugars (homoglycans). A single bacterium produces LPSs with O-
chains characterised by a wide range of lengths as a result of 
incomplete synthesis of the polysaccharide chain (Raetz and 
Whitfield, 2001); this different degree of polymerization is 
responsible for the “ladder-like” pattern, showed by SDS-PAGE 
(Kittelberger and Hilbink, 1993) typical of a smooth LPS. The high 
structural variability of the O-polysaccharide is ascribable to the 
large number of sugar residues (in both pyranose and furanose 
rings, anomeric and absolute configurations) that can build up the 
repeating units as well as to the glycosidic sequence and to the 
presence of non-carbohydrate substituents such as phosphate, 
amino acids, sulphate, acetyl or formamide groups, often present in 
a non-stoichiometric fashion (Adinolfi et al., 1996). The function 
of these substituents is frequently unknown although it can be 
speculated that bacteria can modify their LPSs to mask themselves 
to the host immune system.  
 
1.4 LPS and Elicitation of Host Immune Response 
1.4.1 Innate Immunity and Adaptive Immunity 
 From the moment of birth and throughout our lifetime, 
humans are continuously exposed to a multitude of potential 
pathogen bacteria, through inhalation, direct contact and ingestion. 
The ability to avoid most of these infections depends on the 
adaptive immune system which remembers the previous encounters 
with specific pathogens and destroys them when they attack again 
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(Alberts et al., 2007). Adaptive immune responses, however, are 
slow to develop on the first exposure to a new pathogen, since it is 
required the activation and expansion of specific cells that take 
approximately 7 days prior to give an effective response. For this 
reason, the first days of exposure to a new pathogen see the 
intervention of the innate immune system (Alberts et al., 2007). 
Indeed, innate immune system is the first line of defense against 
invading organisms while the adaptive immune system acts as a 
second line of defense and also affords protection against re-
exposure to the same pathogen; moreover the innate immune 
responses are not specific to a particular pathogen in the way that 
the adaptive immune responses are. 
The strategy of recognition typical of the innate immune system 
relies on the detection of constitutive and conserved microbial 
molecular targets, that are common to many pathogens but are 
absent in the host; these latter are known as PAMPs or (Pathogen 
Associated Molecular Patterns) and are recognised by specific 
receptors, the PRRs (Pattern Recognition Receptors) present on the 
surface of some phagocytic cells that rapidly destroy them. It is 
worth to note that in Vertebrates, the skin and other epithelial 
surfaces, including those lining the lung and gut, provide a physical 
barrier between the inside of the body and the outside world, thus 
can be considered part of the innate immune system (Alberts et al., 
2007). The microorganisms that pass this first barrier are 
recognised by the sentinels of innate immunity which are 
phagocytes, or white blood cells, or leukocytes, that are 
distinguishable in: neutrophils, polymorphonuclear neutrophilic 
leukocytes (PMN), macrophages and monocytes (Figure 1.9).  
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           Figure 1.9 Overview of the innate and adaptive immune responses. 
 
Macrophages and neutrophils show a variety of cell surface 
receptors, which make them able to recognise different types of 
microorganisms; the attack of a ligand to these receptors induces 
actin-polymerization that allows the plasma membrane of 
phagocytes to surround the pathogens and to incorporate them 
forming a phagosome which becomes acidified (Figure 1.10). In 
addition to being phagocytic, macrophages and neutrophils have 
granules, called lysosomes, that contain lysozyme and hydrolases; 
the phagosome fuses with one or more lysosomes to generate a 
phagolysosome in which the lysosomal contents are released to 
degrade bacterial cell wall (Figure 1.10). After degradation, 
phagolysosomes exhibit the antigenic determinants on their cell 
surface with the consequent triggering of the mechanism of specific 
immune response (Figure 1.10) (Janeway et al., 2001).  
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         Figure 1.10 Phagocytosis mechanism as starting point of the innate immunity. 
 
Compared to the innate immunity, specific immunity (or acquired 
or adaptive immunity) represents a more sophisticated system of 
defense. A peculiarity of this second line of defense is the ability to 
discriminate between exogenous antigens and autologous antigens 
(Janeway et al., 2001). Therefore acquired immunity strengthens 
the role of the innate immune response, amplifying, focusing and 
directing this response against foreign agents. It is possible to 
schematically distinguish two types of specific immunity: humoral 
immunity and cell-mediated immunity (Figure 1.11). The main 
components of acquired immunity are two other types of white 
blood cells that are called lymphocytes, which are divided into B 
lymphocytes (expression of humoral immunity and developed in 
the bone marrow) and T lymphocytes (expression of cell-mediated 
immunity and developed in the thymus). The acquired immune 
response consists in a first step of antigen-processing by 
macrophages and dendritic cells (termed “antigen presenting cells” 
or APC) and a second step of presentation to T and B lymphocytes 
which ensure the recognition by specific receptors (TCR and BCR, 
T and B cell receptors) expressed on their cell membrane. The 
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binding of the antigen to these receptors determines the activation, 
proliferation and differentiation into effector cells by a process of 
clonal selection. In details, in the humoral immune response, 
activated B cells (or plasma cells) secrete antibodies (or 
immunoglobulins) that circulate in the bloodstream and permeate 
other body fluids, where they bind specifically to the foreign 
antigen that stimulated their production, causing its destruction 
(Figure 1.11). In cell-mediated immune response, some T cells, 
termed cytotoxic, attack the leukocytes which present the antigenic 
determinants complexed to proteins of the major histocompatibility 
complex of class I (MHC I), and destroy them (Figure 1.11).  
               
             Figure 1.11 The humoral and cell-mediated immune responses.  
 
Other T cells, the helper T immature cells, recognise the complex 
formed between the antigen and MHC class II proteins, and 
produce cytokines, known as macrophage colony-stimulating factor 
and gamma interferon, which promote the activity of macrophages. 
Moreover, the helper T cells secrete interleukin-2, which stimulates 
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the proliferation of abovementioned cytotoxic T cells (Alberts et 
al., 2007). Following expulsion of the antigen, the immune 
response gradually comes to an end. Some cells, produced during 
clonal expansion, undergo a phase of differentiation into memory 
cells, which are capable, in case of a possible new encounter with 
the same antigen, to respond more quickly and with higher 
efficiency (Alberts et al., 2007). 
1.4.2 LPS and Innate Immunity 
 As described in the above paragraph 1.4.1, innate immune 
response is activated after recognition of bacterial conservative 
molecular targets termed PAMPs, by specific innate immune 
receptors, termed PRRs (Janeway, 1989). PAMPs have three 
common features that make them ideal targets for innate immune 
recognition: 
1.  are produced only by microbes and not by host 
2.  are invariant between microorganisms of a given class 
3.  are essential for microbial survival (Medzhitov, 2001) 
In case of Gram-negative bacteria, lipopolysaccharides respond to 
all aforesaid three features, being recognised as PAMPs by a 
component of a family of PRRs known as Toll-Like Receptors 
(TLRs). Upon recognition of the real endotoxic principle of LPS, 
the lipid A moiety, the host innate immune system is immediately 
activated. The core oligosaccharide or, in smooth bacterial 
colonies, the O-chain, are the antigenic determinants recognised by 
the adaptative immunity. TLRs comprise a family of ten 
transmembrane receptors in humans, which are characterised by an 
extracellular leucine-rich repeat (LRR) domain and an intracellular 
Toll/IL-1 receptor (TIR) domain (Hashimoto et al., 1988; 
Medzhitov et al., 1997). Among all TLRs, TLR4 is the receptor 
designated to recognise the LPS macromolecule, but its detection 
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requires several accessory molecules. The first host protein 
involved in LPS recognition is a serum protein, the LBP (LPS-
binding protein) that forms a high affinity complex with LPS lipid 
A released from bacterial lysis or replication, or still bound to the 
outer membrane of the intact microbial cell (Pålsson-McDermott 
and O'Neill, 2004). The N-terminal domain of LBP is responsible 
for the LPS lipid A binding while the C-terminal domain is specific 
for the further recognition by CD14 (Figure 1.12). This latter can 
be found in two forms, soluble (secreted into serum) and membrane 
bound (as glycophosphoinositol-linked protein on the surface of 
macrophages) (Haziot et al., 1996), and has a crucial role in the 
enhancement of host response to endotoxins since it facilitates the 
recognition of LPS by the final receptor complex TLR4/MD-2. It 
was demonstrated that CD14-deficient mice have a profound defect 
in responsiveness to LPS, thus showing the pivotal role of CD14 in 
LPS-recognition process (Haziot et al., 1996). Once CD14 binds to 
the LPS, it has been shown that CD14 can chaperone LPS from 
LBP to TLR4 at the cell surface. This latter is linked, through its 
extracellular domain, to a small glycoprotein, MD-2 (myeloid 
differentiation factor 2), which turns out to be absolutely necessary 
for the proper functioning of TLR4 receptor; indeed, the same MD-
2 protein is able, by itself, to recognise lipid A with a good affinity, 
and also to discriminate different lipid A types. Therefore, TLR4 
might be considered as a "pseudo-receptor", since, in the absence 
of MD-2, does not recognise its ligand. The TLR4/MD-2 complex 
has been shown to bind LPS with higher affinity than soluble MD-
2 (Akashi et al., 2003). However, the binding affinity of MD-2 or 
the MD-2/LPS complex for TLR4 is the same (Visintin et al., 
2005).  
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                           Figure 1.12 Schematised model of LPS signaling. 
 
TLR4 with the MD-2 protein forms an heterodimer that recognizes 
a common structural motif in different LPS molecules (see details 
in Section III). The binding of LPS to TLR4/MD-2 receptorial 
complex can activate two different immune response pathways 
(Figure 1.12) (Park et al., 2009). In the first case, it results in 
activation of the transcription factor NF-κB, which regulates the 
expression of genes encoding for inflammatory cytokines; whereas 
the second pathway results in activation of MAP-kinases which 
regulate the transcription of genes involved in increasing the 
stability of particular regions of the mRNA. In both cases, the final 
result is the amplification of the transduction signal with the 
consequent massive production of inflammatory proteins thus 
eliciting the inflammatory process (Figure 1.12) (Park et al., 2009).
 
If the inflammatory response is amplified and uncontrolled, due to 
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the high toxicity of the LPS from the infecting pathogen, there may 
occur a fulminating septic shock syndrome. 
1.5 Gram-negative infections in Cystic Fibrosis 
1.5.1 Cystic Fibrosis: an overview 
 Cystic Fibrosis (CF) is the most common lethal single gene 
disorder in Europe. The CF condition arises due to an autosomal 
recessive gene defect with an incidence of approximately 1/2000 
live births in the Western hemisphere. The basic genetic defect in 
CF reflects mutations in a gene, located on the long arm of 
chromosome 7, encoding for an epithelial chloride channel, named 
Cystic Fibrosis Transmembrane Regulator (CFTR) (Figure 1.13), a 
protein of 1480 residues (De Soyza et al., 2012). Over 1000 
mutations are described to date, but the most common disorder is 
the ΔF508, present in one or both alleles in approximately 90% of 
CF patients (Riordan, 2008), that leads to a single amino acid 
mutation generating a failure in CFTR folding and maturation. 
CFTR is a cyclic AMP-regulated chloride channel expressed on the 
apical membrane of the epithelial cells in the airways, pancreas, 
intestine, testis and exocrine glands, as well in some non-epithelial 
cell types (Lukacs and Verkman, 2011). It is constituted by two 
membrane-spanning domains (MSD1 and MSD2), two nucleotide-
binding domains (NBD1 and NBD2) that participate in ATP 
binding and hydrolysis, and a regulatory domain (R) whose 
phosphorylation regulates channel gating (Lukacs and Verkman, 
2011). CFTR maintains the ion and fluid homeostasis since it is the 
unique ABC protein that functions as ion channel. 
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           Figure 1.13 The CFTR trans-membrane protein. 
 
Mutations in CFTR protein cause the CF phenotype characterised 
by multiple organ system collapse including liver, gastrointestinal, 
reproductive and pulmonary involvement, leading to death. 
However, a wide variability in the clinical expression is found 
among patients. Up to 20% of affected infants are born with 
intestinal obstruction and present inspissated meconium (meconium 
ileus). Other patients are diagnosed with various modes of 
presentation from birth to adulthood and with considerable 
variability in the severity and rate of disease progression. Even 
within the same CFTR genotype, there is evidence that other genes, 
as well as environmental factors, make important contributions to 
the pulmonary phenotype. Moreover, inactive CFTR causes an 
immune-deficiency against pathogens thus producing chronic 
bacterial lung infections which are a hallmark of the condition with 
episodic worsening “exacerbations” leading to multiple courses of 
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antibiotics, hospitalisation and precipitous terminal decline (De 
Soyza et al., 2012).  
In healthy conditions a mucus layer permeates epithelium surface 
allowing an efficient ciliar beat and providing for an optimal 
lubrificant activity. The normal hydration of epithelia is due to their 
capability to absorb and secrete salts with water moving 
osmotically in response to salts gradient. In this scenario, CFTR 
represents the Cl
-
 channel, while the epithelia Na
+
 channel (ENaC) 
and the Na
+
/K
+
-ATPase regulate Na
+
 transport in and out the 
membrane (Figure 1.14). Mucus clearance is guaranteed by CFTR 
that acts either as Cl
-
 channel or as an inhibitor of the ENaC; 
indeed, when airway surface liquid (ASL) reduces, the channel 
ENaC is inhibited while CFTR starts to secrete Cl
-
 anions with the 
consequent water osmotic passage across the membrane that 
reconstitutes the normal ASL hydration (Figure 1.14). In a CF 
tissue, abnormal CFTR allows little to no Cl
-
 ion movement and an 
unregulated Na
+
 adsorption, resulting in a severe dehydration that 
causes a collapse of mucus layer on periciliary liquid layer (Figure 
1.14). Retention of sticky secretions further promotes bacteria 
persistence and prevents mucociliary clearance of virulence factors 
(Figure 1.14). These processes collectively promote further airway 
damage and inflammation leading to the vicious cycle paradigm.  
   
Figure 1.14 Ions movement through epithelia of healthy (left) and cystic fibrosis    
individuals (right). 
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Recently, CFTR has been shown to be a negative regulator of a 
central pro-inflammatory controller Nuclear Factor kappa B (NF-
κB) (Hunter, 2010). Hence, mutations in CFTR may be themselves 
pro-inflammatory. Cytokines of relevance in CF include interleukin 
8 (IL-8), IL-1, IL-6, IL-17 and TNF-α (Salva et al., 1996; Raoust et 
al., 2009). These cytokines have a pro-inflammatory effect through 
vasodilatation, direct chemokinesis, neutrophil priming and 
angiogenesis. Recently, more novel pro inflammatory moieties that 
have been associated with inflammation in CF include endogenous 
damage associated molecular patterns (DAMPS) such as lipid 
metabolites as ceramide (Brodlie et al., 2011). Indeed, CF-
dependent damage of lysosomes promotes ceramide accumulation. 
Biological membranes are mainly constituted by cholesterol, 
sphingomyelin and phospholipids. In lysosomes sphingomyelin is 
converted to ceramide through the acid sphingomyelinase (Asm); 
then ceramide is degraded in sphingosine by acid ceramidase (Ac). 
Lysosomes damages in respiratory cells induce an imbalance of 
both enzymatic activities that leads to a net accumulation of 
ceramide. As a consequence, the rate of cell death increases with an 
accumulation of DNA that facilitated pathogen infections (Döring 
and Gulbins, 2009). Moreover, ceramide accumulation also 
induces, as described above, a pro-inflammatory status since there 
is an increase synthesis and release of cytokines (Brodlie et al., 
2011).      
Despite elevated numbers of airway innate immune cells, there is 
clearly impaired immunity in CF phenotype. Data showed 
neutrophil dysfunction in CF, with evidence of neutrophil 
undergoing necrosis resulting in DNA release and increased 
mucous viscosity, compounding the problem of bacterial 
attachment (Callaghan and McClean, 2012). Another aspect of host 
immune defences that are compromised in CF regards the 
macrophage clearance of pathogens (Callaghan and McClean, 
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2012). Recent studies report that dysfunctional CFTR in 
macrophages impairs their bacteriocidal activity (Del Porto et al., 
2011). Indeed, in normal conditions, after phagocytosis by lung 
macrophages, microbes enter the phagosome and lysosomes 
forming the phagolysosome (Figure 1.10) (see also paragraph 
1.4.1). This mature organelle exhibits a low pH that destroys 
ingested bacteria. In case of defective CFTR-dependent 
acidification of lysosomal pH (Barasch et al., 1991), it has been 
observed a significant survival of the most common CF pathogen, 
P. aeruginosa (Di et al., 2006). Furthermore, many components of 
the humoral immune response are ineffective in cystic fibrosis such 
as host defence peptides (HDPs) which are impaired by 
dehydration of ASL (Boucher, 2007). Secretion of proteases in CF 
lung further compromises immune system functions, indeed it is 
possible to observe a predominance of neutrophil elastase that 
destroys a large number of anti-microbial proteins, degrades mucin 
(Henke et al., 2011) and increase IL-8 production from epithelial 
cells (Cosgrove et al., 2011). This latter is crucial since growth of 
many opportunistic bacterial species results enhanced in presence 
of IL-8.   
1.5.2 Cystic Fibrosis as a complex microbial pathology 
 Characteristic opportunistic cystic fibrosis pathogens 
include Haemophilus influenza, Staphylococcus aureus (Liou et al., 
2001), and Pseudomonas aeruginosa (Gomez and Prince, 2007). 
Important but less common bacterial pathogens include the 
Burkholderia cepacia complex (BCC) (Mahenthiralingam et al., 
2005), non tuberculous Mycobacteria,  Acinetobacter spp (Coenye 
et al., 2002), Stenotrophomonas spp (Brooke, 2012), Achrombacter 
spp (Emerson et al., 2010; Spicuzza et al., 2009) and Pandorea 
genus (Coenye et al., 2000). Though some of these can 
occasionally infect normal human lungs, aforesaid pathogens are 
predominantly opportunistic pathogens. A common clinical pattern 
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is a sequential replacement of pathogens over time from 
Haemophilus and S. aureus with Pseudomonas usually becoming 
the predominant pathogen by adulthood (Rosenfeld et al., 2001).  
 
 
Figure 1.15. Cross section of bronchus showing mucus retention and bacterial infection 
(on the right) 
 
Epidemiology of P. aeruginosa is characterised by an early stage 
of infection, that lasts about three months, followed by a chronic 
establishment of the inflammation that causes persistent respiratory 
symptoms and decline in pulmonary functions (Gibson et al., 2003; 
Ciganà et al., 2009). During the first period there is co-infection of 
different P. aeruginosa strains but then, with evolving of the 
inflammation, a single clone remains established. The 
establishment of a permanent relationship with the host chemically 
implies the adaptation of the bacterium to the CF airway which is 
possible due to its intrinsic genetic and phenotypic plasticity; 
indeed, it has previously been observed that P. aeruginosa isolates, 
early adapted to the lungs of CF patients, show peculiar genotypic 
and phenotypic characteristics which are not found in chronically 
infected individuals, implying that the chronic P. aeruginosa strain 
becomes completely different to the initially acquired strain (see 
chapther 5) (Di Lorenzo et al., 2014; Mena et al., 2008). Selective 
pressures on bacteria in persistent chronic CF infection are 
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plausible with exposure to repeated antibiotics, continual exposure 
to host defense molecules and changes in the local environment 
caused by worsening lung disease all likely forces (Eberl and 
Tummler, 2004). Certain features emerge in Pseudomonas 
aeruginosa strains from patients with advanced CF lung disease; 
indeed, antimicrobial resistance rates including pan-resistant strains 
are highly prevalent. Furthermore development of alginate and the 
“mucoid phenotype” and a hypermutator phenotype are also 
common during chronicity of infection (Waine et al., 2008). 
Biofilm forming capacity is common in strains isolated in cystic 
fibrosis, particularly those who have persistent infection for years 
(Hoiby et al., 2010). Biofilms are complex communities of bacteria 
with physical and functional aspects. They contribute to 
pathogenesis by increasing resistance to phagocytosis, but also by 
increasing antibiotic resistance (Hoiby et al., 2010; Bagge et al., 
2000). The importance of multispecies biofilms is that supposedly 
low pathogenicity bacteria such as oral “commensal” can induce 
virulence factor upregulation in Pseudomonas aeruginosa. The 
effect of complex biofilm growth on cell surface virulence 
determinants is to date still an emerging field.   
As for the second most dominant pathogen, Burkholderia is less 
prevalent than Pseudomonas but is responsible for the most feared 
infections. Previously, infections with “Burkholderia cepacia” 
were attributed to a single species. Indeed, such infections are 
caused by a variety of bacterial species, grouped into the 
Burkholderia cepacia complex (BCC) (Mahenthiralingam, 2000). 
Currently this complex comprises over 10 related species named 
genomovars which are phenotypically similar but genotypically 
different. The most prevalent clinical isolates from CF patients are 
B. cenocepacia strains (genomovar III) and B. multivorans strains 
(genomovar II) (De Soyza et al., 2004) and infection with the 
former is most often associated with patient-to-patient spread and 
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fatal invasive infection (the so-called “cepacia syndrome”) (Govan 
and Deretic, 1996). Lung transplantation, whilst intensive and 
aggressive, is to date the only treatment that offers improved 
quantity and quality of life of CF patients with advanced lung 
disease. BCC’s impact on the survival of CF patients following 
lung transplantation is viewed as so detrimental that infection with 
these organisms is considered a relative or absolute 
contraindication for transplantation (De Soyza and Corris, 2003). 
Post-transplant survival rates are 15% to 63% lower than those of 
CF patients not infected with BCC (Alezander et al., 2008), with 
death usually resulting from BCC sepsis in the early post-operative 
period. It is important to underline that there are great differences 
in vitro among different isolates from the same genetic lineage e.g. 
for the renowned B. cenocepacia epidemic strain  ET-12 clonal 
strains J2315 and K56-2 strains behave differently when used in 
vitro and in vivo models (Mahenthiralingam et al., 2000). Hence 
this heterogeneity illustrates the importance of examining multiple 
clinical bacterial isolates and not generalising the results from 
studies of a single strain. Molecular differences among the BCC 
family has been suggested as the cause of their variable 
pathogenicity, and their LPS has been proposed as potentially 
important in this. Studies conducted soon after genomovar 
designation have assessed LPS chemotypes within the BCC (De 
Soyza et al., 2004). So far strains tested belonging to B. cepacia 
genomovar I and B. multivorans had smooth LPS. In contrast, 
isolates belonging to B. cenocepacia, expressed either rough or 
smooth LPS chemotype (Silipo et al., 2007). Importantly two 
clones of the B. cenocepacia ET-12 lineage differed with J2315 
and  K56-2 having a rough and a smooth chemotype respectively. 
Subsequent studies in clinical BCC strains assessing chemotype 
have demonstrated both rough and smooth LPS chemotypes are 
found. Other genomovars studied had predominantly smooth LPS 
though B. multivorans and B. vietnamiensis strains expressing 
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rough LPS were noted (Ieranò et al., 2009). Moreover, it was 
demonstrated that BCC strains may differentially express LPS 
dependent on the local environment. This is clinically important  as 
airway mucus may serve as a semi-solid growth media within CF 
lungs.  
Nowadays, despite genetic bases of the pathology, a wide branch 
of research on CF is focused on the epidemiology, the 
pathogenicity and the treatment of CF pathogens infections. Thus, 
studies on virulence factors characterising CF pathogens are aimed 
to elucidate their chemical structure and biological activity, aid to 
identify new targets for therapies. 
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2.1 Extraction and Purification of  LPSs and LOSs 
 The first approach aimed to the structural elucidation of  
LPS/LOS is represented by their extraction from intact microbial 
cells. This is conventionally achieved through two complementary 
procedures, that lead to the selective isolation of R-LPS (LOS) and 
S-LPS exploiting their different amphiphilic character; indeed the 
latter has higher hydrophilicity, due to the presence of the 
polysaccharide moiety of the O-chain, whereas the former, which 
lacks such portion, has a greater hydrophobic character. Thus, these 
different physical-chemical properties allow to perform a selective 
extraction of the LOS and LPS, with a high degree of purity. 
Liophilised bacterial cells are firstly washed with acetone, water 
and ethylic to remove cell contaminants. After this initial step of 
purification, the procedure of extraction can take place. Typically, 
rough-type LPSs are extracted with a phenol-chloroform-petroleum 
ether procedure (PCP) (Galanos et al., 1969) while smooth-type 
LPSs are extracted with the hot phenol-water protocol (Westphal 
and Jann, 1965).
 
  
The PCP extraction consists in the treatment of dried bacterial cells 
with phenol/chloroform/light petroleum in proportions 5:8:2; LOS 
is precipitated from pure phenol adding drops of water. After this 
extraction, cells undergo a second treatment with 90% 
phenol/water 1:1 at 68°. The two phases are then extensively 
dialysed and liophilised. As previously mentioned, typically the 
presence of the long O-chain moiety increases the hydrophilic 
nature of endotoxins, thus LPS molecules are extracted in the water 
phase even though several factors, as the occurrence within the 
repeating unit of hydrophobic groups as well as charged 
monosaccharides or the length of the polysaccharide chains, may 
modulate LPS solubility in water. Thus, it can be detected either in 
the water or in the phenol extract.  
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After the extraction procedure, enzymatic treatments to remove 
proteins and nucleic acids are executed. The typical protocol 
consists in LPS/LOS purification with nucleases (DNAse and 
RNAse) and protease  followed by dialysis in order to remove 
digested material. The screening for detection of LPS is realised by 
SDS polyacrylamide electrophoresis gel (SDS-PAGE) followed by 
silver nitrate staining which allows to define the typology of the 
extracted material and its purification degree (Kittelberger and 
Hilbink, 1993). The presence of LPS is testified by the observation 
of the typical “ladder-like” pattern of the electrophoretic migration, 
due to the presence of molecules differing in their structure for the 
number of repeating units composing the O-polysaccharide moiety. 
Conversely, LOS appears as a dark band that quickly migrates at 
the bottom of the gel, denoting the lower molecular weight of LOS 
lacking O-chain domain.  
2.2 Structural determination of the saccharide moities  
 Structural investigation of LPS/LOS is a difficult task since 
their amphiphilic nature determines the tendency to form micelles 
with low solubility in both aqueous and apolar organic solvents. 
Several strategies have been developed to overcome this obstacle, 
including the usage of solvent mixtures and chemical modifications 
or degradation of the molecules to improve dissolution in simple 
solvent systems. 
The common protocol consists in the analysis of the lipid portion 
and saccharide moiety separately by using several hydrolysis 
techniques, as aqueous 1% acetic acid or acetate buffer. The above 
mild conditions are sufficient to cleave selectively the acid-labile 
glycosidic linkage between the Kdo residue and the non-reducing 
glucosamine of the lipid A, thus releasing the oligo-/polysaccharide 
moiety in the water solution. This linkage is very labile due to:  
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I. the absence of a whichever electron withdrawing group at 
position adjacent to anomeric (C-3 in this case since 
anomeric is C-2) that favors the formation of the reaction 
intermediate oxonium carbocation; 
 
II. the passage from chair to half-chair conformation during the 
formation of the oxonium ion fastened by the presence of 
non substituted carbons;  
 
III. the presence of a hydroxyl group in axial configuration at 
C-5 that contributes to a steric energy release in the 
formation of the intermediate carbocation.                                 
   The insoluble lipid A moiety can then be recovered by 
centrifugation and several washes with distilled water, whereas the 
supernatant is constituted by O-antigen still linked to core region, 
but this does not complicate the structural investigation since, in 
terms of monosaccharide residues number, the contribute of the 
core fraction is negligible respect to the O-chain. A disadvantage of 
above described methodology, based on an acid treatment, is that it 
produces a Kdo reducing unit with a microheterogeneity of various 
conformations (α and β anomers of pyranose and furanose rings, 
condensed or anhydro forms) that can render the study of the 
oligosaccharide by NMR spectroscopy particularly difficult. Thus, 
typically, the procedure to determine the primary structure of the 
core oligosaccharide portion consider the de-lipidation of the lipid 
A by means of alkaline treatment in two steps: first, a mild 
hydrazinolysis in anhydrous conditions to remove ester-linked fatty 
acids; second, a strong alkaline hydrolysis is performed to obtain 
the cleavage of amide-linked acyl chains (Holst, 2000). The 
obtained fraction is represented by an homogenous phosphorylated 
oligosaccharide, comprehensive of the lipid A disaccharide 
backbone, that can be easily studied through chemical and 
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spectroscopical investigations. Obviously, base-labile substituents 
of glycidic or non-glycidic nature are lost during this procedure. 
Therefore, it is possible to use the acid approach as a complement 
to the alkaline degradation, in order to evaluate the occurrence of 
base-labile groups lost during the alkaline treatment (i.e. 
pyrophosphate groups). 
The primary structure determination of the saccharide portions so 
far obtained currently exploits state-of-art NMR experiments and 
soft-ionisation mass spectrometry techniques, together with 
compositional and linkage chemical analyses that allow the 
determination of: 
 the quali-quantitative composition of sugar residues 
 the absolute configuration of each monosaccharide 
 the cyclisation ring sizes  
 the glycosilation points of each monosaccharide 
 the anomeric configuration of the linkages 
 the monosaccharide sequence 
 the location of non-carbohydrates substituents 
Additional information on the nature and the sequence of 
monosaccharides can be obtained from ad hoc selectively 
cleavages of the polysaccharide such as partial acid hydrolysis, 
acetolysis, Smith degradation, β-elimination and solvolysis. 
2.2.1 Chemical analyses of the saccharide moities 
 Chemical analyses (Figure 2.1) are useful to obtain 
important preliminary information regarding primary structure of 
poly/oligosaccharides. The procedure that provides the usage of 
Gas-Chromatography coupled with Mass-Spectrometry (GC-MS), 
can only be realised after conversion of the monosaccharides into 
apolar and volatiles derivatives. There is a plethora of techniques 
that can be employed to identify the monosaccharide type as well 
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as the glycosilation positions, thus the appropriate choice of the 
derivatisation method can highlight specific features of the sugar 
residues within the native LPS/LOS structure. Typically, the 
qualitative analysis by GC-MS is achieved by treating the oligo-
/polysaccharide with MeOH/HCl leading to solvolysis of the 
molecule and to the formation of the O-methyl glycoside for each 
monosaccharide. Subsequent acetylation with acetic anhydride in 
pyridine produces the per-acetylated O-methyl glycosides (MGA), 
that can be injected and analysed by GC-MS. Comparison of the 
retention times from the GC analysis and the fragmentation pattern 
from the MS spectra analysis with opportune standards allow to the 
identification of the monosaccharide residues. Quantification 
analysis can then be obtained by using an internal standard, that 
usually is per-acetylated inositol. Since the MGA protocol provides 
a solvolysis in acid conditions, several isomers for each 
monosaccharide may form (i.e. pyranose and furanose either α and 
β anomers) resulting in the occurrence of many peaks in the 
corresponding chromatogram. Although not severely influencing 
the identification of the monosaccharides, this can lead to their 
misquantification. Therefore, an alternative and complementary 
approach that can be used leads to the formation of acetylated 
alditol derivatives. In this case, after strong acid hydrolysis with 
Trifluoroacetic Acid (TFA), the carbonyl moiety of the free 
residues is reduced with NaBH4, thus providing a single molecule 
for each monosaccharide. The alditols acetylated are then injected 
and analysed via gas-chromatographic techniques.  
A further procedure of chemical analysis that delivers the 
distinction between enantiomers provides that the solvolysis is 
executed with an enantiomerically pure alcohol as 2-(+)-octanol or 
2-(+)-buthanol, thus the absolute configuration of each 
monosaccharide residues can be determined (Leontein and 
Lönngren, 1978). Indeed, after acetylation and injection to GC-MS, 
the comparison of the retention time of the acetyl 2-(+)-octyl 
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glycosides with the one of a standard mixture of O-2-(±)-octyl-
glycosides of standard monoses in D or L configuration allows the 
assignment of the monosaccharide configuration.  
The determination of the ring size and of the glycosilation sites of 
the monosaccharides is a further information obtainable through 
GC-MS analysis. The procedure consists in an extensively 
methylation of the oligo/polysaccharide with CH3I in strongly 
alkaline conditions. Then, the permethylated oligo-polysaccharide 
is hydrolysed in acid conditions and reduced with a marked hydride 
(NaBD4). The alditols so obtained have free hydroxyl groups at the 
positions previously involved in glycosidic linkages and 
cyclisation, that can be acetylated. These partially methylated 
alditols acetylated can be analysed by GC-MS and the fragments 
observed in the MS spectra are diagnostic for specific substitution 
patterns of acetyl and methoxyl groups, since molecule cleavages 
preferably occur in correspondence of a methoxyl group, better 
sustaining the positive charge because of resonance effects. To 
obtain desired information it is necessary to consider that position 
of the acetyl groups in the fragments accounts for the attachment 
point or for the position of ciclysation of the pyranose or furanose 
cycle whereas the methyl groups correspond to free positions, not 
involved in linkages. The reduction of the carbonilic function with 
sodium borodeuteride discriminates the fragments originated from 
the reduced position (even masses) form those originated from the 
last position (odd masses) (Hakomori, 1964). Information obtained 
from these chemical analyses helps and confirms the interpretation 
of subsequent NMR and MS experiments. 
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                Figure 2.1 Convenient strategy for GC-MS  analysis of LPS (LOS). 
 
2.2.2 NMR Spectroscopy Analysis of the saccharide moieties 
 Nuclear Magnetic Resonance represents the most useful and 
decisive technique in the field of structural investigation of 
carbohydrates. This is due to the possibility of analysing molecules 
in solution in a native state, owing to the good solubility observed 
for oligo- and polysaccharides in aqueous solutions. During the 
structural study of saccharides, nuclei usually observed are 
1
H, 
13
C 
and 
31
P, to detect phosphate groups and unusual phosphorous 
containing substituents.  
Analysing a typical monodimensional 
1
H-NMR spectrum for an 
oligo-/polysaccharide, it is possible to distinguish three different 
regions: 
 The region between 5.5 and 4.6 ppm relative to the anomeric 
protons signals 
 The region between 4.6 and 2.6 ppm where the ring proton 
signals are located 
 The region between 2.5 and 1.0 ppm that is typical of the 
deoxy positions signals 
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Furthermore, from a 
13
C NMR spectrum it is possible to obtain 
information about: 
 104-105 ppm : anomeric carbon atoms involved in a glycosidic  
linkage  
 80-60 ppm : oxymethylene or carbinolic carbon atoms 
 60-45 ppm : carbon atoms linked to nitrogen 
 ~ 30 ppm : aliphatic methylene carbons of deoxy-sugar residues 
 20-17 ppm : methylene carbon atoms of 6-deoxy-sugar residues 
and of acetyl residues 
The region relative to the ring protons signals is considerably 
narrow, and usually the identification of all chemical shifts is not 
made possible on the basis of the sole one dimensional NMR 
analysis. Thus, a combination of homo- and hetero-nuclear 2D-
NMR experiments (such as DQF-COSY, TOCSY, NOESY, 
1
H,
13
P-
HSQC, 
1
H,
13
C-HSQC, 
1
H,
13
C-HMBC) are required in order to 
assign all the spin systems, to determine the location and the nature 
of non-carbohydrate substituents and to characterise the 
monosaccharide sequence. In detail, TOCSY and DQF-COSY 
spectra allow the correct identification and assignment of all ring 
protons, and on the basis of these data, the assignment for all 
13
C 
resonances usually follows from the analysis of the 
1
H,
13
C-HSQC 
spectrum; the intra-residue pattern of dipolar correlations in the 2D 
NOESY and ROESY spectra gives the proof for specific 
configurations; as example, NOE correlations between H-1/H-3 
and H-5 are univocally diagnostic for a β-gluco-configuration, on 
the other hand a NOE connectivity between H-1 and only H-2 is 
indicative of a α-gluco-configuration. In general, protons 
orientations on the rings can be deduced from the 
3
JH,H coupling 
constant values that follow the Karplus law and assume high values 
(8 ÷ 10 Hz) in case of trans-diaxial orientation of vicinal protons 
and considerably lower values (< 4Hz) in case of equatorial/axial 
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orientation. These values can be attained from DFQ-COSY 
spectrum. Anomeric proton and carbon chemical shifts are the first 
hint for the anomeric configuration determination for each 
monomer, since usually α-configured proton signals appear at 
lower fields respect to corresponding β-anomers, whereas the 
opposite situation occurs for carbon chemical shifts. Anomeric 
configurations are then confirmed by the 
3
JH1,H2 and by 
1
JC1,H2 
values. In detail, in monosaccharides with the H-2 axial (as 
glucose, galactose), a 
3
JH1,H2 around 8 Hz is indicative of a β-
orientation, whereas below 3 Hz of an α-configuration. Sugars with 
the H-2 equatorial (as mannose) show both 
3
JH1,H2 below 3 Hz. 
Moreover a 
1
JC1,H2 below 165 indicates a β-anomer, above 170 Hz 
a α-anomer. The downfield shift of ring proton signals (acylation 
shift) is useful to determine O- and N-acylation sites. O-
phosphorylated protons undergo a similar down-field shift. In the 
1
H,
13
C-HSQC spectrum, the down-field shift, or glycosilation shift, 
of carbon resonances (2 ÷ 10 ppm), allows to locate the positions of 
glycosidation and these may found confirmation in information 
previously obtained by means of chemical analyses. Information 
regarding the cyclisation ring is obtained by the observation in the 
1
H,
13
C-HMBC spectrum of intra-residual long range correlations, 
i.e. H-1/C-5 and C-1/H-5 for pyranosidic rings or H-1/C-4 and C-
1/H-4 for furanosidic rings. These latter are also identified by a low 
field displacement of all the ring resonances for the 
monosaccharide. Information concerning the sequence of the 
monosaccharides within the oligosaccharide (or the repeating unit 
of the polysaccharide) are then deduced from the observation of the 
inter-residual dipolar correlations in 2D NOESY and ROESY 
spectra (Figure 2.2) and from the existence of scalar long range 
correlations, in the 
1
H,
13
C-HMBC spectrum, among the 
1
H and 
13
C 
nuclei involved in glycosidic linkages. Eventually, 
1
H,
31
P-HSQC 
allows the localisation of the phoshorylation sites within the 
saccharide structure. 
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            Figure 2.2 Inter-residue NOE correlations between disaccharides 
 
2.2.3 Mass Spectrometry Analysis of the saccharide moieties 
 Mass spectrometry represents to date an essential and 
complementary technique in the structural characterisation of 
lipopolysaccharides and lipooligosaccharides especially with the 
development of soft ionisation techniques like MALDI (Matrix 
Assisted Laser Desorption Ionisation), ESI (ElectroSpray 
Ionisation), and the fragment analysis in MS/MS experiments. 
Apart from the ESI MS normally used in GC-MS analyses, mass 
spectrometric techniques allowing the definition of the molecular 
weight of the intact molecule are particularly useful, since they can 
provide additional information to the 1D and 2D NMR analyses 
that sometimes can be hard to construe. Usually, for carbohydrates, 
MALDI and ESI MS spectra are performed in negative ion mode, 
due to the presence of a great number of potentially ionising groups 
(hydroxyl or phosphate functions), nevertheless spectra in positive 
ion mode are also performed 
MALDI-TOF analysis, in particular, gives an ideal profile of the 
sample by sketching all the molecules composing it, thus giving a 
picture of the eventual presence of different glycoforms differing 
for the presence of one or more glycidic or non-glycidic residues. 
This methodology consists in a soft ionisation of the sample that is 
suspended in a specific matrix that assists the analyte in ionisation 
phenomenon. The matrix has important roles among which the 
protection of the sample from the laser energy assuring a soft 
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ionisation with formation of single charged ions. Recently it has 
been pioneered the birth of new MALDI MS approaches through 
development of new methods of preparation and experimental 
study on the intact sample yielding a “picture” of the intact 
endotoxin, without any loss of structural information that can arise 
when the MS analysis is executed on derivatives of selective 
degradation necessary in the structural elucidation protocol 
(Sturiale et al., 2005). These procedures provide good spectra of 
intact molecular ions of lipopolysaccharides comprehensive of the 
heterogeneity inferred by the lipid A presence, showing high 
sensitivity also at relatively high molecular mass. The usage of 
high energy laser source allows to cleave the labile linkage between 
the Kdo and the glucosamine backbone lipid A, in a similar way to 
the acetate buffer treatment (see paragraph 2.2.1). In case of LOS, 
in the deriving spectra there are three regions of signals originated 
by the lipid A, the core oligosaccharide and the intact LOS. In LPS, 
due to the dispersion of molecular weight of the O-polysaccharide, 
information on the size of the repeating unit can be deduced. 
 
2.3 Structural determination of the lipid A moiety 
 The lipid fraction obtained by precipitation, after mild acid 
treatment of LPS (or LOS) consists of a mixture of intrinsically 
heterogeneous lipid A molecules. The structural approach makes an 
extensive use of mass spectrometry analysis by MALDI-TOF and 
ESI MS techniques, as well as NMR spectroscopy and chemical 
analyses both on the native and selectively degraded lipid A 
fractions. The lipid A structure characterisation requires the 
determination of: 
 the saccharide backbone 
 the amide and the ester linked fatty acids 
 the distribution of the acyl chains on the sugar backbone 
 the phosphorylation sites 
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 the sites of heterogeneity relative to the acylation pattern that is 
number, type and distribution of the acyl chains or relative to the 
non-stoichiometric presence of phosphate substituents. 
The determination of the nature, the ring size, the attachment point 
and the absolute configuration of the sugar components of the lipid 
A is performed has already described (see paragraph 2.2.1). 
2.3.1 Chemical analyses of the lipid A moiety 
 Fatty acids determination is usually achieved through GC-
MS analysis of their methyl ester derivatives. Lipid A is first 
treated with HCl and then neutralised with NaOH and acyl chains 
are then extracted in CHCl3, methylated with diazomethane and 
analysed by GC-MS. O-linked  acyl chain can be extracted from 
the entire molecule through an alkaline treatment that consists with 
NaOH, followed by  methylation with diazomethane and analysis 
by GC-MS. The choice of cleavage conditions allows the selective 
detection of the linkage type of the fatty acids (Rietschel, 1976). 
 
2.3.2 Mass Spectrometry Analysis of the Lipid A moiety 
 Mass Spectrometry is the most common approach used in 
lipid A structural determination. MALDI-TOF and ESI-MS data 
allow gaining insights into the number of lipid A species present in 
the fraction, the presence of polar heads and the distribution of acyl 
residues on each GlcN units of the disaccharide backbone (Que et 
al., 2000).
 
Novel general approaches gaining structural insights on 
the native and selectively degraded lipid A fractions have been 
developed. In particular, combining MALDI-MS or ESI-MS and 
selective chemical degradations it is possible to understand the 
acylation profile of the molecule. Firstly, the amide linked fatty 
acids are identified by MS analysis of completely de-O-acylated 
lipid A with anhydrous hydrazine (Holst, 2000). An enormous 
advantage  in lipid A structural analysis is the treatment with 
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NH4OH (Silipo et al., 2002). This procedure selectively cleaves the 
ester linked acyloxyacyl groups, leaving untouched the amide-
linked acyloxyacil groups. Thus, MS analysis of the ammonium 
treated lipid A allows the detection of the secondary fatty acid 
distribution, which is one of most demanding issues in the 
structural determination of the LPS lipidic moiety (Sforza et al., 
2004; Sturiale et al., 2005).
 
These approaches must be supported by 
the classical chemical analyses of the lipid A, which imply the 
removal of ester-linked fatty acid moiety by mild alkaline 
treatment, or complete removal by strong alkaline treatment and 
GC-MS analyses of fatty acids as methyl ester derivatives (Hase 
and Rietschel, 1976).  MALDI spectra can be executed in positive 
and negative mode. The use of the former mode is expedient to 
differentiate the fatty acid allocation between the two GlcN of lipid 
A in case of asymmetric distribution; this is possible since during 
the execution of positive ion MS spectra a selective ionisation after 
fragmentation of the GlcN backbone occurs, and the only oxonium 
ion that is visible is relative to the non-reducing GlcN (Domon and 
Costello, 1988). On the other hand, both negative and positive mass 
spectra furnish indication of the presence of non-stoichiometric 
phoshorylation sites. The intact or the fully O-deacylated lipid A 
are also used to study the location of the phoshorylation sites. 
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Premise 
 Here is reported the first study on the chemical and 
biological properties of the lipooligosaccharide (LOS) endotoxin 
isolated from Burkholderia dolosa  strain IST4208, an isolate 
recovered from a cystic fibrosis (CF) patient in the major 
Portuguese CF center (Di Lorenzo et al., 2013). Burkholderia 
dolosa is a member of the Burkholderia cepacia complex (BCC) 
(see Section I, paragraph 1.5.2) and was the first BCC species to be 
identified involved in patient-to-patient transmission: the same 
isolate was found in 36 patients characterised by accelerated 
decline in lung function and, compared with patients colonised with 
B. multivorans, reduced survival (Kalish et al., 2006). Furthermore, 
five of the patients colonised by B. dolosa died from cepacia 
syndrome, a rapid decline in pulmonary function, within four 
months, differently to other BCC infections. These findings provide 
additional evidence that B. cepacia complex species differ to each 
others in their virulence and clinical implications and emphasize 
the importance of examining, at chemical level, the virulence 
factors of BCC strains (Caraher et al., 2007). Understanding how 
these divergent clinical outcomes arise by studying  differences in 
the biology between important Bcc strains like B. dolosa, B. 
cenocepacia and B. multivorans might allow new therapeutic 
strategies to emerge, to help improve transplant outcome and to 
extend the life expectancy of CF patients. Thus, it has been carried 
out a complete study of structural and immunological properties of 
B. dolosa endotoxin by means of chemical analyses, MALDI mass 
spectrometry, and NMR spectroscopy the . 
 
 
Chapter 3 
Elucidation of the Structure and the Biological Activity of LOS isolated from 
Burkholderia dolosa 
 
 
60 
 
3.1 Isolation and SDS-PAGE analysis of B. dolosa 
LOS 
 LOS was obtained from cells of Burkholderia dolosa strain 
IST 4208 through the hot phenol-water extraction protocol 
(Westphal and Jann, 1965), then purified with DNase, RNase, and 
proteinase K, followed by extensive dialysis, and gel-permeation 
chromatography. Purity was examined by SDS-PAGE. The B. 
dolosa LPS fraction revealed that the extracted lipopolysaccharide 
was a rough-type LPS ( LOS) due to the presence of a single dark 
band at the bottom of the gel diagnostic of a low molecular weight 
molecule.
 
3.2 Chemical analyses of LOS from B. dolosa 
 Monosaccharide analysis (see Section V) of the LOS from 
B. dolosa revealed the presence of 2,6-dideoxy-2-amino-D-glucose 
(D-quinovosamine, D-QuiN), 4-amino-4-deoxy-L-arabinose (L-
Ara4N), D-Glc, D-Gal, D-GlcN, L-glycero-D-manno-heptose (L,D-
Hep), 3-deoxy-D-manno-oct-2-ulopyranosonic acid (D-Kdo), and 
D-glycero-D-talo-oct-2-ulopyranosonic acid (D-Ko).                 
Methylation analysis revealed the occurrence of terminal QuiN, 
terminal Glc, terminal Gal, terminal Hep, 3-substituted Glc, 7-
substituted Hep, 2,6-disubstituted Gal, 3,4-disubstituted Hep, 3,7-
disubstituted Hep, 2,3,7-trisubstituted Hep, 4,5-disubstituted Kdo, 
and terminal Ko all in pyranose rings.Fatty acids analysis (see 
Section V) showed the presence of (R)-3-hydroxyhexadecanoic 
acid (C16:0 (3-OH)) with an amide linkage, and of (R)-3-
hydroxytetradecanoic (C14:0 (3-OH)) and tetradecanoic acid 
(C14:0) with an ester linkage (Hughes et al., 1997). 
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3.3 Structural characterisation of  LOS     
oligosaccharide moiety by NMR spectroscopy 
 In order to determine the primary structure of the 
oligosaccharide portion of B. dolosa LOS, the lipid A part was 
cleaved by mild hydrolysis with acetate buffer (see Section V), and 
the oligosaccharide fraction purified by gel permeation 
chromatography and characterised by NMR spectroscopy.  In order 
to assign all the spin systems and to establish the monosaccharide 
sequence, a plethora of homo- and heteronuclear 2D NMR 
experiments (DQF-COSY, TOCSY, ROESY, NOESY, 
1
H,
13
C 
HSQC, 
1
H,
13
C HSQC-TOCSY, and 
1
H,
13
C HMBC) was performed. 
In particular, starting from anomeric proton signals, TOCSY and 
DQF-COSY spectra allowed the correct identification and 
attribution of all ring protons and the subsequent assignment of 
each carbon atom from analysis of the 
1
H,
13
C HSQC spectrum. The 
anomeric configuration of each monosaccharide was attributed on 
the basis of the 
3
JH-1,H-2 coupling constant values obtained by DQF-
COSY, whereas the relative configuration of sugar residues was 
assigned on the basis of the 
3
JH,H ring coupling constants; finally, 
the intra-residue pattern of dipolar correlations gave further 
confirmation of the anomeric configurations. 
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Figure 3.1 1H NMR spectrum of product core oligosaccharide with zoom of 
anomeric region. 
 
In the anomeric region of the 
1
H NMR spectrum (Figure 3.1), 
eleven anomeric signals were identified (A-M, Table 3.1); 
furthermore, the signals at 1.85/ 2.05 ppm were attributed to the H-
3 methylene protons of the Kdo residue. The relative intensities and 
the shifts of anomeric signals suggested marked heterogeneity, 
typical of non-stoichiometric carbohydrate substitutions. In 
accordance with chemical analyses, spin systems B, C, D, E, G 
were all identified as Hep residues, as indicated by their 
3
JH-1,H-2 
and 
2
JH-2,H-3 coupling constants (below 3 Hz), and by the intra-
residue NOE of H-1 with H-2. Moreover, the 
13
C chemical shift 
value of C-6 of these heptose residues (all below 72 ppm) allowed 
to identify them as L,D-Hep residues. Residues A and H (Table 3.1) 
were identified as galacto-configured monosaccharides because of 
4.34.44.54.64.74.84.95.05.15.25.35.4 ppm
H1 A
H1 B
H1 C
H1 D H1 F
H1 E
H1 F’
H1 G H1 H
H1 I
H1 L
H1 M
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their low 
3
JH-3,H-4 and 
3
JH-4,H-5 values (~3 Hz and 1 Hz 
respectively). In particular, residue A was identified as α-Gal, 
based on the H-1 and C1 chemical shifts (5.35 and 97.3 ppm, 
Figure 3.1, Table 3.1), the 
3
JH-1,H-2 value, and the intra-residual 
NOE contact of H-1 with H- 2 (all in agreement with an α-
anomeric configuration and a 
4
C1 ring conformation). The 
anomeric 
1
JC-1,H-1 
3
JH-1,H-2 values (164 and 8.0 Hz, respectively) of 
residue H (H-1 at 4.56 ppm) indicated a β-anomeric configuration; 
this was further corroborated by intra-residue NOE connectivity 
between H-1 and H-3/H-5 signals in the NOESY spectrum. Spin 
systems F, F’, L, and M (Table 3.1) were identified as Glc residues 
by their characteristically large 
3
JH,H ring coupling constants (~9 
Hz). The strong intra-residue NOE contacts of H-1 L and M with 
H-3 and H-5 of both residues L and M, together with the 
3
JH-1,H-2 
coupling constants (7 Hz) were diagnostic of a β-configuration, 
whereas the intra-residue NOE contact of H-1 with H-2, and the 
3
JH-1,H-2 coupling constants (3 Hz) were indicative of a α-anomeric 
configuration for residues F and F’. Residue I was recognised as a 
β-QuiN: the gluco configuration was indicated by the 3JH,H ring 
coupling constants (~9 Hz). The intra-residue NOE contacts of H-1 
with H-3 and H-5, and the 
3
JH-1,H-2 coupling constant were 
indicative of a β-anomeric configuration. The 1H,13C HSQC 
spectrum showed the presence of a correlation of H-2 I, at 3.69 
ppm, with a nitrogen-bearing carbon signal at 54.1 ppm. The 
downfield shift of the H-2 I proton resonance was diagnostic of N-
acetylation at this position; this was confirmed by the dipolar 
correlation of H-2 I with the methyl protons of the acetyl group at 
1.96 ppm. The spin system of Kdo K was assigned starting from 
the diastereotopic H-3 methylene proton signals, resonating in a 
shielded region at 1.85 and 2.28 ppm (H-3ax and H-3eq, 
respectively). The Kdo residue was present in multiple forms, 
because of its free reducing end; nevertheless, the signals from the 
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α-reducing unit were clearly assignable, and the α-anomeric 
orientation at C-2 was assigned by the chemical shift values of H-3 
and by the values of the 
3
JH-7,H-8a and 
3
JH-7,H-8b coupling   constants 
(Birnbaum et al., 1987; Holst et al., 1994). Ko residue (J) was 
detected by the presence of the characteristic inter-residue NOE 
contact in 2D NOESY spectra between H-3eq of Kdo (K) and H-6 
of Ko (J); this is also diagnostic for a α-D-Ko-(2→4)-α-D-Kdo 
linkage (Birnbaum et al., 1987; Bock et al., 1994).
 
               
The downfield shift of the carbon resonances identified the 
glycosilated positions: O-2 and O-6 of residue A; O-2, O-3, and O-
7 of B; O-3 and O-4 of C; O-3 and O-7 of D; O-3 of F'; and O-4 of 
Kdo (K). Residues E, F, G, H, I, L, M, and J were non-reducing 
terminal sugars, in agreement with the methylation data (see 
paragraph 3.2). The oligosaccharide sequence was established on 
the basis of the intra-residue NOE contacts identified in the 
ROESY and NOESY spectra (Figure 3.2), and in the long-range 
scalar correlations in the HMBC spectrum. The linkage of the 
heptose C (H-1 at 5.19 ppm) to O-5 of Kdo K was proven by the 
NOE connectivity between H-1 of the Hep C and H-5 of K (4.16 
ppm). Given the L,D relative configuration of Hep C, the presence 
of further NOE contacts between H-1 of Hep C and H-6 and H-7 of 
K ultimately proved the D-configuration for the Kdo residue (Bock 
et al., 1994). Residue C was in turn substituted at O-3 and O-4; the 
NOE contacts (Figure 3.3) of H-4 C (3.97 ppm) and H-3 C (3.93 
ppm) with H-1 of residue L (4.46 ppm) evidenced that the O-4 of 
α-Hep C was glycosilated by residue L, the β-Glc. Moreover, 
residue C was also substituted at O-3 by residue B of α-Hep, 
according to the NOE of H-3 and H-2 C with H-1 B. Residue B 
was identified as a 2,3,7-trisubstituted α-Hep. The NOE contacts of 
H-1 M (4.30 ppm) with H-1 and H-2 B (5.20 and 4.08 ppm, 
respectively) evidenced that the O-2 of residue B was glycosilated 
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by the β-Glc residue M. Furthermore, the NOE correlation of H-3 
B (3.91 ppm) with H-1 A (5.35 ppm) proved the substitution of 
residue B at O-3 with the α-Gal residue A. Residue B was also 
glycosilated at O-7 by the terminal α-Hep G, as attested by the 
NOE contact between H-1 G (4.82 ppm) and H-7 B (3.63/3.55 
ppm). Residue A was substituted at O-2 and O-6; thus, the NOE 
correlation of H-6 A (4.00/3.57 ppm) with H-1 F (4.95 ppm) of α-
Glc gave evidence of the substitution of residue A at O-6 by the α-
Glc F. An alternative spin system was identified for residue F, 
namely residue F'; this was recognised as a 3-α-substituted Glc that 
was, in turn, non-stoichiometrically substituted at position 3 by β-
Gal H, as shown by the NOE contact of H-3 F' (3.85 ppm) with H-
1 of residue H (4.56 ppm). Residue A was, in turn, also substituted 
at position O-2 by the α-Hep residue D (4.97 ppm), as showed by 
the NOE correlation of H-2 of A (3.56 ppm) with H-1 of D. Unit D 
was, in turn, glycosilated at O-3 by residue E as attested by the 
NOE contact of H-3 D (4.03 ppm) with H-1 E (4.95 ppm). Finally, 
residue D was shown to be glycosilated, in a non-stoichiometrical 
fashion, at O-7 (3.63/3.55 ppm) by residue I, as evidenced by the 
NOE correlation between H-1 I (4.50 ppm) and H-7 (3.63/3.55 
ppm) of residue D. The HMBC spectrum confirmed the assigned 
structure, as it contained all the required long-range correlations to 
demonstrate the proximity of the residues.
 
Thus, in summary, all of the data allowed to establish the overall 
oligosaccharide structure that is reported below: 
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                          H                                          G                      L                     
                     β-Gal                                    -Hep -Glc                                         
       ↓        ↓                     ↓                                                 
                     3                  A                 B   7                     4                       K                          
-Glc-(1→6)- -Gal-(1→3)- -Hep-(1→3)- -Hep-(1 5)- -Kdo 
                F/F’                   2                      2                      C                     4                                                       
                                          ↑                      ↑                                              ↑           
              -Hep-(1→3)- -Hep            β-Glc                  2  
                 E             D      7                   M                                           -Ko          
                             ↑                                                                    J 
                                   β-QuiNAc            
                                         I                                                    
 
 
 
 
 
  
Figure 3.2 Overlapped TOCSY (blue) and NOESY (pink) spectra of product core 
oligosaccharide  
A B C
E
D F
G
F′
H I
L
M
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Chemical shift  (
1
H/
13
C) 
Unit 1 2 3 4 5 6 7 8 
A 5.35 3.56 3.73 3.99 3.64 4.00/3.57 
 
 
2,6-α-Gal 
97.3 74.4 71.3 70.3 71.2 64.6  
 
B 
5.20 4.08 3.91 3.55 3.70 3.64 3.63/3.55 
 
2,3,7-α-Hep 
99.1 77.2 79.9 68.9 70.7 71.9 70.1 
 
C 
5.19 3.95 3.93 3.97 3.81 3.91 3.92/3.49  
3,4-α-Hep 
99.1 65.7 71.6 71.6 72.1 68.7 63.0  
D 
4.97 3.88 4.03 3.70 3.53 3.95 3.63/3.55  
3,7-α-Hep 
97.4 70.7 76.5 71.5 72.2 70.4 70.1  
E 
4.95 4.00 4.11 3.64 3.53 4.07 3.63  
t-α-Hep 
102.3 69.8 69.3 71.1 71.1 67.9 62.9  
F 
4.95 3.71 3.70 3.43 3.58 3.74   
t-α-Glc 
97.4 68.5 70.6 71.5 71.2 60.3   
F’ 
4.90 3.67 3.85 3.44 3.44 3.76   
3-α-Glc 
97.6 71.1 82.5 72.9 68.0 60.3   
G 
4.82 3.88 3.76 3.64 3.53 3.91 3.62  
t-α-Hep 
100.6 69.9 70.4 71.1 71.1 68.7 62.9  
H 4.56 3.49 3.60 3.82 3.64 3.67   
t-β-Gal 103.3 71.1 72.0 68.5 75.2 60.5   
I 4.50 3.69 3.73 3.24 3.40 1.21   
t-β-QuiNAc 100.6 54.1 74.7 75.6 75.4 16.2   
L 4.46 3.22 3.58 3.56 3.35 3.64   
t-β-Glc 102.0 73.4 75.7 68.9 76.3 60.8   
         M 4.30 3.26 3.58 3.40 3.35 3.64   
t-β-Glc 101.3 72.2 75.8 71.6 76.4 60.8   
 
 
 
K - - 1.85/2.28 4.02 4.16 3.71 3.78 3.87/3.58 
4,5-α-Kdo 174.1 n.d. 33.4 71.9 69.1 71.6 69.3 62.7 
          J - - 3.70 3.93 n.d 3.56 3.99 3.86/3.59 
      t-α-Ko n.d. n.d. 70.8 71.6 n.d 71.8 71.9 62.8 
Table 3.1 1H and 13C NMR chemical shifts of the oligosaccharide derived from mild  
hydrolysis of the LOS from Burkholderia dolosa. N.d. is not determined.  
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Figure 3.3 Zoomed region of overlapped TOCSY (grey) and NOESY (black) spectra of 
product core oligosaccharide in which the relevant inter-residual NOE contacts are 
reported. 
 
3.4 Structural characterisation by MALDI mass 
spectrometry of the intact LOS and lipid A 
 Intact LOS was analysed by MALDI-MS to gain further 
information on both lipid A and the core region. This approach is 
very useful as it allows the study of integral LOS molecules 
(Sturiale et al., 2005; Sturiale et al., 2011) without any chemical 
manipulation, thus preventing the loss (either by alkaline or acid 
treatment) of labile groups (e.g., phosphate, acetyl), typically 
present on LPSs (see also Section I, paragraph 2.2.3). LOS was 
analysed by using a sample preparation procedure specifically 
optimised for these amphiphilic molecules (Sturiale et al., 2005; 
Sturiale et al., 2011). The negative-ion MALDI mass spectrum of 
intact LOS showed, in addition to the molecular ions related to the 
native LOS mixture (m/z 3400-4000), fragments between m/z 1400 
and 2300 (Figure 3.4). These originated from the β-elimination 
ppm
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cleavage of the labile glycoside bond between Kdo and the lipid A 
moiety, which yielded either oligosaccharide (OS) ions (B-type 
ions) or lipid A ions. This low-mass region (Figure 3.4) presented a 
very heterogeneous OS mixture, including the peak at m/z 2225.6 
(OS1), which matched a dodecasaccharide of five Hep residues, 
five Hex residues, one Kdo residue, and one Ko residue—the core 
oligosaccharide structure determined (above) by NMR 
spectroscopy. Minor species were also present: m/z 2063.9 (OS2), 
2033.5 (OS3), 1871.6 (OS4), and 2164.0 (OS5); these differed 
from OS1 by the lack of one terminal Hex and/or Hep and one 
Ara4N residues (Figure 3.4). Each OS peak possessed a minor but 
confirmed twin-ion peak (Δm/z 44), which matches neutral loss of a 
CO2 molecule from the reducing terminal Kdo. It is worth noting 
that the oligosaccharide ion with the terminal QuiNAc residue was 
not detected in the MALDI analysis. The same mass region (m/z 
1400-2300) also included ion peaks derived from a mixture of 
tetra-acylated lipid A, distinguishable by the absence or presence of 
one/two Ara4N residues, (Figure 3.4). Species L1 (m/z 1444.8) 
matched a tetra-acylated bis-phosphorylated disaccharide backbone 
carrying one 14:0 (3-OH) acyl chain in the ester linkage and two 
16:0 (3:OH) acyl chains in amide linkage; one of these, on GlcN II, 
was further substituted by a secondary 14:0 fatty acid. Species L2 at 
m/z 1575.6 (Δm/z 131 from L1) and L3 at m/z 1706.1 (Δm/z 131 
from L2) were tetra-acylated lipid A, and carried one and two 
Ara4N residues, respectively.  
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Figure 3.4 MALDI TOF MS analysis of the intact LOS from Burkholderia dolosa; (A) 
Negative-ion mass spectrum showing both LOS molecular ions and their ion fragments, 
attributable to the core oligosaccharides and to the reported lipid A structure(s). (B) Detail 
of the lower mass region (m/z 1250 – 2450) including lipid A and core oligosaccharide 
(OS) ion fragments and their assignments. (C) Detail of the higher mass region (m/z 3000 
– 4280)  reporting the composition of each LOS species as emerges from the 
heterogeneity of the core fraction and lipid A components, mainly due to non-
stoichiometrically linked terminal sugar moieties. 
 
The identity of either a primary ester-linked 14:0 (3-OH) or a 
secondary amide-linked 14:0 fatty acid on the GlcN II was 
established by the MS/MS analysis of the lipid A moiety after 
a
b c
1100 1800 2500 3200 3900 4600Mass (m/z)
0
10
20
30
40
50
60
70
80
90
100
%
 I
n
te
n
si
ty
1444.8
3799.6
1575.6
3607.5
3668.9
3476.5 3738.72225.6
3930.82033.5
1989.5
1706.1
OS
LOS
lipid A
2182.0
L1
L2
L3
1250 1490 1730 1970 2210 2450
Mass (m/z)
1444.8
1575.6
2225.6
2033.5
1706.1 1989.5
1871.6
2063.9
2164.0
Ara4N
Ara4N
OS4
OS1
OS1: m/z 2225.6 
OS2: m/z 2063.9  = OS1 – Hex
OS3: m/z 2033.5 = Os1 – Hept
OS4: m/z 2164.0 = Os1– Hept + AraN
OS5: m/z 1871.6 = OS1– Hept – Hex
OS2
OS3
OS5
2182.0
L2OS1
3000 3320 3640 3960 4280
Mass (m/z)
3799.6
3607.5
3668.8
3476.4
3637.9
3738.6
3930.83445.9
L1OS1
L3Os1
L2OS3 L3OS3 
L2OS4
L1OS3
L2 OS2
L2 OS5
L1
L2
L3
OH
O
NH
O
OH
OH
NH
O
OO
O
O
OH
P
OH
O
O
P
O
OH
O
O
16
O
14
O
O
OH
OH NH2
O
OH
OH
NH2 O
OH
14
16
Chapter 3 
Elucidation of the Structure and the Biological Activity of LOS isolated from 
Burkholderia dolosa 
 
 
71 
 
acetate buffer hydrolysis. This treatment left the lipid A fraction 
partially dephosphorylated. In particular, the positive-ion MS/MS 
spectrum of the pseudomolecular ion [M+Na]
+
 at m/z 1387.89 
(corresponding to the tetra-acylated monophosphorylated lipid A) 
presented a very interesting fragmentation pattern, with a 
significant fragmentation due to the rupture of the glycosidic 
linkage between the two GlcN units (Figure 3.5). It gave rise to a 
tri-acylated B-type ion at m/z 954.6 carrying one 14:0 (3-OH), one 
14:0, and one 16:0 (3-OH) residue at the non-reducing GlcN unit, 
and a very intense diacylated B-type ion (base-peak) at m/z 726.4 
that arose from further loss of the 14:0 moiety (Figure 3.5).  
 
 
Figure 3.5 MALDI MS/MS spectrum (positive ionisation) and fragmentation pattern of 
the monophosphorylated, tetra-acylated lipid A moiety obtained by acetate buffer 
hydrolysis 
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The assignment of the main LOS molecular ions (Figure 3.4) 
resulted from the combination of the lipid A moieties and the core 
oligosaccharide species. LOS composed of tetra-acylated lipid A 
and OS species were found at m/z 3668.8 (L1+ OS1), 3799.6 
(L2+OS1), 3930.8 (L3+OS1), 3637.9 (L2+OS2), 3476.4 (L1+OS3), 
3607.5 (L2+ OS3), 3738.6 (L3+OS3 and L2+ OS4) and 3445.9 
(L2+OS5). In summary, MS analysis of the intact LOS completed 
and confirmed the previous structural hypotheses and allowed the 
full assignment of the LOS structure from the cystic fibrosis 
pathogen B. dolosa (Figure 3.8). 
3.5 Assessment of the Biological Activity of B. dolosa 
LOS 
 To establish the biological activity of pure LOS from 
Burkholderia dolosa, commercially available HEK293 cells, stably 
transfected with LPS-recognising molecular complex CD14, MD-2 
and TLR4 (Invivogen) have been stimulated with different 
concentrations of B. dolosa LOS (1, 10, and 100 ng/mL). E. coli 
serotype OIII:B4 is well known to possess a fully hexa-acylated 
lipid A that acts as an agonist on TLR4/MD-2 receptors (see 
Section III), thus was used at the same concentrations as a positive 
control. Activation of NF-kB (nuclear factor kappa B) and IL-8 
release were the read-outs of this experiment. The results showed 
that the intact LOS from B. dolosa had a potent immunostimulatory 
activity as it was able to trigger activation of NF-kB at the same 
level as for E. coli LPS at all concentrations tested (Figure 3.6A); 
IL-8 release matched the E. coli behavior (Figure 3.6A).  
It has been assessed also whether, and to what extent, B. dolosa 
LOS could interfere with TLR4-mediated signaling induced by 
lipid A of E. coli. Several natural and synthetic lipid A structures 
have been reported to exhibit high potential as antagonists against 
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endotoxically active LPS (see Section III). For this purpose, HEK 
hTLR4/MD2/CD14 cells (HEK293 hTLR4) were pre-incubated 
with different amounts (1, 10, and 100 ng) of B. dolosa LOS for 1 h 
and then re-stimulated with 10 ng of E. coli LPS for 4 h. NF-kB 
activation and IL-8 production were evaluated as above. It was 
found that cell priming (pre-incubation) with B. dolosa LOS at the 
lowest concentration (1 ng/mL) was able to change both NF-kB 
activation (Figure 21B) and IL-8 production (Figure 3.6B), relative 
to E. coli LPS stimulation alone. At the higher concentrations (10 
and 100 ng/mL), no significant differences were observed in IL-8 
release and NF-kB activation by either of the two LPS forms 
following pre-incubation (Figure 3.6B). 
Then, it was tested the release of inflammatory cytokines by bone 
marrow-derived macrophages (BMDMs), collected and 
differentiated from wild-type C57BL/6 female mice. BMDMs 
expressing the entire TLR repertoire were stimulated with different 
concentrations (1, 10, or 100 ng/mL) of either B. dolosa LOS or E. 
coli OIII:B4 LPS. After 12 h of stimulation, secretion of TNF-α 
(tumor necrosis factor alpha), IL-6 and IL-10 was measured by an 
ELISA assay. It was found that 100 ng/mL B. dolosa LOS elicited 
significantly higher amounts of inflammatory cytokines (e.g., TNF-
α and IL-6) than E. coli LPS (Figure 3.6A). Even at 10 ng/mL, the 
amount of produced IL-10 with B. dolosa LOS was statistically 
significantly higher (p<0.05; Figure 3.6A).  
Finally, a competition assay in BMDMs to assess whether B. 
dolosa LOS could interfere with TLR4-mediated signaling induced 
by LPS of E. coli was executed. BMDMs were pre-incubated for 1 
hour with different amounts (1, 10, or 100 ng/mL) of B. dolosa 
LOS for 1 h and then re-stimulated with 10 ng/mL E. coli LPS for 
12 h. Cytokine secretion was measured with an ELISA assay. 
Results showed that cell priming with B. dolosa LOS did not 
antagonize the endotoxic activity of E. coli LPS at all 
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concentrations tested (Figure 3.7B). Indeed, the release of IL-6, IL-
10, and TNF-α was significantly higher (p<0.05) when BMDMs 
were pre-exposed to B. dolosa LOS, relative to E. coli LPS 
stimulation alone (Figure 3.7). The above immunology data 
confirm that the LOS from B. dolosa is a powerful pro-
inflammatory agent and a major virulence factor.  
 
Figure 3.6 NF-κB activity and IL-8 production of HEK293 hTLR4 stimulated with 
Burkholderia dolosa LOS and E. coli LPS. (A) Fold of NF-κB activation (left panel) upon 
stimulation of HEK293 hTLR4 after 4 h with either 1, 10 and 100 ng/mL of B. dolosa 
LOS or commercial hexa-acylated E. coli LPS; (right panel) IL-8 secretion after 
stimulation for 4 h as above. (B) TLR4-dependent antagonistic activity of B. dolosa LOS 
on hexa-acylated E. coli LPS. Fold of NF-κB activation (left panel) and IL-8 release (right 
panel) upon stimulation of HEK293 hTLR4 after 1 h with 1, 10 and 100 ng/mL of B. 
dolosa LOS and then exposed to 10 ng/ml of E. coli LPS (4 h). p< 0,05 after Student t-
Test  
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Figure 3.7 Cytokines release in BMDMs stimulated with B. dolosa LOS and E. coli LPS. 
(A) TNF-α, IL-6 and IL-10 released by BMDMs after stimulation with either 1, 10 and 
100 ng/mL of  Burkholderia dolosa LOS or Escherichia coli LPS measured by ELISA at 
12 h. (B) TLR4-dependent antagonistic activity of B. dolosa LOS on hexa-acylated E. coli 
LPS in BMDMs. TNF-α, IL-6 and IL-8 release upon stimulation of BMDMs for 1 h with 
1, 10 and 100 ng/mL of B. dolosa LOS and then re-exposed to 10 ng/ml of E. coli LPS 
(12 h). Cytokine secretion was measured through ELISA assay. p<0,05 after Student t-
Test  
 
3.6 Discussion 
  The complete structure and biological activity of LOS from 
a B. dolosa clinical isolate retrieved from a CF patient showed 
interesting features peculiar for this bacterium. Composition of the 
B. dolosa lipid A species displayed a relatively homogeneous tetra-
acylated lipid A bearing Ara4N residue(s) (De Soyza et al., 2008). 
The substitution of Ara4N in LPS molecules is essential for 
bacterial survival, as it prevents the interactions with antibiotic 
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compounds and host antimicrobial peptides (Hamad et al., 2012). 
These residues are positively charged under physiological 
conditions and so they reduce the net charge on the bacterial 
membrane surface. By preventing ionic attraction, these residues 
prevent membrane permeability by positively charged 
antimicrobial peptides.  
The core oligosaccharide from B. dolosa showed to have a novel 
structure. From the chemical point of view, the B. dolosa LOS also 
has no negative charge at the outer core, which contains neither 
phosphate groups nor uronic acids. This confers on the LPS an 
overall neutral characteristic that renders it resistant to cationic 
antimicrobial peptides. The Burkholderia genus has a highly 
conserved LPS inner core structure, with several characteristics 
replicated in the current study. The main feature is the presence of 
the [3,4-α-L,D- Hep-(1→5)-α-D-Kdo-(4→2)-α-D-Ko] trisaccharide 
in the inner core. Notably, within this genus, the Ko residue is 
frequently not at the terminal, but rather bears an Ara4N residue. 
The presence of Ko monosaccharide is limited to a few bacterial  
LPS molecules, such as those of Acinetobacter (Vinogradov et al., 
1997), Yersinia (Vinogradov et al., 2002) and Serratia (Vinogradov 
et al., 2006). 
Usually, as in the present case, the α-L,D-Hep of the above-
mentioned trisaccharide bears another Hep residue linked at O-3 
and glycosilated at O-4 by a β-D-Glc residue. In this B. dolosa 
strain, the latter Hep residue of inner core is glycosilated at O-2, O-
3, and O-7, as previously noted for B. multivorans (Hughes et al., 
1997); however, the heptose carries an additional heptose at O-7, as 
found in B. cenocepacia ET-12 LOS (Silipo et al., 2007), and at O-
2 there is a β-D-Glc, and at O-3 there is a α-D-Gal. This latter 
monosaccharide was, in turn, substituted at position O-2 by an α-
Hep residue and at O-6 by a α-D-Glc which can be, in turn, non-
stoichiometrically glycosilated by a β-D-Gal residue. 
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Finally, the latter Hep was glycosilated at position O-3 by another 
Hep. Interestingly, this α-Hep-(1→3)-α-Hep disaccharide is 
infrequently found as a component of the outer core of LOSs 
(Holst, 1999), and its presence might involve the existence of an 
additional different heptosyl transferase. Moreover, in the outer 
core region, we found the presence of a non-stoichiometric residue, 
the β-D-QuiNAc linked to the α-Hep-(1→3)-α-Hep disaccharide. 
In summary, B. dolosa LOS possesses a peculiar structure, the 
biosynthesis of which requires further study. From a biological 
point of view, it was observed that B. dolosa LOS acts as potent 
inflammatory agent through the TLR-4, MD- 2, CD-14 pathway, 
thereby inducing high levels of NF-kB and IL-8 release from 
HEK293 cells stably transfected for LPS complex recognition 
(HEK293 hTLR4). These data were corroborated by the results 
obtained from analysis of inflammatory cytokines released in 
BMDMs after stimulation with intact LOS from B. dolosa. The 
high levels of TNF-α, IL-10, and IL-6 secretion confirm the 
virulence and support the concerns about this cystic fibrosis 
pathogen. Lipid A contributes to the majority of the endotoxic 
activity of LPS. A number of factors influence the lipid A 
biological activity, including the number and the distribution of 
acyl chains, the phosphorylation pattern, and the presence of 
charged groups on the polar heads. The correlation between 
increasing acylation of lipid A and elevated cytokine induction has 
previously been reported in Pseudomonas (Ernst et al., 1999) and 
Burkholderia (Ernst et al., 1999). Interestingly, lipid A from B. 
dolosa did not show high levels of acylation, but the entire LOS 
still remains a potent immunostimulator with HEK293 cells.  
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Figure 3.8 Structure of the LOS from Burkholderia dolosa. The dotted lines indicate non-
stoichiometric substitution. The anomeric configuration of lipid A residues is assigned in 
analogy to all Burkholderia LPS lipid A elucidated so far. 
 
 
Taking into account these findings, it might be speculated that the 
novel and heterogeneous structure of the core oligosaccharide 
portion plays a key function in the molecular mechanism of the 
interaction with the TLR-4/MD-2 receptors, thus demonstrating a 
notable role in the pathogenicity of B. dolosa. Further studies will 
be performed to test this hypothesis. 
In conclusion, this study improves the understanding of the 
endotoxin structure-function relationship, which is of pivotal 
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importance in the comprehension of the overall process of 
pathogenesis of such important microorganisms. 
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Premise 
 Environment is a never-ending source of microorganisms, and 
new bacteria are currently associated with pulmonary exacerbations 
in cystic fibrosis (Atkinson et al., 2006). Among these newly 
identified organisms are bacteria belonging to the genus Pandoraea 
(Coenye et al., 2000). Pandoraea is a novel genus composed of 
aerobic Gram-negative rod-shaped microbes with polar flagella 
(Stryjewski et al., 2003). These microorganisms have been isolated 
from the lung tissue, blood, sputum, and urine of cystic fibrosis 
(CF) patients and other primary chronic lung diseases (Stryjewski 
et al., 2003; Daneshvar et al., 2001). Chronic lung inflammation, 
the major contributor to morbidity and mortality in CF patients, is 
exacerbated by the upregulation of the pro-inflammatory cytokines 
IL-8 and IL-6, which have been shown to lead to increased 
neutrophil recruitment and further enhancement of lung 
inflammation (Tabary et al., 2000; Yu et al., 2002). Recent in vitro 
data demonstrated that 19 Pandorea strains from five species 
examined elicited a pro-inflammatory response with a remarkable 
production of cytokines, such as IL-8 and IL-6 in lung epithelial 
cells, and that P. pulmonicola strains showed the most potent pro-
inflammatory response. This might be an important mechanism of 
virulence for this genus, which likely contributes to the 
pathogenesis of colonised CF patients (Caraher et al., 2008). 
However, the role of the genus Pandoraea in the course and 
prognosis of CF lung disease merits further study at molecular level 
due to its demonstrated invasive potential and reports of decline in 
lung function. Since the O-chain is the antigenic determinant of the 
LPS, rendering this latter highly immunogenic, the present work 
reports for the first time the structure of the O-chain from the LPS 
extracted from the Pandoraea pulmonicola strain LMG 18108, a 
clinical isolate from a US CF patient (Coenye et al., 2000), which 
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represents one of the most virulent and predominant species within 
the Pandoraea genus that has emerged recently in the Irish CF 
population (Costello et al., 2011). 
4.1 Purification and Chemical Analyses of the LPS 
 Large-scale isolation of the LPS for structural analysis was 
achieved by the hot phenol/water extraction method (Westphal and 
Jann, 1965)
 
and checked by SDS-PAGE (see Section V) 
(Kittelberger and Hilbink, 1993). The sample showed a 
polydisperse banding fashion, giving rise to the ladder-like pattern 
typical of S-LPS due to the occurrence of molecules with a 
different number of repeating units in the O-chain. Compositional 
analyses of the P. pulmonicola LPS revealed the presence of L-
Rha, 3,6-dideoxy-3-amino-D-glucose (D-quinovosamine, D-
Qui3N), D -GlcN, D -GalN, and a minor amount of 4-amino-4-
deoxy-L-arabinose (L-Ara4N), D-Man, D-Glc, D-Gal, L-glycero-D-
manno-heptose (L,D -Hep), and 3-deoxy-D-manno-oct-2-
ulopyranosonic acid (Kdo). To determine the structure of the O-
chain portion, a mild hydrolysis with acetate buffer was performed 
to cleave the labile ketosidic linkage between the GlcN of lipid A 
and Kdo. The water-soluble polysaccharide was purified by gel-
permeation chromatography and characterised by NMR 
spectroscopy. 
4.2 NMR analysis of the LPS O-chain from P. 
pulmonicola 
Spin systems and saccharide sequence of the O-chain were 
assigned through a combination of homo- and heteronuclear NMR 
experiments .  
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Figure 4.1 1H NMR spectrum of the O-chain portion. In the inset the expanded anomeric 
region is shown. 
 
In the anomeric region of the 
1
H NMR spectrum (Figure 4.1), three 
anomeric signals were identified related to three different spin 
systems referred to as A, B, and C (Table 4.1). Residues A and B 
possess an α-configuration, whereas C was identified as a β-
configured monose. In the aliphatic region of the 
1
H NMR 
spectrum, three singlets at δ = 1.34, 1.21, and 1.11 ppm were 
attributed to methyl groups, whereas the two doublets resonating at 
δ = 2.60 and 2.25 ppm are diagnostic of a diastereotopic methylene 
group. These latter signals suggested the presence of an unusual 
non-glycidic substituent linked to a monosaccharide of the O-chain. 
Furthermore, the large value of the geminal coupling of the 
methylene group (Table 4.1, 
2
JH,H = 17.7 Hz) is indicative of a five-
membered cyclic structure (Zatonsky et al., 2002; Molinaro et al., 
2003). 
Spin system A (H-1, δ = 5.61 ppm; Figure 4.1, Table 4.1) was 
identified as gluco-configured by its characteristic large 
3
JH,H ring 
coupling constants (~9 Hz). The H-1 and C-1 chemical shifts, the 
H1 A H1 B
H1 C
H1 A
H1 B
H1 C
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3
JH-1,2-H value, and the intra-residual NOE contact of H-1with H-2 
are all in agreement with an α-anomeric configuration. 
Furthermore, H-2 of A is correlated with a nitrogen-bearing carbon 
atom in the HSQC spectrum (δ = 53.0 ppm), and the downfield 
shift of the proton resonance of H-2 of A at δ = 3.78 ppm is 
diagnostic of N-acetylation at this position, which was also 
confirmed by the dipolar correlation with the methyl protons of the 
acetyl group resonating at δ = 1.78 ppm in the NOESY spectrum. 
These data allowed us to identify residue A as an α-2-acetamido-2-
deoxyglucose (α-D-GlcpNAc).  
Residue B (H-1 at δ = 5.27 ppm) was recognised as a galacto-
configured monosaccharide owing to its small 
3
JH-3,H-4 and 3JH-4,H-5 
values (~3 and 1 Hz, respectively). In fact, the H-5 resonance of B 
was definitely identified by a NOE effect with H-4 of B. The 
correlation between H-2 (δ = 4.06 ppm) and a nitrogen-bearing 
carbon atom (δ = 51.1 ppm) and the NOE contact of the same 
resonance with the methyl protons of the acetyl group resonating at 
δ = 1.87 ppm allowed its identification as an α-2-acetamido-2-
deoxygalactose (α-D-GalpNAc). 
The spin system C (H-1 at δ = 4 ppm) was identified as a β-3,6 
dideoxy-3-amino-D-glucose (β-D-Quip3N). The gluco 
configuration was inferred from the ring 
3
JH,H coupling constants 
(~10 Hz), whereas the intra-residual NOE contact of H-1 with H-3 
and H-5 and the 
3
JH-1,H-2 coupling constants are diagnostic of a β-
anomeric configuration. Moreover, the signal from H-3 of C is 
correlated with a signal of a nitrogen-bearing carbon atom (δ = 57.4 
ppm). 
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     Table 4.1 1H and 13C NMR chemical shifts of sugar residues of the O-chain moiety. 
 
The sequence and linkage positions of the monosaccharides 
within the repeating unit of the O-polysaccharide were established 
by observation of the inter-residual dipolar correlations in the 2D 
NOESY spectra (Figure 4.2) and from the scalar long-range 
correlations present in the 
1
H,
13
C HMBC spectrum. Furthermore, 
the downfield shifts of the carbon resonances are diagnostic of the 
positions of glycosilation: O-3 of A, O-4 of B, and O-2 of C (Table 
4.1). The strong NOE contact between H-1 of C and H-4 of B (δ = 
4.20 ppm) and the weak NOE contacts between H-3 of B and H-5 
of B (Figure 4.2) are an indication of the (1→4) linkage between 
the residues C and B. Moreover, the strong NOE correlation 
between H-1 of B and H-3 of A (δ = 5.27 and 3.42 ppm, 
respectively) suggests the substitution at O-3 of residue A by the α-
D-GalpNAc unit of B. The linkage of residue A to O-2 of β-
Quip3N of C was proven by the NOE connectivity between H-1 of 
A and H-2 of C (δ = 3.46 ppm). The sequence of the carbohydrate 
repeating unit was confirmed by the long-range correlations present 
in the HMBC spectrum, because it contained all of the required 
contacts to demonstrate the proximity of the residues.      
 
Chemical shift (1H/13C)
Unit 1 2 3 4 5 6
A 5.76 3.93 3.57 3.74 3.80 3.76/3.92
3-α-GlcNAc 95.6 53.0 79.2 72.0 71.8 62.6
B 5.42 4.21 3.90 4.35 4.14 3.92
4-α-GalNAc 99.8 51.1 68.2 79.4 72.6 62.6
C 4.71 3.61 4.04 3.25 3.43 1.26
2-β-QuiN 105.7 72.7 57.4 74.4 74.6 18.1
Chemical shifts for the 3-hydroxy-2,3-dimethyl-5-oxoprolyl group: C1 to C5 at 176.1, 72.8, 79.7, 46.2 (δH 2.40, 2.75) and  180.0 
ppm respectively. Two methyl  groups at δC/δH 19.5/1.49 (CH3-2) and  23.5/1.36 (CH3-3). Two acetyl groups at δC/δH 23.8/2.02 
and 23.4/1.93.
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              Figure 4.2 Section of the NOESY spectrum of the O-chain. In red inter-residual 
NOE connectivities are shown, while intra-residual are indicated in black.  
 
In the HMBC spectrum, the methylene signals show a long-range 
correlation with the signals of three unsubstituted carbon atoms: a 
quaternary carbon atom (C-2, δ = 72.8 ppm), a carbonyl group (C-
5, 180.0 ppm), and another oxygen-bearing carbon (C-3, δ = 79.7 
ppm). Both the signals of C-2 and C-3 correlate with two of the 
methyl signals (δ = 1.34 and 1.21 ppm, respectively) present in the 
1
H NMR spectrum. The methyl groups are located at 
tetrasubstituted carbon atoms C-2 and C-3 (Figure 4.3). In 
agreement, the NOESY spectrum shows a cross-peak of only the 
CH3 (C-3) signal and the methylene protons of C-4, whereas in the 
HMBC spectrum only CH3 of C-2 shows a long-range scalar 
correlation with another carbonyl signal (δ = 176.1 ppm, Figure 
4.3), which is, in turn, correlated with the H-3 of residue C. 
Furthermore, the NOESY spectrum displays a cross-peak between 
the two methyl groups CH3, which indicates they are in a syn-
(pseudo) axial orientation. 
A1-B2
B1-A3
C1-B4
B1-A4
A1-C2
A1-A2
A1-A4
B1-B2
B1-B5
B1-B3
C1-C3 C1-C5
A1-B1
B1-A1
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Figure 4.3 Section of the HMBC (red) and HSQC (blue) spectrum of the O-chain. The 
relevant long-range connectivities which allowed the identification of the aglycon are 
indicated.  
 
 
Taking together all the above data and all the literature data 
(Zatonsky et al., 2002; Molinaro et al., 2003)
 
a non-sugar five-
membered ring with an exocyclic carbonyl group, named 3-
hydroxy-2,3-dimethyl-5-oxoprolyl, was identified as the unusual 
acyl group at N-3 of Qui3N. The absolute configuration of this acyl 
group was not determined. This conclusion was confirmed by GC–
MS analysis of the methylation data; the mass spectrum shows an 
ion peak for a carbohydrate derivative with a rather high 
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retention time, and the fragmentation pattern (Figure 4.4) reveals a 
partially methylated derivative of Qui3N with retention of the N-
acyl group. 
 
 
 
     
 
 
 
 
Figure 4.4 The permethylated and acetylated derivative of Qui3N bearing the 3-hydroxy-
2,3-dimethyl-5-oxoprolyl group as found in GC-MS.  
 
Thus, all the data are in agreement with the structure formulated as 
 [→2-β-D-Quip3NAcyl-(1→4)-α-D-GalpNAc-(1→3)-α-D-
GlcpNAc-1→]n  
and shown in Figure 4.6.  
This structure was further confirmed by MS. Actually, MALDI-
TOF MS analysis of the intact LPS chains from P. pulmonicola 
(Figure 4.5) allowed the identification of a main series of peaks 
differing by 724 Da, the incremental mass of the trisaccharide 
repeating unit, further substantiating the above findings. 
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Figure 4.5 MALDI mass spectrum of the native P. pulmonicola LPS (high mass-region). 
Main peak differences are due to the O-chain repeating unit accounting for 724.3 Da. 
Minor molecular mass distributions arise from the structural heterogeneity of lipid A and 
core oligosaccharide domains. 
 
 
 
 
 
 
                 Figure 4.6 The O-chain moiety of LPS from Pandoraea pulmonicola 
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4.3 Discussion 
   This is the first work on the structure of the O-polysaccharide 
chain derived from the lipopolysaccharide isolated from P. 
pulmonicola strain LMG 18108, the most virulent and predominant 
Pandoraea species among Irish CF patients. Case reports have 
demonstrated that many CF patients experience a decline in lung 
infection after chronic P. pulmonicola colonisation. This may be 
due to the ability of the P. pulmonicola LPS to increase IL-6 and 
IL-8 production in lung epithelial cells (Caraher et al., 2008). 
Because the LPS is one of the most important bacterial virulence 
factors and it is known to activate host inflammation by multiple 
mechanisms, it is crucial to elucidate the primary structure of this 
macromolecule as well as its antigenic determinant portion, the O-
antigen, to understand its biological activity and its role in bacterial 
pathogenicity. Different strains among the same species and genus 
can produce highly different O-polysaccharides, specifically 
recognized by the host’s acquired immune system that produces 
specific antibodies.  The structure of the O-chain from P. 
pulmonicola strain LMG 18108 has been elucidated by chemical 
analyses and 2D NMR spectroscopy. The data revealed that P. 
pulmonicola produces a smooth-type LPS characterised by a 
trisaccharide O-chain repeating unit: [→2-β-D-Quip3N-(1→4)-α-
D-GalpNAc-(1→3)-α-D-GlcpNAc-1→]n. A five-membered ring 
aglycon residue has been found covalently attached through its 
exocyclic carbonyl group to the amine group of Qui3N. This cyclic 
structure has been identified as a 3-hydroxy-2,3-dimethyl-5-
oxoproline. Taking into account the fact that the antigenic portion 
of the LPS characterises the external cellular surface of Gram-
negative bacteria, conferring on it the uniqueness indispensable for 
antibody recognition, it might be speculated that the non-sugar 
substituent found in the O-chain moiety might play a role in the 
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molecular mechanism of pathogenicity of P. pulmonicola. 
Moreover, being one of the major targets of the host’s adaptive 
immune response, the determination of the O-antigen sequence is 
an important prerequisite for vaccination studies incorporating 
either conjugates of synthetic carbohydrate antigen or protein 
conjugates of synthetic oligosaccharides or peptides that mimic 
complex bacterial polysaccharide antigens (Fernandez Santana et 
al., 2006). 
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Premise 
 
 Pseudomonas aeruginosa, the major pathogen involved in 
lethal infections in cystic fibrosis (CF) population, is able to cause 
permanent chronic infections that can persist over the years (see 
also Section I, paragraph 1.5.2). This ability to chronic colonise CF 
airways is related to a series of adaptive bacterial changes 
involving also the immunostimulant lipopolysaccharide (LPS) 
molecule. The structure of LPSs isolated from several P. 
aeruginosa strains showed conserved features that can undergo 
chemical changes during the establishment of the chronic infection. 
Commonly it is observed loss of the O-chain polysaccharide, that 
results in a non-typable strain sensitive to the serum complement 
(Smith et al., 2006), differences in lipid A structure such as the 
addition of amino-arabinose and palmitate, that causes an increase 
of the bacterial resistance to the host innate immune response or to 
the most common used antibiotics (mainly to β-lactam antibiotics), 
as well as an increment of the pro-inflammatory response (Ernst et 
al., 1999; Bragonzi et al., 2009). Although genetic evidences in the 
O-chain polysaccharide biosynthetic locus have been described, 
very little is known about the mechanisms involved in the other 
chemical changes that occur in the LPS of CF chronic strains.  
Infection seriousness, high versatility and antibiotic resistance and 
its ability to acquire further resistance, are hallmark of chronic lung 
infections caused by P. aeruginosa in CF population. Given these 
premises, understanding the molecular mechanism of infection that 
eventually leads to pulmonary failure is an essential step in order to 
pursue an effective treatment.  
In the present work, it is reported the elucidation of the structure 
and the biological activity of the R-LPS (LOS) isolated from the 
persistent CF isolate P. aeruginosa strain RP73, in order to give 
further insights in the adaptation mechanism of the pathogen in the 
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CF environment. The complete structural analysis of P. aeruginosa 
RP73 LOS was achieved by chemical analyses, NMR spectroscopy 
and MALDI MS spectrometry, while the assessment of the 
biological activity was attained testing the in vivo pro-inflammatory 
capacity of the isolated LOS molecule, using LPS from PAO1, the 
most widely used P. aeruginosa laboratory strain, as benchmark. 
 
5.1 Isolation and Compositional Analysis of LOS from 
Pseudomonas aeruginosa RP73 
 LOS was extracted from dry cells by the 
phenol/chloroform/light petroleum procedure and analysed by SDS 
PAGE by using E. coli O55 LPS as benchmark (Galanos et al., 
1969; Kittelberger and Hilbink, 1993). The silver staining revealed 
a migration pattern to the bottom of the gel typical of a low-
molecular weight lipopolysaccharide. The isolated LOS was further 
purified by enzymatic hydrolysis with DNAse, RNAse and 
protease, followed by dialysis. Compositional analyses, carried out 
by GC/MS indicated the presence of L-Rha, D-Glc, D-GlcN, D-
GalN, L-glycero-D-manno-heptose (L,D-Hep), 3-deoxy-manno-oct-
2-ulopyranosonic acid (Kdo) and, in low amount, 2,6-dideoxy-2-
amino-D-glucose (D-quinovosamine, D-QuiN), according to 
previously published data about P. aeruginosa core oligosaccharide 
(Rowe and Meadow, 1983; Sadovskaya et al., 1998)). Methylation 
analysis revealed the occurrence of terminal-L-Rha, terminal-D-
Glc, 3-substituted-L,D-Hep, 6-substituted-D-GlcN, 3,6-
disubstituted-D-Glc, 3,4-disubstituted-D-GalN, terminal-Kdo, 4,5-
disubstituted-Kdo and, in trace, terminal-D-QuiN and 3-substituted-
L-Rha. Fatty acids composition, obtained by GC/MS analysis of 
their methyl ester derivatives, showed the presence of 3-
hydroxydodecanoic acid [C12:0(3OH)], 3-hydroxydecanoic 
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[C10:0(3-OH)] and dodecanoic acid (C12:0) in agreement with 
lipid As isolated from other Pseudomonas. 
5.2 Structural Characterisation of OS Product by 
NMR spectroscopy 
 LOS from P. aeruginosa RP73 was completely de-acylated 
by mild hydrazinolysis and strong alkaline hydrolysis with hot 
KOH (see Section V). After desalting on a Sephadex G-10 column 
and lyophilisation, the core oligosaccharide comprehensive of the 
lipid A glucosamine-backbone was obtained. To elucidate the full 
structure of core oligosaccharide (OS) of P.aeruginosa RP73 LOS, 
a complete 1D and 2D NMR analysis (DQF-COSY, TOCSY, 
NOESY, ROESY, 
13
C,
1
H -HSQC, 
13
C,
1
H HMBC and 
31
P,
1
H 
HSQC) was performed.                                                               
The 
1
H NMR spectrum of OS (Figure 5.1), together with the 
1
H,
13
C 
HSQC spectrum, showed the occurrence of 11 anomeric signals 
(A-L, Table 5.1, Figure 5.1), while signals resonating at 1.88/2.11 
ppm  and 1.96/1.67 were identified as the H-3 methylene proton 
signals of Kdo residues K and J (Table 5.1, Figure 5.1). Anomeric 
configurations were assigned on the basis of the 
3
JH1,H2 coupling 
constants and the intra-residual NOE contacts; the relative 
configuration of each residue was assigned based on vicinal 
3
JH,H 
coupling constants. The α-configuration of both Kdo residues was 
attributed on the basis of the chemical shift values of H-3 and of 
the 
3
JH7,H8a and 
3
JH7,H8b coupling constants (Birnbaum et al., 1987; 
Holst et al., 1994).
 
 
Chapter 5 
Structural and Biological Study of the LOS isolated from the chronic strain 
Pseudomonas aeruginosa RP73 
 
 
100 
 
 
 
Figure 5.1 1H NMR spectrum of core oligosaccharide (OS) with zoom of anomeric region 
(top-right). 
 
All sugar residues were present as pyranose rings, according to 
either 
13
C chemical shift values and the presence of long range 
correlations between C-1/H-1 and H-5/C-5 in the 
1
H, 
13
C HMBC 
spectrum (for Kdo residues between C-2 and H-6) (Silipo et al., 
2004). The 
31
P NMR spectrum gave evidence for the presence of 
six different monophosphate ester groups in the range of chemical 
shift between 1.30 and 5.10 ppm. The disaccharide backbone of the 
lipid A moiety was represented by residues A (δ = 5.53 ppm, Table 
5.1) and I (δ = 4.75 ppm, Table 5.1) that are the α-GlcN1P and β-
GlcN4P, respectively; the gluco configuration was indicated by 
high 
3
JH,H ring proton values (8–10 Hz). In details, the H-2 of both 
residues A and I correlated with two nitrogen-bearing carbon atoms 
at δ = 54.4 and δ = 55.4 ppm. Moreover, the H-1 of residue A 
showed to possess the typical multiplicity of a phosphorylated α-
1.52.02.53.03.54.04.55.05.5 ppm
4.64.85.05.25.45.6 ppm
A B C
D
E E’
F
G
H
I
L
J3ax
J3eq
K3ax
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anomeric proton signal (
3
JH-1,H-2= 3.2 Hz, 
3
JH-1,P= 8.1 Hz), as 
reported in the 
31
P,
1
H HSQC (Figure 5.4). Phosphorylation of 
residue I at position O-4 was assigned by the observation of the H-
4 and C-4 downfield shifts (3,61 ppm and 73.8 ppm respectively, 
Table 5.1) and by the presence of correlation in the 
1
H,
31
P HSQC 
spectrum with a signal at 3.97 ppm (Figure 5.4);  the chemical shift 
values of H-1/C-1 I, the 
3
JH1,H2 coupling constant (8.7 Hz) and the 
intra-residual NOE correlation of H-1 with H-3 and H-5 were 
indicative of its β-anomeric configuration. A minor spin system 
was also identifiable for GlcNII residue in which phosphate at 
position O-4 was missing, based on the chemical shift of H-4 and 
C-4; this allowed to establish that phosphate at position 4 of GlcNII 
is not stoichiometrically present. The spin systems C and D were 
identified as α-manno configured residues due to the low coupling 
constant values 
3
JH1,H2 and 
3
JH2,H3 (below 3 Hz), diagnostic of H-2 
equatorial orientation, moreover in the TOCSY spectrum it was 
possible to assign from H-2 all the other resonances of the ring 
protons allowing to identify it as a heptose monosaccharide. The 
chemical shift value of C-6 of residues C and D shown in the 
HSQC spectrum (below 70 ppm) led to the final identification as L-
glycero-D-manno-heptoses (Hep
I
 and Hep
II
, respectively), in 
accordance with the compositional analysis. Finally, the 
observation of chemical shift values at δ = 4.40, δ = 4.22 for H-2 C 
and H-4 C, as well as the presence of cross peaks in the 
1
H,
31
P 
HSQC spectrum with signals at 1.48 and 4.21 ppm respectively 
were indicative of O-phosphorylation at these positions (Figure 
5.4). Likewise, for residue D chemical shifts at δ = 4.08 ppm, δ = 
4.31 ppm for H-4 D and H-6 D and the presence of cross peaks in 
the 
1
H,
31
P HSQC spectrum with signals at 5.04 and 4.26 ppm 
(Figure 5.4) were diagnostic of phosphorylated positions. Residue 
B (δ= 5.49 ppm, Table 5.1), identified as a galacto-configured 
monosaccharide owing to the small JH,H values for H-3/H-4 and H-
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4/H-5 (3 and 1Hz, respectively), possessed a signal for C-2 at 50.4 
ppm indicating that C-2 was a nitrogen-bearing carbon atom; these 
characteristics allowed the identification of spin system B as a α-
GalN. The spin systems F, G and L were attributed to glucose 
residues due to the large ring 
3
JH,H coupling constants; in details, 
both residues F and G were identified as α-anomeric configured 
glucoses whereas L was identified as a β-anomeric configured 
glucose. Residues E and E' were recognised as two α-rhamnose 
residues being characterised by low 
3
JH-1,H-2 and 
3
JH-2,H-3 values, 
indicative, as previously mentioned, of α-manno-configuration, and 
in addition, by the occurrence in the TOCSY spectrum of 
correlations to methyl signals in the shielded region at 1.14-1.15 
ppm, respectively. Finally, a further spin system (H-1 H at 4.84 
ppm, Table 5.1), present in non-stoichiometric ratio, was identified 
as β-QuiN owing to the 3JH,H ring coupling constants (~9 Hz), the 
intra-residual NOE contact of H-1 with H-3 and H-5, and the 
3
JH1,H2 coupling constant. Moreover, the 
1
H-
13
C HSQC spectrum 
showed the presence of a correlation of H-2 H, at 2.99 ppm, with a 
nitrogen-bearing carbon signal at 56.6 ppm.                                            
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             Table 5.1 Chemical shift  (1H/13C) of the de-acylated LOS. 
 
Low-field shifted carbon signals were useful to identify substitution 
at O-3 of residues C, D and E, O-6 of A and I, whereas residues B 
and L were di-substituted at O-3 and O-4 for the first 
monosaccharide and at O-3 and O-6 for the second residue. Sugar 
residues E', F, G and H were recognised as terminal residues; 
finally, residue K was identified to be Kdo substituted at positions 
O-4 and O-5 whereas residue J resulted to be a terminal Kdo. 
Abovementioned results were in full accordance with the 
methylation analysis.     
 
Unit  1  2  3  4  5  6  7 8 
A  
6-α-GlcN1P  
5.53 
90.5  
3.30 
54.4  
3.78 
69.4  
3.49 
69.6  
4.04 
72.4  
4.18/3.65 
69.3  
  
B  
3,4-α-GalN 
5.49 
96.5  
3.71 
50.4  
4.34 
76.5  
4.38 
75.4 
4.34 
71.8 
3.66 
61.7  
  
C 
3-α-Hep2,4P 
5.24 
97.3  
4.40 
74.3  
4.05 
73.7  
4.22 
72.3  
4.29 
74.2  
3.95 
71.2  
3.78/3.52 
63.5  
 
D  
3-α-Hep4,6P 
5.08 
101.9  
4.30 
69.3  
4.13 
76.5  
4.08 
72.5 
4.02 
68.8  
4.31 
70.0  
3.78/3.52 
63.5  
 
E  
3-α-Rha 
5.03 
100.5 
3.37 
73.0  
3.89 
80.1  
3.63 
72.4 
4.02 
71.0  
1.14 
16.4  
  
E’  
t-α-Rha 
5.03 
102.2 
4.18 
69.9  
3.67 
70.1  
3.33 
71.8 
3.89 
71.8  
1.15 
16.4  
  
F  
t-α-Glc 
4.91 
99.1 
3.38 
71.7  
3.72 
72.3  
3.64 
N.D. 
3.95 
71.2  
3.78 
59.8  
  
G  
t-α-Glc 
4.89 
97.9 
3.45 
73.0  
3.72 
73.5  
3.36 
69.6 
3.67 
72.1  
3.61 
60.7  
  
H 
t-β-QuiN 
4.84 
100.9 
2.99 
56.6  
3.53 
74.2  
3.18 
73.2 
3.38 
75.2  
1.30 
16.9  
  
I 
6-β-GlcN4P 
4.75 
99.3 
2.93 
55.4 
3.72 
72.3  
3.61 
73.8 
N.D. 
N.D.  
3.34 
62.5 
  
L 
3,6-β-Glc 
4.55 
104.3  
3.33 
73.5  
3.54 
82.0  
3.57 
68.2  
3.57 
74.3  
3.77/3.71 
66.3  
  
K 
4,5-α-Kdo 
- 
174.4  
- 
101.7  
1.88/2.11 
34.3  
4.00 
71.0  
4.16 
68.2  
3.72 
69.5  
N.D. 
N.D.  
3.67 
63.0  
J 
t-α-Kdo 
- 
174.4  
- 
101.7  
1.96/1.67 
34.9  
4.05 
65.6  
3.96 
66.6  
3.66 
70.1  
N.D. 
N.D.  
3.58 
62.7  
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                Figure 5.2 NOESY spectrum of the oligosaccharide product. 
 
 
Figure 5.3 Section of the NOESY (black) and TOCSY (grey) spectra of oligosaccharide 
from P. aeruginosa RP73. The most relevant inter-residue NOE cross-peaks are indicated. 
              
ppm
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Figure 5.4 Section of the 1H NMR and 1H, 31P HSQC spectra of fully de-acylated LOS 
from Pseudomonas aeruginosa RP73. The localization of the phosphate groups is 
indicated. 
                                                    
The sequence of the monosaccharide residues was inferred by 
using NOE correlations of the ROESY and NOESY spectra 
(Figures 5.2 and 5.3) and by long-range scalar correlations of 
1
H,
13
C-HMBC. The typical lipid A backbone, composed by 
residues A and I, was validated by the inter-residual NOE contact 
of H-1 I with H-6 A and by the corresponding long-range 
correlation. NOE cross peaks between H-5 K/H-6 I, H-3eq K/H-6 J, 
and H-1 C/H-5 K (Figure 5.3) confirmed the typical Pseudomonas 
inner core backbone composed of [α-L,D-Hep(1→5)-[α-Kdo-
(2→4)]-α-Kdo (Bystrova et al., 2002; Bock et al., 1994). 
Moreover, heptose C was in turn substituted in position O-3 by 
heptose residue D owing to the NOE contact between H-1 D/H-3 C 
(Figure 5.3) and to the relative long range correlation. This latter 
heptose monosaccharide was, in turn, substituted by GalN residue 
(B). The two glucose residues F and L, were linked to residue B to 
O-4 and O-3, respectively, as shown by NOE correlations H-1 F/H-
CP2/H2 CP2/H3
ppm
3.23.43.63.84.04.24.44.64.85.05.25.45.6 ppm
6.0
5.5
5.0
4.5
4.0
3.5
3.0
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4 B (Figure 5.3) and H-1L/H-3 B. Residue L was in turn 
substituted at O-6 and O-3 positions by residues G and E/E', 
respectively. Finally residue H was found to be linked, in a non 
stoichiometrical fashion, to the residue E at position O-3 (δ = 3.89 
ppm, Table 5.1) as shown by the NOE correlation H-1 H/H-3 E 
(Figure 5.3). The full oligosaccharide skeleton from P. aeruginosa 
RP73 LOS is depicted below: 
 
                             
 
 
Eventually, by chemical analyses and MALDI MS on the intact 
LOS (not shown) it was possible to ascertain the presence of a 
further L-alanine residue which must be occurring on GalN residue 
and the absence of the typical carbamoyl group sitting at position 
O-7 of Hep
II
 (Sadovskaya et al., 1998; Sánchez Carballo et al., 
1999). 
Overall, the above data revealed that core OS from P. aeruginosa 
RP73 LPS is a heterogeneous structure very similar to those 
previously proposed ones (Knirel et al., 2001; Kooistra et al., 
2003), including another cystic fibrosis clinical isolate (Knirel et 
al., 2001) and some other strains containing O-antigen (Dean et al., 
2002; Bystrova et al., 2002). So, resuming the NMR data there was 
no substantial difference between this LPS and other CF LPSs; 
what substantially differed was the lipid A part of the LOS (see 
below). 
P P
│                 │                                           
G L                     B                   D 6                 C 4                    K
α-Glc-(1→6)-β-Glc-(1→3)-α-GalN-(1→3)- -Hep-(1→3)-α-Hep-(1 5)-α-Kdo-(2→6)-β-GlcN-(1→6)-α-GlcN
3                      4                    4                      2                    4   1                                              
↑                      ↑                       │                   │                 ↑                                                 ↑
E/E’ 1                      1                        P                     P 2                                                 P
α-Rha α-Glc α-Kdo
3                      F J
↑
1
β-QuiN
H
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5.3 Structural Characterisation by MALDI Mass 
Spectrometry of the Lipid A moiety 
 
 The lipid A carbohydrate backbone was already established 
by NMR spectroscopy as above described. In order to analyse the 
fatty acid number, location and distribution on lipid A moiety 
MALDI mass spectrometry was used directly on lipid A itself 
obtained by a mild hydrolysis with acetate buffer; this is typically 
performed to cleave the labile glycosidic linkage between Kdo 
residue and the GlcNII of lipid A. The negative-ion MALDI mass 
spectrum of native lipid A from P. aeruginosa RP73 is reported in 
Figure 5.5 where it was immediately apparent the very profound 
chemical difference of this lipid A blend compared with canonical 
CF P. aeruginosa lipid A. It was in fact a pattern of molecular ion 
peaks, in the mass range 800-2000 amu, representative of a 
complex mixture essentially consisting of bis- and mono-
phosphorylated penta-acylated, tetra-acylated and tri-acylated 
species; where in mono-phosphorylated species phosphate is 
lacking from GlcNII (see above).  
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Figure 5.5 Negative ion MALDI-TOF spectrum of the lipid A from Pseudomonas 
aeruginosa RP73. Assignment of the ion peaks is shown in the top-right panel.  The main 
lipid A specie structure is reported in the top-left panel. 
 
 
The hexa-acylated lipid A was present in a very minor amount, no 
traces of hepta-acylated species were found. The location of either 
the primary ester-linked C10:0 (3-OH) or the secondary amide-
linked C12:0 (3-OH) fatty acid on the GlcNII was established by 
ammonium hydroxide hydrolysis protocol and/or the MS/MS 
analysis of the lipid A moiety (Silipo et al., 2002; Sturiale et al., 
2011). In details, the intense peak at m/z 1417.84 (Figure 5.5) was 
attributable to a bis-phosphorylated disaccharide backbone 
characterised by a C10:0 (3-OH) and a C12:0 (3-OH) in ester 
linkage and in amide linkage respectively on GlcNII, and by a 
further C10:0 (3-OH) in ester linkage and a C12:0 (3-OH) in amide 
linkage on GlcNI; this latter C12:0 (3-OH), in turn, was substituted 
by a C12:0 residue. These assignments were supported by the 
MS/MS spectrum (not shown): the Y ion at m/z 626.4 confirms that 
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GlcNI is di-acylated, peak at m/z 1229.5 originates from the C10:0 
(3OH) loss, while peak at m/z 1217.5 corresponds to the C12:0 
loss. Absence of a peak corresponding to a C12:0 (3OH) loss (216 
amu) confirms that these fatty acids are linked in amide linkages. 
Specie at m/z 1337.86 (Figure 5.5) was consistent with the same 
above mentioned penta-acylated lipid A lacking the phosphate 
group on the GlcNII. Peaks at m/z 1353.86 and 1433.83 (+16 amu) 
corresponded to structures bearing a C12:0 (3-OH) instead of the 
C12:0 residue. At lower mass range was also present an ion peak at 
m/z 1167.74 (Figure 5.5) representative of a mono-phosphorylated 
tetra-acylated lipid A that lacks in the C10:0 (3-OH) carried by 
GlcNI at position O-3; the relative bis-phosphorylated specie was 
also found in a minor peak at m/z 1247.72 (Figure 5.5). The mono-
phosphorylated tri-acylated specie was represented by the minor 
ion peak at m/z 985.57 (Figure 5.5) characterised by the absence of 
both C10:0 (3-OH) in ester linkage on GlcNI and the secondary 
fatty acid C12:0; the relative bis-phosphorylated specie was not 
detected in this analysis. Minor peaks at m/z 1520.03, 1536.02, 
1600.00 and 1615.99 are related to hexa-acylated species with a 
further C12:0 (m/z 1520.03 and 1600.00) or a C12:0 (3-OH) (m/z 
1536.02 and 1615.99) linked to the C12:0 (3OH) of the GlcNII. No 
traces of addition of amino-arabinose or palmitate to lipid A 
species, typical of CF-associated P.aeruginosa lipid A phenotypes, 
was observed. Interestingly, the elucidated structure of lipid A from 
P.aeruginosa RP73 was found to possess the same fatty acids 
location and distribution of a non-mucoid non-cystic fibrosis blood 
isolate grown in LB medium already described as very low 
inflammatory molecule (Ernst et al., 1999). This prompted to verify 
the in vivo pro-inflammatory capacity. 
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5.4 In vivo pro-inflammatory effect of the LOS from 
P. aeruginosa RP73 
 Since it was established that lipid A is the LPS moiety able 
to elicit the host innate immune system and that this capability 
strictly depends on its general architecture, it was tested the in vivo 
pro-inflammatory capacity of the particular LOS structure of P. 
aeruginosa RP73 strain. It was analysed leukocytes recruitment in 
the bronchoalveolar lavage fluid (BALF) of C57Bl/6NCrlBR mice 
exposed for 16 h to LOS and LPS of strains RP73 and PAO1 
respectively, by intranasal instillation. When cellular recruitment in 
BALF in mice treated with LOS from RP73 clinical isolate was 
compared to those treated with LPS from PAO1 reference strain, 
there was no significant difference in the two groups in recruited 
total cells and macrophages number (data not shown), however 
significant lower recruitment of neutrophils was observed in mice 
exposed to LOS from RP73 clinical isolate when compared to those 
treated with LPS from PAO1 reference strain (LOS RP73 vs LPS 
PAO1 p<0.05) (Figure 5.6), accordingly to the MPO activity 
measured in BALF (Figure 5.6). Thus, it is possible to conclude 
that LOS from the chronic strain of P. aeruginosa RP73 possesses 
a low inflammatory activity that is consistent with the elucidated 
hypo-acylated structure of its lipid A moiety (Hajjar et al., 2002).
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Figure 5.6  Neutrophils recruitment and MPO release in murine lungs after 16 h treatment 
with LOS derived from P. aeruginosa RP73 CF isolate and LPS from PAO1 reference 
strain.  
 
5.5 Discussion 
The lipopolysaccharide molecule isolated from strains of P. 
aeruginosa belonging to environment, CF and non-CF isolates, has 
been extensively investigated due to its essential role in the 
bacterial virulence and resistance to the common used antibiotics in 
the treatment of infection. Clearly, in order to develop therapeutic 
intervention strategies in P. aeruginosa infections, the assessment 
of its structure is a pivotal first step to enhance our insights into the 
*
* *
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microbial capability to cause infection and to modify their 
genotypic and phenotypic characteristics. In the present work it is 
reported the structure and immunological activity of the LPS 
isolated from the cystic fibrosis chronic strain P.aeruginosa RP73. 
As expected, as first chemical modification of the chronicisation 
this LPS lacked the O-antigen (Smith et al., 2006), it was indeed a 
LOS. As mentioned above, all P. aeruginosa LPSs, investigated so 
far, possess a conserved inner core region composed by two 
residues of 3-deoxy-D-manno-octulosonic acid (Kdo), two residues 
of L-glycero-D-manno-heptose (Hep) and a 2-amino-2-deoxy 
galactose residue (GalN), which is the branching point of the core 
oligosaccharide (Bystrova et al., 2002; Bock et al., 1994). 
Likewise, P. aeruginosa RP73 LPS inner core showed the presence 
of the aforesaid typical monosaccharide residues and the GalN 
residue was substituted by an N-alanyl group (Sadovskaya et al., 
1998; Sánchez Carballo et al., 1999), and the two Hep residues 
possessed a total of four phosphate groups as found in a P. 
aeruginosa cystic fibrosis rough-LPS isolates (Knirel et al., 2001). 
P. aeruginosa outer core region is more variable but it is still 
possible to find a common architecture composed by two glucose 
moieties and a rhamnose residue, the first monosaccharide 
composing the O-polysaccharide region (Bystrova et al., 2002; 
Pier, 2003). Overall, there was no consistent difference in LPS core 
oligosaccharide of this strain and the other CF strains of P. 
aeruginosa.  
Very interesting chemical characteristics were found in the lipid 
A structure of the LPS under study. Indeed, in stark contrast with 
previous reports about lipid A isolated from cystic fibrosis strains, 
P. aeruginosa RP73 showed to possess mainly a penta-acylated 
lipid A with no amino-arabinose and/or palmitate residues; the 
presence in very low amount of the hexacyl- or the total absence of 
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the heptacyl- type lipid A found in other cystic fibrosis isolates 
(Ernst et al., 1999), as well as the total absence of amino-arabinose 
residues, render RP73 lipid A unique in its case. Given these 
results, it was tested in a murine model of intranasal instillation the 
pro-inflammatory capacity of this particular LOS. In the lung of 
mice treated with the purified LOS of P.aeruginosa RP73, 
neutrophils recruitment was eloquently lower with respect to LPS 
from reference strain PAO1. It has been extensively described in 
several papers that on the canonical P.aeruginosa lipid A skeleton 
the glycosilation by amino-arabinose and/or acylation by palmitate 
residues strongly increase the production of pro-inflammatory 
molecules by eukaryotic cell and that this chemical modifications 
are the hallmark of the CF  P. aeruginosa lipid A (Ernst et al., 
1999; Hajjar et al., 2002). On the basis of previous notions (Hajjar 
et al., 2002; Alexander and Rietschel, 2001) about the connection 
between the acylation state of lipid A and the capability to elicit the 
inflammatory response, the observed low inflammatory power, 
fulfilled by LOS from P. aeruginosa RP73, is not surprising since 
its under-acylated structure is identical to a non-cystic fibrosis P. 
aeruginosa lipid A previously described (Ernst et al., 1999).
 
                                                                               
Altogether these results corroborate what has been previously 
shown concerning the reduction of the immunopotential of LPS 
extracted from late P. aeruginosa isolates from CF patients respect 
to their clonal early isolate (Ciganà et al., 2009), that is consistent 
with the phenotypic changes that characterise P. aeruginosa strains 
during the establishment of chronic infections (Smithe et al., 2006). 
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Premise 
 
 Burkholderia cenocepacia represents one of the most 
prevalent clinical cystic fibrosis (CF) isolates in which there were 
recognised a number of different strains, e.g. the B. cenocepacia 
epidemic strain ET-12 clonal strains J2315 and K56-2 strains 
(Mahenthiralingam
 
et al., 2005) that showed to behave differently 
when used in vitro and in vivo models (De Soyza et al., 2003). 
Furthermore, pulmonary infections caused by B. cenocepacia 
strains are viewed as so detrimental that lung transplantation, to 
date the only treatment that offers improved quantity and quality of 
life in CF patients, is frequently excluded for infected patients (De 
Soyza et al., 2003; Hadjiliadis et al., 2007). 
During the infection process, bacteria within the CF airways are 
exposed to stressing selection pressures, such as antibiotic 
treatments, oxygen limitations and host immune defenses 
(Harrison, 2007; Hogardt and Heesemann, 2013), that lead to the 
emergence of clonal variants exhibiting different phenotypic 
characteristics also inherent to the bacterial pathogenesis, such as 
production of different size of biofilm and different antimicrobial 
sensitivity patterns (Mahenthiralingam
 
et al., 2002). Comparing to 
Pseudomonas aeruginosa, the major CF pathogen about which 
many studies have been performed in the past years (see also 
Chapter 5), very little is known about the molecular mechanisms  
involved in the adaptation of B. cenocepacia to the CF lung 
environment. A contribution to this field of research was given by a 
number of published papers (Leitão
 
et al., 2008; Coutinho et al., 
2011) focused on the phenotypic and genome-wide expression 
analyses of serial BCC clonal variants isolated during different 
stages of infection in CF patients, where authors demonstrated that 
the adaptation process mainly affects metabolic pathways leading 
to alteration of the bacterial cell wall structure (Coutinho et al., 
Chapter 6 
Structural Determination of endotoxins from clinical isolates of Burkholderia 
cenocepacia retrieved at different stages of colonisation 
 
 
119 
 
2011). Being one of the major component of the outer membrane of 
Gram-negative bacteria, the lipopolysaccharide (LPS) is considered 
one of the cell wall component that should be affected by the most 
consistent changes in its structure during the adaptation of B. 
cenocepacia in the course of chronic infection. To elucidate this 
matter, the present work reports the characterisation of the 
complete structure of the LPS isolated from a CF patient (patient J) 
(Coutinho et al., 2011)
 
who was chronically colonised by B. 
cenocepacia for three and half years until death with the “cepacia 
syndrome” (Coutinho et al., 2011). In details, it is showed the 
structure of LPS isolated from IST439, the first B. cenocepacia 
isolate recovered, which presumably initiated the infection; 
IST4113 (Figure 6.1), obtained almost 3 years later after a period 
of exacerbated infection and intravenous therapy (Figure 6.1); and 
IST4134, the last isolate retrieved from the patient immediately 
before death with cepacia syndrome (Figure 6.1). Recently, 
IST4129, a less virulent isolate recovered from the same patient 32 
months after the beginning of the infection, has also been included 
in this research (Coutinho et al., 2011).  
 
           
                        Figure 6.1 Clinical isolates from patient J. 
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6.1 Isolation and Chemical Analyses of LPSs isolated  
from B. cenocepacia strains IST439, IST4113 
IST4129, IST4134 
 The lipopolysaccharide from B. cenocepacia  IST439, 
IST4113, IST4129 and IST4134 was extracted by the hot 
phenol/water method (Westphal and Jann, 1965). Extracted 
material was purified with nucleases and proteases followed by 
dialysis, gel permeation chromatography and eventually examined 
by SDS electrophoresis (Kittelberger and Hilbink, 1993).  B. 
cenocepacia IST439 revealed that the extracted lipopolysaccharide 
was a smooth-type LPS, while strains IST4113, IST4129 and 
IST4134 showed the presence of a rough-type LPS. 
Monosaccharide analysis of LOSs from IST4113, IST4129 and 
IST4134 resulted identical in all the three strains and showed the 
presence of D-GlcN, 4-amino-4-deoxy-L-arabinose (L-Ara4N), D-
Glc, D-Gal, L-glycero-D-manno -heptose (L,D-Hep), 3-deoxy-D-
manno-oct-2-ulopyranosonic acid (D-Kdo) and D-glycero-D-talo-
oct-2-ulopyranosonicacid (D-Ko). The above composition was 
already reported for B. cenocepacia ET-12 clone LMG 16656 (also 
known as J2315) (Silipo et al., 2007). The strain IST439 revealed 
the same composition of the other three strains but showed also the 
presence of a further D-ribose residue. Methylation studies were 
consistent to previously found data (Silipo et al., 2007)
 
for all 
strains and showed the subsequent composition: 3,4-disubstituted 
Hep, 3,7-disubstituted Hep, 7-substituted Hep, terminal Hep, 2,6-
disubstituted Gal, 6-substituted Glc, terminal Glc, terminal Ara4N, 
6-substituted GlcN, 4,5-disubstituted Kdo,   and, in particular, only 
strain IST439 revealed the presence of a 2-substituted ribofuranose 
(Ribf) and 4-substituted GalN. Fatty acids analysis showed the 
presence of (R)-3-hydroxyhexadecanoic acid (C16:0 (3-OH)) in 
amide linkage and of (R)-3-hydroxytetradecanoic (C14:0 (3-OH)) 
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and tetradecanoic acid (C14:0) in ester linkage. The overall 
chemical composition matched with the archetypal Burkholderia 
LPSs/LOSs (Silipo et al., 2007).  
6.2 Structural Determination of oligo-/polysaccharide 
moieties of LOSs/LPS from strains B. cenocepacia 
strains IST439, IST4113  IST4129, IST4134 by 
NMR spectroscopy  
 The primary structure of the LPS/LOSs isolated from the four 
strains was achieved by chemical analyses, mass spectrometry and 
NMR spectroscopy on intact and partially degraded LPS/LOSs. In 
order to characterise the monosaccharide sequence, both LPS and 
LOSs were hydrolysed using typical mild acidic conditions 
followed by centrifugation that gave a lipid A as sediment  and a 
water soluble carbohydrate fraction (see Section V). The 
carbohydrate fractions were purified by gel-permeation 
chromatography and analysed by NMR spectroscopy. The 
overlapping of 
1
H-NMR spectra is reported in Figure 6.2. The 
1
H-
NMR spectrum relative to strain IST439 showed two main signals 
in the anomeric region at δ = 5.09 and 4.99 ppm (Figure 6.2, Table 
6.1) belonging to the O-chain polysaccharide moiety, while the 
1
H-
NMR spectra relative to the other three strains exhibited eight 
anomeric signals relative to the core oligosaccharide (Figure 6.2). 
Furthermore, the presence of the spin system of Kdo K was 
demonstrated by the detection of the diastereotopic H-3 methylene 
protons signals, which resonate in a shielded region at δ = 1.87 and 
2.03 ppm (H-3ax and H-3eq respectively) for all the oligosaccharide 
fractions obtained from strains IST4113, IST4129 and IST4134. 
The assignment of the 
1
H and 
13
C resonances for the four 
carbohydrate fractions was performed by the analysis of the 2D 
NMR spectra. In particular, the proton resonances were assigned 
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from DQF-COSY, TOCSY, NOESY and ROESY spectra, while 
the 
13
C resonances were attributed by 
1
H,
13
C-HSQC and 
1
H,
13
C-
HMBC spectra.     
              Figure 6.2 1H NMR spectra of products after mild acid hydrolysis. 
 
Here we describe the structural assignment, by NMR analysis, of 
the O-polysaccharide (OPS) from strain IST439. The delineation of 
the structural characterisation by NMR spectroscopy of the core 
oligosaccharides from strains IST4113, IST4129 and IST4134 is 
not reported since the LOSs showed to be identical to each other 
and to the previously described core oligosaccharide from B. 
cenocepacia ET-12 strain J2315 (Silipo et al., 2007).           
 
  
IST 439 
IST 4113 
IST 4129 
IST 4134 
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       Table 6.1 Chemical shift  (1H/13C) of the O-chain moiety from strain IST439. 
 
 The two spin systems identified in the 
1
H-NMR spectrum of 
IST439 were designed as A (H-1 at δ = 5.09 ppm) and B (δ = 4.99 
ppm). Spin system A was identified as a ribofuranose residue due 
to the correlations observed in the DQF-COSY and TOCSY spectra 
from the H-1 A signal up to a diastereotopic methylene signal at 
position C-5. The anomeric configuration was attributed by the low 
3
JH-1,H-2 value obtained from the DQF-COSY spectrum, indicative 
of β-configuration in aldofuranose rings (less than 2 Hz), and by 
the chemical shift of C-4 (around 83.0 ppm in case of β-
configuration) (Ahrazem et al., 2002). The downfield displacement 
of C-2 signal in the 
1
H,
13
C-HSQC spectrum (Figure 6.3) indicated 
glycosilation at this position. Spin system B (H-1 at δ = 4.99 ppm) 
was identified as an α-galactose as attested by the low 3JH3,H4 and 
3
JH4,H5 values (3 Hz and 1 Hz, respectively) as well as the TOCSY 
scalar correlations between the anomeric signal and the other ring 
protons until the H-4 resonance; moreover, the intra-residual NOE 
correlation of H-1 B with H-2 B, the anomeric proton and carbon 
chemical shifts (δ = 4.99 ppm and 95.5 ppm) and the 3JH1,H2 were 
Chemical shift δ (1H/13C) 
Unit 1 2 3 4 5 6 
A 5.09 4.15 4.03 3.95 3.77-3.59 --- 
2-β-Rib 106.6 78.7 67.2 82.3 62.5 ---- 
B 4.99 4.02 3.93 3.61 3.63 4.03 
4-α-GalNac 95.5 50.0 76.2 78.9 60.5 70.8 
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all in agreement with an α-anomeric configuration and a 4C1 ring 
conformation.  
 
     Figure 6.3 1H,13C-HSQC spectrum of the O-chain moiety from IST439 strain. 
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Figure 6.4  Section of the NOESY (blue and green) and TOCSY (orange) spectra of 
polysaccharide from IST439 strain. The most relevant inter-residue NOE cross-peaks are 
indicated. 
 
The detection of a signal for C-2 at 50.0 ppm indicated that it was a 
nitrogen-bearing carbon atom; furthermore, the downfield shift of 
proton resonance of H-2 B was diagnostic of N-acetylation at this 
position, which was also corroborated by the NOE contact of H-2 B 
with the methyl protons of the acetyl group resonating at δ = 1.92 
ppm. Thus residue B was identified as a α-GalNAc. The downfield 
shift of its C-4 (δ = 78.9 ppm) was indicative of glycosilation at 
this position. ROESY and NOESY spectra (Figure 6.4) gave 
possibility to elucidate the linkage between the two residues, and 
thus of the repeating unit of the O-polysaccharide from B. 
cenocepacia strain IST439. In details, the anomeric proton of 
GalNAc B gave a NOE correlation with H-2 and H-1 proton 
signals of ribose A, whose anomeric signal showed a NOE 
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correlation with the H-4 of residue B. These data were confirmed 
by the long scalar range connectivities obtained by the 
1
H,
13
C-
HMBC spectrum. 
 In summary, the OPS structure from B. cenocepacia strain IST439 
was found to have the following repeating unit, previously 
identified in another Burkholderia strain (Cox and Wilkinson, 
1989):  
                 [→2)-β-D-Ribf-(1→4)-α-D-GalpNAc-(1→] 
 
6.3 MALDI-MS Analysis on intact LOSs/LPS from  
strains B. cenocepacia strains IST439, IST4113 
IST4129, IST4134 
 MALDI mass spectrometry analysis on the intact LPS of strain 
IST439 completely confirmed the structural hypotheses (Figure 
6.5). In details, in the mass range 1400-2400 Da of the negative-ion 
MALDI mass spectrum (Figure 6.5) ion peaks relative to lipid A 
species and to core oligosaccharide species were present, derived 
from the rupture of the labile glycosidic linkage between Kdo and 
lipid A. Ion peaks relative to lipid A species were as previously 
described (Silipo et al., 2007). 
The ion peak A (m/z = 2033.3) was indicative of an oligosaccharide 
composed by five heptoses, three hexoses, one Kdo, one Ko and 
one Ara4N, while ion peaks B (m/z = 2166.2) carried an additional 
amino-arabinose residue (Figure 6.5). The species derived from the 
core oligosaccharide were in accordance with the structure already 
elucidated elsewhere (Silipo et al., 2007). The mass range 3000-
4000 Da, (Figure 6.5) containing peaks relative to either 
oligosaccharide and lipid A, also confirmed previously analysis 
Chapter 6 
Structural Determination of endotoxins from clinical isolates of Burkholderia 
cenocepacia retrieved at different stages of colonisation 
 
 
127 
 
(Silipo et al., 2007).  Furthermore, the mass range 7280-15400 Da 
showed ion peaks relative to the OPS confirming the 
abovementioned disaccharide repeating unit structure (not shown). 
  
 
          Figure 6.5  MALDI mass spectrum of of intact LPS from strain IST439. 
 
   Negative-ion MALDI mass spectra executed on the intact LOSs 
isolated from the three strains IST4113, IST4129 and IST4134 are 
identical each other and very similar to previously described mass 
spectra performed on intact LOS of B. cenocepacia ET-12 strain 
J2315 (Silipo et al., 2007), confirming NMR analysis. For 
illustrative purpose, the MALDI mass spectrum on the intact LOS 
of strain IST4113 showed at mass range 1300-2500 Da a plethora 
of OS species (Figure 6.6), presenting from four to six heptoses and 
from three to five hexoses, one Kdo, one Kdo and showing or not 
one amino-arabinose residue. In particular, the ion peak termed 
OS3 (m/z = 2032.5) was indicative of the core oligosaccharide 
elucidated by NMR analysis. The LOS molecular ions in the mass 
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range 3000-4200 Da (Figure 6.7), given by the combination of the 
peaks of lipid A species and the OS species, confirmed the NMR 
analysis. Interestingly, as mentioned above, species carrying 
additional heptoses and/or hexoses were present in the MALDI 
mass spectra but they were not detected by NMR spectroscopy.   
 
 
Figure 6.6  MALDI mass spectrum of the intact LOS from strain IST4113 (mass range 
1300-2500). 
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Figure 6.7  MALDI mass spectrum of the intact LOS from strain IST4113 (mass range 
3000-4200). 
 
  By merging information deriving from chemical, NMR 
spectroscopy and MALDI mass spectrometry analyses, it was 
possible to define the complete structure of the LPS/LOSs isolated 
from the four clinical strains of Burkholderia cenocepacia which 
can be reassumed in the following monosaccharide sequences: 
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6.4 Discussion 
 During chronic infection, Burkholderia cenocepacia is 
subjected to in vivo selection processes, resulting in less virulent 
variants showing different phenotypic features from the original 
colonising strain. In the present study, it has been demonstrated that 
Burkholderia cenocepacia chronic strains are characterised by the 
loss of the O-chain polysaccharide moiety on their LPS molecules 
compared to the initial colonizing strain that possesses a smooth-
type LPS. Results wer obtained from a combination of chemical 
analyses, NMR spectroscopy and MALDI mass spectrometry 
experiments, performed on four clinical isolates retrieved during 
the patient care period at the HSM CF Treatment Center Hospital 
in Lisbon (Coutinho et al., 2011). These results, together with data 
belonging to the extensive phenotypic and genotypic approaches 
performed by Coutinho et al., provide essential contribution to the 
understanding of the adaptive and evolutionary mechanisms 
employed by Burkholderia cenocepacia to chronic colonise CF 
lungs, with the ultimate goal to improve therapeutic outcomes of 
chronic infections in cystic fibrosis patients. From the chemical 
viewpoint, the elucidated structures are in agreement with the 
LPS/LOS structures from the Burkholderia genus so far 
characterised. In details, the lipid A moiety showed the typical 
Burkholderia disaccharide backbone possessing a [P→4-β-D-
GlcpN-(1→6)-α-D-GlcpN1→P] sequence that possesses two 
Ara4N residues linked to the phosphate groups. The inner core is 
composed by the characteristic Ara4N-Ko-Kdo trisaccharide, 
previously elucidated in other Burkholderia species (Isshiki et al., 
1998; Gronow et al., 2003), carrying a high heptosylated sequence 
from which starts the outer core region. This latter normally shows 
the presence of a non-stoichiometric Rha-QuiNAc disaccharide, 
linked to the α-Hep-(1→2)-α-Gal disaccharide of the outer core, 
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not found in the present analysis, that plays as a cap for the linkage 
of the O-chain polysaccharide to the core region. The 
abovementioned structure is identical for the three examined 
Burkholderia chronic strains IST4113, IST4129 and IST4134 
showing a rough-type LPS. The original colonising strain IST439, 
presenting a smooth-type LPS, showed the presence of a 
disaccharide repeating unit, linked to the outer core, composed by 
the [→2)-β-D-Ribf-(1→4)-α-D-GalpNAc-(1→] sequence, already 
described elsewhere (Cox and Wilkinson, 1989).  
The investigation of mechanisms and dynamics of microbial 
evolution within a host environment, and how it relates to 
pathogenicity and virulence, is currently a topic of paramount 
importance in health sciences. 
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Premise 
 One common mechanism of resistance against antimicrobial 
peptides in Gram-negative bacteria is the addition of 4-amino-4-
deoxy-L-arabinose (L-Ara4N) to the lipopolysaccharide (LPS) 
molecule. Burkholderia cenocepacia exhibits extraordinary 
intrinsic resistance to antimicrobial peptides and other antibiotics. 
It was previously discovered that, unlike other bacteria, B. 
cenocepacia requires L-Ara4N for viability. Conditionally lethal B. 
cenocepacia mutants impaired in L-Ara4N synthesis and transport 
revealed accumulations of membranous material in the bacterial 
cells, which were reminiscent of the phenotype found in bacteria 
with defects in LPS export to the outer membrane (Ortega et al., 
2009). Therefore, it is possible to hypothesize that L-Ara4N 
modification of the LPS in B. cenocepacia is critical for the proper 
export of the LPS molecule to the outer membrane and that the 
lethality of L-Ara4N depleted cells is due to the inability to 
properly assemble the outer membrane. Genetic manipulations of 
bacteria by gene deletion are a valuable method to unravel gene 
function. However, this approach becomes limited when the gene 
of interest is essential for bacterial viability. The essentiality of L-
Ara4N production and L-Ara4N transfer to lipid A-core OS 
preclude from directly assessing the role of the L-Ara4N 
modification in mediating the resistance of B. cenocepacia to 
polymyxin B (Ortega et al., 2009).
 
In the present work, with a 
combination of structural analyses and ad hoc molecular biology 
experiments it is assessed the biological role of amino-arabinoses 
on Burkholderia cenocepacia LPS structural architecture by using 
B. cenocepacia suppressor mutants that remain viable despite the 
deletion of genes required for L-Ara4N synthesis and transfer to the 
LPS.   
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7.1 Isolation of suppressor B. cenocepacia strains  
 To isolate suppressor mutants in a strain with an inactivated 
L-Ara4N biosynthesis gene cluster (arn), it was first constructed 
the conditional strain Prha-arn by placing the arn gene cluster 
under the control of the rhamnose inducible promoter (Prha). This 
straincan only form colonies when arn gene expression is turned on 
by the addition of rhamnose. These colonies were then examined 
for polymyxin B sensitivity. Three polymyxin B-sensitive colonies 
were isolated, which resulted in polymyxin B-sensitive B. 
cenocepacia mutants lacking arnBC (ΔarnBC). The deletion of the 
arnBC genes in the three mutants was confirmed by polymerase 
chain reaction (PCR) amplification. To distinguish between L-
Ara4N synthesis and L-Ara4N transfer onto the lipid A-core OS, it 
was constructed a mutant that can synthesize L-Ara4N but lacks the 
L-Ara4N transferase ArnT, resulting in the strain ΔarnT-arnBC+.         
Both ΔarnBC and ΔarnT-arnBC+ strains harbouring suppressor 
mutation(s) were viable irrespective of rhamnose in the medium 
indicating that the suppressor mutation(s) can rescue growth of B. 
cenocepacia in the absence of L-Ara4N synthesis or L-Ara4N 
transfer to the lipid A-core OS. In contrast to the parental or 
conditional Prha-arn strains grown with rhamnose, the suppressor 
strains ΔarnBC and ΔarnT-arnBC+ failed to grow in the presence 
of polymyxin B regardless of rhamnose addition, demonstrating 
that production and transfer of L-Ara4N to the lipid A-core OS are 
critical for polymyxin B resistance in B. cenocepacia.  
 
Introduction of a replicative plasmid expressing arnT into DarnT-
arnBC
+
 restored polymyxin B resistance, confirming that the 
polymyxin B sensitive phenotype was due to the loss of arnT. 
Similarly, genomic complementation of the L-Ara4N synthesis 
defect in ΔarnBC by reintroducing the parental genes restored 
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polymyxin B resistance in the presence of rhamnose. The 
complemented ΔarnBC-araBC + strain retained viability with or 
without rhamnose in the growth medium, indicating that the 
suppressor mutation(s) was stable. These results demonstrate that 
suppressor mutation(s) allow for viability of B. cenocepacia in the 
absence of L-Ara4N synthesis and transfer to lipid A-core OS, and 
that transfer of L-Ara4N to lipid A-core OS is required for 
polymyxin B resistance in B. cenocepacia.  
 
It was also determined the minimal inhibitory concentration 
(MIC) of the arn mutants to more precisely assess their level of 
sensitivity to polymyxin B. MIC values for parental B. cenocepacia 
to polymyxin B are unknown since the bacterium can grow at 
concentration of up to 4000 mg/mL of polymyxin B (Loutet et al., 
2011). In contrast, ΔarnBC (lacking the ability to synthesize L-
Ara4N) and ΔarnT-arnBC+ (lacking the L-Ara4N transferase) had 
MIC values of 0.25 mg/mL each. Therefore, L-Ara4N production 
and L-Ara4N transfer to LPS are critical for bacterial viability and 
for the extreme resistance to APs. 
 
7.2 Isolation and SDS-PAGE analysis of LPS from   
suppressor B. cenocepacia strains 
 Extraction of the LPS for structural elucidation was 
achieved by the hot phenol/water protocol (Westphal and Jann, 
1965)
 
and checked by SDS-PAGE (Kittelberger and Hilbink, 1993) 
(see Section V). Samples isolated from suppressor mutants showed 
the ladder-like pattern typical of S-LPS due to the occurrence of the 
O-chain. No difference in the migration pattern or modality of O-
antigen repeats was observed for any of the strains examined when 
compared with the parental isolate (Figure 7.1). However, LPS 
extracted from ΔarnBC and ΔarnT-arnBC+ displayed more 
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intensely stained bands relative to those of the parental strain. The 
staining pattern was consistent and reproducible, and could not be 
attributed to chemical differences with the LPS other than the 
absence of L-Ara4N (see below). This suggested that loss of L-
Ara4N in the lipid A-core OS may cause an effect on silver 
staining, as indicated by the observed loss of the intense staining 
and reversion to the parental staining pattern in the complemented 
strain ΔarnBC-arnBC+ (Figure 7.1).     
 
    Figure 7.1. LPS profile of B. cenocepacia strains on Tricine-SDS-polyacrylamide gel. 
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Figure 7.2 Genetic strategy used to isolate a suppressor B. cenocepacia strain that 
remains viable in absence of L-Ara4N synthesis. A) Genetic organisation of the arn 
operon in B. cenocepacia and construction of conditional Prha-arn strain. B) Wild type 
and conditional Prha-arn B. cenocepacia strains grown on LB agar with or without 0.4% 
rhamnose. C) Suppressor enrichment by growing conditional Prha-arn under non-inducing 
conditions.   
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7.3 Structural analyses of LPS isolated from 
suppressor B. cenocepacia strains 
 A detailed analysis was performed to determine the 
composition and structure of the LPS produced by the mutants, but 
since the presence of O-polysaccharide in parental and mutant 
strains complicates the structural analysis of the lipid A-core OS 
moiety, it was first introduced a wbiF (BCAL3122) gene deletion in 
the parental strain and the ΔarnBC, ΔarnT-arnBC+ and ΔarnBC-
arnBC
+
 mutants. Deletion of wbiF results in the loss of a 
rhamnosyltransferase that is required for O-chain synthesis and, 
therefore, the mutant lacks surface O-chain. Carbohydrate and fatty 
acid analyses performed by gas-liquid chromatography/mass 
spectrometry (GLC-MS) on purified LPS samples from O-chain 
defective ΔarnBC and ΔarnT-arnBC+ mutants confirmed the 
absence of L-Ara4N both in the lipid A and inner core OS, and 
detected no other modifications. Mass spectrometry analyses of 
lipid A and core OS using matrix-assisted laser 
desorption/ionisation time of flight mass spectrometry (MALDI-
TOF) were performed to further confirm their structures (Figure 
7.3). The negative-ion MALDI-TOF mass spectrum showed ion 
peaks related to lipid A and core OS fragments, as well as 
molecular ions of intact LOS molecules. The fragmentation is 
characteristic for the cleavage of labile bond between Kdo and lipid 
A (Sturiale et al., 2005). The MALDI-TOF mass spectrum obtained 
from the LPS sample of the O-chain defective ΔarnBC-arnBC+ 
strain showed ion peaks corresponding to core oligosaccharide (at 
m/z 1547; Figure 7.3) containing four heptoses, two hexoses, one 
Kdo, and one Ko residue and a mixture of tetra- and penta-acylated 
lipid A species (Figure 7.3). The ion peak A at m/z 1444.7 
corresponded to tetra-acylated di-glucosamine backbone carrying 
one 14:0 (3-OH), one 14:0 and two 16:0 (3-OH) fatty acids. Peak B 
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at m/z 1575.5 and peak C at m/z 1706.3 corresponded to the tetra-
acylated species in peak I with one and two additional L-Ara4N 
residues respectively (Figure 7.3). Peak D at m/z 1801.5 
corresponded to penta-acylated lipid A species carrying additional 
14:0 (3-OH) residues and one L-Ara4N. Peaks corresponding to 
lipid A-core OS quasi-molecular ions were present in the mass 
range between m/z 2500 and 4000 (Figure 7.3). The MALDI-TOF 
mass spectrometry data obtained from LPS samples of  O-chain 
defective strains ΔarnT-arnBC+ (Figure 7.3B) and ΔarnBC (Figure 
7.3C) showed essentially the same pattern of molecular ions as 
described above for tetra- and penta-acylated lipid A species, but 
without detecting the presence of any species carrying L-Ara4N 
(Figures 7.3B,C). Moreover, the absence of L-Ara4N in lipid A-
core OS species at higher masses demonstrated that not only the 
lipid A but also the core OS lacked L-Ara4N (Figures 7.3B,C). 
These results were further confirmed by NMR analysis (Figure 
7.4). Therefore, it is possible to conclude that the only change 
observed in LPS molecules prepared from the O-polysaccharide 
defective mutants ΔarnT-arnBC+ and ΔarnBC is the absence of L-
Ara4N in the lipid A-core OS, while the lipid A-core OS structure 
in the O-chain defective mutant ΔarnBC-arnBC+ is identical to that 
of parental LPS. These results also suggested that ArnT is required 
for the modification of both lipid A and core OS with L-Ara4N. 
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Figure 7.3 MALDI-MS spectra from purified core OS produced by O-chain defective 
mutants. Purified core OS fractions from the ΔarnT-arnBC+ ΔwbiF (A), ΔarnBC-arnBC+ 
ΔwbiF (B), and ΔarnBC ΔwbiF (C) strains were investigated using MALDI-TOF mass 
spectrometry.  
 
 
Figure 7.4 1H-NMR spectra of core OSs from O-chain defective derivatives of arnT-
arnBC+, arnBC-arnBC+, and arnBC strains. 
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7.4 Assessment of the role of amino-arabinoses on B. 
cenocepacia LPS structure 
 It was previously hypothesized that addition of L-Ara4N to 
the LPS of B. cenocepacia is essential for export of LPS to the 
outer membrane by the Lpt pathway (Ortega et al., 2007). 
Therefore, it was investigated whether ΔarnBC has one or more 
mutations in lpt genes that suppress a putative LPS export defect, 
allowing growth in the absence of L-Ara4N synthesis and/or 
transfer to the LPS. 
B. cenocepacia lpt genes, identified by bioinformatic analyses, 
were PCR-amplified from the ΔarnBC suppressor mutant and 
cloned into a multicopy plasmid. Recombinant plasmids expressing 
these genes were introduced into the conditional strain Prha-arn 
and the resulting colonies were examined for viability in the 
absence of rhamnose. Only a plasmid expressing lptFG could 
rescue the growth of the conditional strain Prha-arn in the absence 
of rhamnose. This indicates that the suppressor effect is due to a 
specific mutation in lptFG. DNA sequencing of the suppressor 
lptFG plasmid revealed a G→C point mutation in codon 31 of 
lptG, which resulted in the substitution of an aspartic acid (D) by a 
histidine (H). The same mutation was also found in the lptG gene 
of the two other ΔarnBC suppressor mutants recovered, suggesting 
that the LptGD31H protein supports viability in strains lacking 
functional arnBC genes. 
To confirm that lptGD31H is sufficient to rescue growth of B. 
cenocepacia in the absence of L-Ara4N synthesis, lptG was PCR-
amplified from parental B. cenocepacia DNA, cloned into a 
plasmid, and the D31H replacement was introduced by site directed 
mutagenesis. This recombinant plasmid was then used to replace 
the native lptG with lptGD31H in the conditional strain Prha-arn. 
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The resulting strain Prha-arn-lptGD31H was viable in the absence of 
rhamnose and L-Ara4N synthesis, confirming that LptGD31H is 
sufficient to fully suppress loss of viability in B. cenocepacia. 
Together, these results demonstrate that the D31H substitution in 
LptG can bypass the requirement of L-Ara4N synthesis for the 
viability of B. cenocepacia. 
7.5 Trasmission electron microscopy analysis on B. 
cenocepacia suppressor mutant cells 
 In a previous study it was reported that conditional mutants 
in the synthesis of L-Ara4N or its transfer to LPS have dramatic 
morphological defects that were attributed to the absence of L-
Ara4N in the LPS molecule (Ortega et al., 2007). Transmission 
electron microscopy was performed on bacteria depleted for L-
Ara4N to determine whether the suppressor strains ΔarnBC and 
Prha-arn-lptGD31H depleted for L-Ara4N displayed normal cell 
morphology. The results demonstrated that cells from both 
suppressor strains have a membrane structure similar to that of the 
parental strain K56-2. In contrast, the conditional strain Prha-arn 
grown in the absence of rhamnose showed cells with cell division 
defects, abnormal membranous subcellular structures and cells 
representing empty sacculi. The abnormal ultrastructure of these 
cells is consistent with a defect in LPS export, which is overcome 
in the presence of the lptGD31H suppressor mutation. 
7.6 Discussion 
 In this work, by using a strategy to delete the L-Ara4N 
biosynthesis genes resulting in stable viable suppressor mutants 
lacking amino-arabinoses in their LPS, it was showed a more than 
16000-fold reduction in resistance to polymyxin B. Based on these 
results demonstrating for the first time that loss of L-Ara4N from 
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the LPS molecule abolishes the extreme resistance of B. 
cenocepacia to APs, it was proposed that the L-Ara4N modification 
of the B. cenocepacia LPS is the key determinant of the extreme 
intrinsic resistance of these bacteria to antimicrobial peptides. 
In B. cenocepacia and Burkholderia species, L-Ara4N may be 
found attached to the phosphate groups of lipid A and the branched 
Ko sugar of the core OS (Isshiki et al., 1998; Molinaro et al., 
2003). Whereas the presence of L-Ara4N in the lipid A is common 
to many bacteria, only those with L-Ara4N in the core OS residue, 
such as Burkholderia, Proteus, and Serratia species demonstrate 
very high levels of resistance to polymyxin B (Boll et al., 1994; 
Silipo and Molinaro, 2010). The addition of L-Ara4N to the core 
OS might therefore provide a higher level of protection to bacteria 
against APs. Moreover, all Burkholderia LPS structurally identified 
to date lack negatively charged sugar residues in any region of the 
LPS besides the Kdo–Ko disaccharide and do not possess any other 
negatively charged molecules besides the two phosphate groups of 
the lipid A. This suggests that the modification of Burkholderia 
LPS with L-Ara4N heavily influences its overall charge 
transforming it in a net positive or neutral molecule, which 
prevents interactions with APs and accounts for the extreme 
resistance by Burkholderia to these molecules (De Soyza et al., 
2008). 
The detailed chemical and structural analyses of the lipid A-core 
OS of the LPS produced by the mutant strains demonstrates a role 
for ArnT, the L-Ara4N transferase, in the transfer of L-Ara4N to 
lipid A and core OS acceptor sites. Prior to this work, there was no 
evidence in the literature that ArnT from other species can catalyse 
the addition of L-Ara4N to a sugar residue in the core OS. ArnT in 
other Gram-negative bacteria, such as Salmonella and Escherichia 
coli only transfers L-Ara4N to the phosphate groups of the lipid A 
(Trent et al., 2001).  
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In a previous study, it was speculated that the L-Ara4N LPS 
modification was required for the export of nascent LPS molecules 
from the periplasmic side of the inner membrane to the outer 
membrane (Ortega et al., 2007). LPS export is achieved by the Lpt 
pathway, which consists of inner membrane, periplasmic, and outer 
membrane proteins working in concert to transport the LPS 
molecule from the periplasmic face of the inner membrane to the 
outer leaflet of the outer membrane (Ruiz et al., 2009; Sperandeo et 
al., 2009). The identification of a point mutation in the LPS 
transporter gene lptG in the current work provides genetic evidence 
to support this hypothesis. LptG is a highly conserved inner 
membrane protein in Gram-negative bacteria and is required for the 
export of LPS to the outer membrane a process that is essential for 
the viability of most Gram-negative bacteria (Ruiz et al., 2009).
 
 
In this study it was discovered here that a single point mutation in 
LptG changing aspartic acid to histidine at position 31 results in a 
protein that bypasses the need of L-Ara4N synthesis for B. 
cenocepacia viability and allows for the proper assembly of outer 
membrane. Strains containing parental LptG (with histidine at 
position 31) are nonviable in absence of L-Ara4N synthesis and 
show membranous invaginations and other morphological 
abnormalities indicative of the inability of to properly assemble the 
outer membrane (Ortega et al., 2007). This suggested that the 
parental LptG is unable to export LPS lacking L-Ara4N 
modification, resulting in a lethal phenotype likely due to the 
failure to organize the outer membrane in the absence of LPS 
export, while LptGD31H can export unmodified LPS which allows 
for proper assembly outer membrane and bacterial viability. 
Previous observations of membranous invaginations and other 
morphological abnormalities observed in B. cenocepacia strains 
depleted in L-Ara4N synthesis support this conclusio(Ortega et al., 
2007). 
Chapter 7 
Assessment of the Biological role of amino-arabinose residues on                             
B. cenocepacia LPS structure 
 
 
148 
 
Nevertheless, the molecular mechanism involving LptG in the 
export of L-Ara4N-modified LPS remains to be elucidated. One 
could speculate that the D31H substitution in LptG allows export of 
unmodified LPS. However, LptGD31H can also export L-Ara4N-
modified LPS, as indicated by the polymyxin B-resistant 
phenotypes of the ΔarnBC-arnBC+ and Prha-arn lptGD31H strains, 
and is confirmed by the chemical analysis of LPS extracted from 
the O-polysaccharide deficient derivative of ΔarnBC-arnBC+ 
strain, which contains the spontaneous lptGD31H allele. 
Interestingly, D31 is a highly conserved residue in LptG proteins of 
Burkholderia and related species, such as Ralstonia and 
Cupriavidus but not in Enterobacteriaceae, Vibrio cholera, or 
Pseudomonas aeruginosa. Interestingly, the bacterial species that 
show no conservation at D31 in LptG do not require L-Ara4N for 
viability suggesting that the native LptG of these bacteria does not 
display any specificity toward L-Ara4N-LPS or unmodified LPS 
for proper export (Kabir, 1982; Moskowitz et al., 2004). The 
conservation of D31 in LptG, together with the observation that L-
Ara4N is present in the lipid A and core OS LPS of different 
Burkholderia species, and the experimental data in this study lead 
us to hypothesize that L-Ara4N not only plays a critical role as a 
determinant of resistance to APs but also provides a molecular 
signature required for LPS export thus playing an essential role in 
determining the architecture of the outer membrane in B. 
cenocepacia and related species. Additionally, by linking the AP-
resistance mediated through L-Ara4N to LPS export and viability, 
B. cenocepacia employs an elegant mechanism to select for a 
progeny that retains high levels of intrinsic resistance to APs. 
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8.1 TLR4/MD-2/LPS interaction: state-of-art 
 Lipopolysaccharide (LPS, endotoxin) elicits a potent innate 
immune response through the interaction with TLR4 (Toll-like 
receptor 4) and MD-2 (myeloid differentiation factor 2) receptor 
complex (Nagai et al., 2002). This recognition is crucial since tiny 
amounts of LPS, released from invading microorganisms, prepare 
the immune system to protect the host against further infection. In 
contrast, excessive exposure (or excessive responses) to LPS can 
lead to uncontrolled inflammatory responses manifested by the 
sepsis-systemic inflammatory response syndrome (SIRS), which is 
associated with high mortality, especially in intensive care units 
(Angus et al., 2001; Rangel-Fausto, 2005). The TLR4/MD-2/LPS 
heterodimer can activate two parallel signaling pathways both 
resulting in production of inflammatory cytokines. The lipid A 
represents the LPS portion recognised by the TLR4/MD-2 receptor 
complex and its bioactivity is strongly influenced by its primary 
structure; of main importance is certainly the grade of acylation and 
the fatty acid (FA) distribution, which determines the three-
dimensional structure of the lipid A moiety (Schromm et al., 2000; 
Seydel et al., 2000) and its agonistic and antagonistic activity 
(Brandenburg et al., 1993; Rietschel et al., 1994).
 
  
Hexa-acylated bisphosphorylated lipid A with an asymmetric 4:2 
lipid chain distribution, found in the majority of enterobacteria (e.g. 
E. coli), is considered to have the highest cytokine-inducing 
capacity in mammals. In contrast, the hypoacylated synthetic 
precursor of E. coli lipid A, the tetra-acylated lipid IVA, has weak 
agonistic effects for some species of mammals and is well known 
to possess a strong antagonistic activity on human cells (Golenbock 
et al., 1991). The crystal structure of the TLR4/MD-2/LPS complex 
showed that the receptors act as a heterodimer composed of two 
copies of the TLR4/MD-2/LPS system, where lipid A, which is 
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accommodated in a hydrophobic pocket formed by two anti-
parallel β-sheets of MD-2, mediates dimerization and activation of 
the (TLR4/MD-2)2 complex (Park et al., 2009). The MD-2 
hydrophobic pocket can accommodate up to five acyl chains; in the 
case of E. coli lipid A, five acyl chains are buried inside the pocket 
while the sixth one is exposed and lies on the surface of MD-2 and 
interacts with TLR4, mediating hydrophobic interactions bridging 
the TLR4/MD-2/LPS multimer, and promoting the activation of the 
immune response (Mend et al., 2010). On the other hand, 
antagonist lipid IVA binds to the human MD-2 (hMD-2) with all 
four acyl chains completely buried inside the hydrophobic pocket 
and in this way it is not able to trigger any dimerization. In 
contrast, lipid IVA can activate the murine TLR4/MD-2 complex, 
demonstrating a species-specific difference in the recognition of 
lipid IVA by MD-2 (Hajjar et al., 2002). MD-2 binds to TLR4 
primarily through hydrophilic interactions such as hydrogen bonds 
and charge interactions, and a few hydrophobic residues were 
found in the binding interface (Park and Lee, 2013; Park et al., 
2009).
 
The TLR4 binding surface can be divided into two sections, 
the A and B patches. The A patch, negatively charged, interacts 
with the positively charged surface of MD-2, and the positively 
charged B patch with the negatively charged surface of MD-2. 
Mutation of amino acid residues involved in this interaction blocks 
TLR4 and MD-2 binding, and LPS signaling. Given this premise, 
several studies, comprising site-directed mutagenesis, molecular 
modeling experiments and comparative analysis with other agonist 
and antagonist molecules (such as eritoran for the latter case and E. 
coli lipid A for the first one), have been dedicated to clarify lipid 
IVA species-specificity identifying residues that are exclusively 
involved in the binding and, in case of murine cells, TLR4 
activation (Gay and Gangloff, 2007; Janeway, 1989).
 
The ability of 
murine MD-2 to bind lipid IVA and activate TLR4 was explained 
with a shift of the lipid A glucosamine backbone that relocates the 
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negative phosphate groups so that they can interact with specific 
positively charged residues on TLR4 allowing the dimerization of 
the complex (Broz and Monack, 2013). Other experiments strongly 
suggested that the main force for receptor dimerization is 
represented by hydrophobic interactions at the dimerization 
interface (Janeway, 1989); however, it was also shown that these 
interactions by themselves are not sufficient to mediate complex 
dimerization (Janeway, 1989). Similarly to lipid IVA, a penta-
acylated lipid A was seen to act as antagonist or also to be poorly 
recognised (as example, the lipid A from environmental strains of 
Pseudomonas aeruginosa) (Hajjar et al., 2002) by the 
hTLR4/hMD-2 complex. 
Despite the large number of investigations, mechanisms 
underlying the TLR4 dimerization and activation merit further 
studies in order to extend the knowledge on lipid A-induced 
activation and its species-specificity. Furthermore, it is of great 
interest studying the binding mode possessed by lipid A moieties 
that have structural features different from the highly studied E. 
coli lipid A in order to better understand the role of each singular 
component of the lipidic portion into the TLR4 activation process.                              
In this scenario, the present study reports, for the first time, a 
combination of theoretical and experimental experiments using 
LOS and isolated lipid A (LA) from the well-known cystic fibrosis 
(CF) pathogen Burkholderia cenocepacia (BC-LOS). The present 
work has a notable importance also if it is contextualised  into CF 
disease problem; indeed since LPS and, in particular, lipid A 
moiety are involved in the above described host–bacterial 
interaction inducing host innate immune response, the investigation 
of the molecular mechanisms of interaction between B. 
cenocepacia LPS and host immune system components is 
mandatory to understand the virulence of the CF pathogen.                                                
The full structure of the B. cenocepacia LOS (BC-LOS) has been 
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previously described (Hamad et al., 2012) and is sketched in Figure 
8.1. The LA showed the typical Burkholderia disaccharide 
backbone, possessing a [P→4-β-D-GlcpN-(1→6)-α-D-GlcpN1→P] 
sequence that also bears two additional Ara4N residues linked to 
the phosphate groups. Moreover, fatty acids composition analysis 
showed the presence of (R)-3-hydroxyhexadecanoic acid (C16:0 
(3-OH)) in the amide linkage and of (R)-3-hydroxytetradecanoic 
(C14:0 (3-OH)) and tetradecanoic acid (C14:0) in the ester linkage, 
matching with the archetypal Burkholderia LPSs/LOSs bearing a 
total of five acyl chains (Hamad et al., 2012). The presence of the 
two Ara4N residues and the peculiar acylation pattern renders 
Burkholderia cenocepacia (BCLA) completely different from the 
E. coli analogue and from all enterobacterial LA. Hence, the 
archetypal mechanism of binding/activation of TLR4/MD2 
complex cannot apply in this case.     
 
                      Figure 8.1 LOS structure from Burkholderia cenocepacia. 
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 In this study, it was investigated the molecular basis of the 
mechanisms of LA recognition by employing a multidisciplinary 
approach comprising molecular microbiology, cellular biology, 
organic chemistry, and molecular modeling. 
8.2 Assessment of the agonist activity of B. cenocepacia 
lipid A on TLR4/MD-2 complex 
In order to test TLR4/MD-2 activation by BC-LOS and its LA 
(BCLA), all experiments were executed by measuring activation of 
transient transfected HEK293 and HEK293T cells coexpressing 
murine or human MD-2 (mMD-2, hMD-2) and murine or human 
TLR4 (mTLR4, hTLR4). Moreover, it was used site-directed 
mutagenesis to swap different amino acid residues of the mouse 
and human MD-2 proteins to determine the critical residues 
involved in the binding to BCLA. Measurement of the activation of 
NF-κB, tested with luciferase assays, was the read-out of all 
performed experiments in which E. coli LPS, its lipid A (the 
synthetic compound 506) (Kotani et al., 1985) (Figure 1.5) or the 
biosynthetic precursor lipid IVA were used as control.   
Preliminary results showed that BC-LOS and BCLA act as 
agonists both for human and mouse TLR4/MD-2 complexes (data 
not shown). In order to further study the structure-activity 
relationship of BCLA, by ad hoc molecular biology, it was 
conceived and constructed a BCLA mutant (LAMUT) lacking the 
Ara4N residues (see also chapter 7) and observed the activation of 
HEK293 cells expressing human or mouse MD-2. Figures 8.2 show 
dose-response curves for human and murine TLR4/MD-2 to BC-
LOS and LOS bearing the LAMUT (MUT-LOS) (Figure 8.2Top), 
and to BCLA and LAMUT (Figure 8.2Bottom), respectively. These 
studies corroborated preliminary results showing that also at a 
minimal concentration (1 ng/mL, Figure 8.2Top) both B. 
cenocepacia LOSs are able to induce activation of TLR4/MD-2. As 
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stated above, these evidences also suggest that a different binding 
mode indeed occurs. Similar experiments were performed by using 
isolated BCLA and LAMUT (Figure 8.2Bottom) and the results 
showed consistent agonistic activity, also for the lowest 
concentration employed (5 ng/mL; Figure 8.2Bottom). However, it 
is important to note a significant difference in NF-κB activation 
induced by BCLA species with or without Ara4N. In the latter, 
LAMUT had a slightly reduced immunostimulatory activity 
(Figure 8.2Bottom).  
 Furthermore, it was also checked to what extent could BC-
LOS interfere with the TLR4 signaling process elicited by the LPS 
of E. coli. In order to answer to this question, it was performed a 
competition assay in which HEK293 cells transfected with either 
hTLR4/hMD-2 or mTLR4/mMD-2 were pre-incubated with BC-
LOS for 1 h and then re-stimulated with E. coli LPS for 4 h (Figure 
8.3). It was observed that the lowest tested concentration (1 ng/mL, 
Figure 8.3) of BC-LOS was not able to change the NF-κB 
activation elicited by 1 ng/mL of E. coli LPS (Figure 8.3). 
Interestingly, when pre-incubation was performed using 10ng/mL 
of BC-LOS, followed by stimulation by 1 ng/mL of E. coli LPS, 
the E.coli LPS-induced NF-kB activation was lower than with E. 
coli LPS alone (Figure 8.3). In particular, a 2-fold reduction of E. 
coli LPS-NF-κB activation was observed when pre-incubation with 
B. cenocepacia MUT-LOS was performed (10 ng/mL; Figure 8.3). 
These results suggest that BC-LOS lacking Ara4N partially 
antagonizes the activity of the archetypical TLR4/MD-2 agonist E. 
coli LPS (Figure 8.3). Hence, summarising the above results, it can 
be assessed that BC-LOS and its lipid A moiety activate HEK293 
cells expressing human or mouse MD-2 and that Ara4N plays a 
significant role in the effective activation of NF-κB by binding to 
the TLR4/MD-2 complex. 
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Figure 8.2 Top) NF-κB activation upon stimulation of HEK293 hTLR4/hMD-2 with BC-
LOS, MUT-LOS and E. coli LPS. Bottom) NF-κB activation upon stimulation of 
HEK293 mTLR4/mMD-2 with BCLA and LAmut. Stimulations with E. coli LPS, 
compound 506 and lipid IVA were used as benchmark. 
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Figure 8.3 Assay on the potential antagonist activity of BC-LOS and MUT-LOS on hexa-
acylated E. coli LPS.  
 
8.3 Identification of amino acid residues of MD-2 
involved in the interaction with LPS 
8.3.1 The hydrophobic pocket 
In order to further investigate the molecular recognition events 
between B. cenocepacia LA and TLR4/MD-2, were generated 
several human and mouse MD-2 mutants that were employed to 
transfect HEK293 cells coexpressing human or mouse TLR4. The 
attention was focused on several residues that reside at the 
dimerization interface of the MD-2 protein, whose importance in 
lipid IVA- and E. coli LPS-induced activation has previously been 
Chapter 8 
The activation of TLR4/MD-2 by LPS from Burkholderia cenocepacia 
 
 
161 
 
tested (Meng et al., 2010; Resman et al., 2009). First analyses were 
focused on Val-82 that resides in the proximity to the pocket 
entrance, at a loop between β-strands 5 and 6, which is comprised 
of several conserved solvent-exposed hydrophobic residues, thus 
contributing to the establishment of crucial hydrophobic 
interactions in the activated receptor complex (Resman et al., 
2009). To introduce a change at this position that could affect LPS 
binding without disturbing the hydrophobic nature of the 
interactions, aliphatic Val82 was substituted by the aromatic 
phenylalanine residue (V82F), with a bulkier hydrophobic side 
chain. Mutation resulted in increased activation of the HEK293 
cells transfected with the hTLR4/hMD-2V82F when stimulated 
with BC-LOS, compared to the control (Figure 8.4). No relevant 
differences were detected between the stimulation with BC-LOS 
and the MUT-form (Figure 8.4). Thus, V82F mutation of the hMD-
2 protein affected the binding of LA to MD-2, inducing a greater 
activation of NF-κB levels. Computational models (see below) 
suggest that the change of van der Waals interactions into CH-π 
interactions could account for a higher affinity. The experiment 
was executed only on HEK293 cells transfected with the human 
receptors since virtually all the hydrophobic residues involved in 
the abovementioned MD-2 hairpin loop are conserved between the 
two species (Meng et al., 2010). Therefore, it is expected that these 
hydrophobic interactions between mTLR4/mMD-2 and LA are 
fairly similar to those concerning the hTLR4/hMD-2 complex 
(Meng et al., 2010).  
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Figure 8.4 NF-κB release upon stimulation of HEK293 hTLR4/hMD-2 and HEK293 
mTLR4/mMD-2  with BC-LOS and MUT-LOS. Stimulation with E. coli LPS was used as 
benchmark. 
 
8.3.2 The surface charged residues 
While the hydrophobic residues of both TLR4 and MD-2 
involved in hydrophobic interactions are conserved among 
different species, the electrostatic interactions that have been 
shown to contribute to receptor activation are mediated by amino 
acid residues that markedly differ between mouse and human MD-
2. In particular, the hMD-2 protein has a positively charged lysine 
residue at position 122 (Lys-122) near the pocket entrance, whereas 
mMD-2 has a negatively charged glutamic acid (Glu-122) moiety 
(Meng et al., 2010).  Moreover, hMD-2 has a positively charged 
lysine at position 125 (Lys-125), while murine MD-2 has a neutral 
hydrophobic leucine (Leu-125) (Meng et al., 2010). In the 
complex, both residues are close to the disaccharide backbone of 
LA (Kim et al., 2007)
 
and have been shown to be important for 
species-specific differences in the recognition of lipid IVA between 
human and mouse MD-2. Therefore these two positions, 122 and 
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125, were mutated on both MD-2 homologues, assuming that these 
substitutions could affect LA binding and consequently influence 
TLR4 activation (Meng et al., 2010). While the single E122K 
mutation on mMD-2 (E122 of murine MD-2 was replaced by the 
corresponding human residue) had little or no effect on the 
activation induced by the BC-LOS or the E.coli LPS, a remarkable 
decrease of the NF-κB activation after stimulation with lipid IVA 
was observed (Figure 8.5Top). As previously demonstrated (Muroi 
and Tanamoto, 2006),  the charge alteration from glutamic acid to 
lysine substantially decreases the agonistic activity of lipid IVA, 
likely due to the removal of the repulsive forces versus the bis-
phosphorylated disaccharide backbone. These interactions  are 
essential for lipid IVA to tilt towards the Cys-95/Cys-105 loop, 
responsible for the binding of MD-2 to TLR4 (Meng et al., 2010). 
Thus, the unchanged B. cenocepacia LA responsiveness suggested 
that replacement of the amino acid in position 122 was not enough 
to alter the TLR4/MD-2 activity. This fact strongly suggests that 
the single 122 residue of the MD-2 protein is not pivotal for BC-
LOS signaling. Additionally, in the docking calculations (see 
below), no major role was observed for this residue in terms of 
predicted binding. These results were partly corroborated by 
luciferase assays performed on HEK293 cells transfected with the 
human MD-2 K122E mutant and with mTLR4. Indeed, 
replacement of Lys122 in human MD-2 by glutamic acid (present 
in murine MD-2) did not affect the BC-LOS signaling, while a 
substantial increase of the NF-kB activation by the B. cenocepacia 
MUT-LOS was observed (Figure 8.5Bottom). This behavior is now 
probably due to the presence of repulsive forces towards the 
phosphate groups of the lipid A, which might facilitate the 
orientation toward the Cys-95/Cys-105 loop. Thus, the different 
BC-LOS responsiveness might be related to the presence of the 
Ara4N residues that mask the negatively charged phosphate 
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groups, and could reduce the repulsive forces introduced with the 
K122E mutation.  
 
    
Figure 8.5 (Top) NF-κB-luciferase reporter assay executed stimulating HEK293 
hTLR4/hMD-2, HEK293 mTLR4/mMD-2, HEK293 mTLR4/mMD-2 E1222K and 
HEK293 mTLR4/mMD-2 E122K L125K cells with BC- LOS and MUT-LOS, E. coli 
LPS and lipid IVA. (Bottom) NF-κB activation by stimulation of: HEK293 hTLR4/hMD-
2, HEK293 mTLR4/mMD-2, HEK293 mTLR4/hMD-2 K122E and HEK293 
mTLR4/mMD-2 E122K with BC-LOS and MUT-LOS. Stimulation with E. coli LPS was 
used as benchmark. 
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On the contrary, the absence of Ara4N residues in the MUT-lipid 
A backbone might explain the augmentation of its agonistic activity 
when tested on HEK293 cells transfected with hMD-2 
K122E/mTLR4. On the other hand, when stimulation occurred on 
cells expressing the double E122K/L125K murine MD-2 mutant 
(Figure 8.5Top), a substantially increased activity of the mutant 
MD-2 was detected, when compared to the wild type MD-2 or 
other tested mutants (Figure 8.5Top). In particular, it was observed 
an appreciable difference between the NF-κB activation induced by 
BC-LOS and the MUT-form (Figure 8.5Top), where the latter 
seemed to have acquired a greater agonistic activity compared to 
the WT BC-LOS. Interestingly, simultaneous mutations of K122E, 
K125L, together with Y41F, and R69G, on human MD-2, have 
been reported to be required to promote an immune response by 
lipid IVA, which is known to be an antagonist of human TLR4/MD-
2 (Meng et al., 2010).
 
 
8.3.3 Conclusions on biological assays results 
Taken together, experiments on human and mouse MD-2 mutants 
allowed to confirm initial hypothesis about the “non-archetypal” 
BCLA binding mechanism to the TLR4/MD-2 receptor. Indeed, 
results provided direct evidence that the peculiar architecture of B. 
cenocepacia LA plays a key role in the interaction with MD-2 as 
well as in the dimerization process. In particular, summarising the 
results regarding modification experiments on charged residues 
(see above), it is possible to suggest that the presence of the amino-
arabinose residues on the BCLA glucosamine backbone affects the 
binding to the TLR4/MD-2 complex, although their absence 
(MUT-LOS and LAMUT) seems to be not sufficient by itself to 
impair the BCLA signaling. This conclusion was drawn on the 
basis of an increased agonistic activity acquired by LAMUT when 
tested on human mutant MD-2 K122E (Figure 8.5); this singular 
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behavior might be explained assuming that the Ara4N residues, 
besides acting as additional anchorage points to the receptor 
complex, act also as a mask of the negatively charged phosphate 
groups on LA backbone. In case of the human MD-2 protein, 
which is characterised by several positively charged residues near 
the pocket entrance, as described above, this “charge-masking 
mechanism”  may be essential to explain the high levels of 
HEK293 cells activation observed in the biological assays. 
Furthermore, it is worth to emphasise again that, even in absence of 
Ara4N, B. cenocepacia LA showed a significant agonist activity 
that could be explained by its peculiar acylation pattern. To pursue 
this hypothesis and to validate speculations derived from luciferase 
assays results, molecular modeling experiments were performed by 
Dr. Sonsoles M.S. and collaborators. 
8.4 Molecular modelling of docking of BC-LOS to the 
MD-2 and TLR4 activation 
The biological results seem to suggest different MD-2 binding 
affinities driving the agonist activity. In order to propose a binding 
mode of MUT- and BC-LOSs, docking calculations were 
undertaken and the two ligands were docked into both MD-2 
proteins, human and murine. Two different docking methodologies 
were used, by means of AutoDock and AutoDock Vina programs; 
while AutoDock is a widely used semi-empirical docking method 
(Goodsell et al., 1996),
 
the recently released AutoDock Vina 
combines empirical and knowledge-based scoring functions, with 
good performance and reduced computing time (Trott and Olson, 
2010). Firstly, the validation of the docking protocols was 
performed with both AutoDock and AutoDock Vina, by docking E. 
coli lipid A from crystallographic structures (PDB codes 3fxi –
human- and 3vq2 –murine-) into the MD-2 protein from their 
corresponding PDB files. Values of root-mean-square deviation 
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and predicted free energy of binding values indicated an excellent 
performance of both programs in predicting the crystallographic 
binding pose for both human and murine MD-2 proteins (Table 
8.1). 
 human MD-2 murine MD-2 
BCLA -20.02/-25.30 -17.73/-23.60 
LAmut -18.22/-18.60 -13.09/-17.20 
E. coli lipid A -24.41/-28.3 
(RMSD = 0.282/0.599) 
-24.73/-27.9 
(RMSD = 0.647/0.394) 
 
Table 8.1 Theoretical free energy of binding for the docking calculations with AutoDock 
4.2 and AutoDock Vina (in bold). Energy values are in kcal/mol.  Root-mean-square 
deviation (RMSD) values are in Å. 
 
8.4.1 Model for the binding of LAMUT and BCLA 
Once both docking programs and docking protocols were shown 
to be efficient and reliable for predicting the binding conformation 
of these type of ligands, and calculations conditions were set up, 
calculations with LAMUT and BCLA were undertaken. First, the 
docking of LAMUT and BCLA structures was carried out. 
Regarding predicted binding energies, results were consistent in 
both AutoDock and AutoDock Vina programs, both predicting 
better values for E. coli lipid A, followed by wild type BCLA and 
then LAMUT, in agreement with the biological data. General 
results are shown in Table 8.1. Both lipid A, BCLA and LAMUT, 
were predicted to bind both human and murine MD-2, with binding 
poses in agreement with the crystallographic binding poses for E. 
coli lipid A (superimposition with E. coli lipid A in Figures 8.6 and 
8.7). Docking poses consisted on four fatty acid chains deeply 
immersed into the hydrophobic pocket of MD-2, making van der 
Waals and CH-π interactions with the side chains of most of the 
lipophilic residues of the MD-2 pocket, mainly consisting of 
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aliphatic Leu, Ile and Val residues, aromatic Phe (numbering 76, 
104, 119, 121, 126, 147, and 151), and Tyr (numbering 102, and 
131) residues. With most of these residues, all the docked poses 
were found to participate in hydrophobic interactions. Given the 
longer length of these four fatty acid chains, higher efficiency in 
the establishment of lipophilic interactions can be deduced. The 
fifth chain is placed into the groove or channel defined by Phe126, 
Leu87, Val82 and Arg90. This channel has been identified in the 
X-ray structures of the complex of TLR4/MD-2 with E. coli lipid A 
(Park et al., 2009) as the allocation site for one lipid chain, 
allowing to complete the hydrophobic interface required for 
dimerization with the second TLR4/MD-2/ligand partner (referred 
to here as TLR4*/MD-2*). This precludes formation of the 
activated TLR4/MD-2/ligand multimer. Also Phe126 has been 
proposed as a switch controlling the agonist/antagonist 
conformation of MD-2, since Phe126 mutation prevents 
dimerization and abolishes downstream signaling (Park et al., 
2009; Kobayashi et al., 2006).   
In summary, the major length of the five fatty acids is able to 
trigger the dimerization excluding from MD-2 pocket the fifth one, 
which builds the dimerization interface in the Phe126, Leu87, 
Val82 and Arg90 groove, analogously to the sixth FA of E. coli 
lipid A.  
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Figure 8.6 B. cenocepacia WT LOS (CPK colours) docked to MD-2. Superimposed fatty 
acids chains from E. coli lipid A are shown in different colours. 
 
 
Figure 8.7 Detail B. cenocepacia WT LOS (CPK colours) docked to MD-2. Superimposed 
fatty acids chains from E. coli lipid A are shown in different colours.  
 
Additionally, the disaccharide scaffold of BCLA and LAMUT, 
together with the phosphate groups, are located in the outer region, 
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establishing electrostatic interactions with the polar residues 
defining this external part of the MD-2 pocket (Figure 8.8). The 
higher predicted affinity for BC-LOS can be explained in terms of 
additional anchorage points arising from the amino-arabinose 
residues. In particular, these Ara4N moieties are able to establish 
additional interactions with MD-2. The hydroxyl (OH) group from 
Tyr102 establishes bridged H-bonding with the OH at position 2 of 
Ara4N and the OH from the FA chain (Figure 8.9), while OH at 
position 3 from the same amino-arabinose establishes a hydrogen 
bond with Ser118 OH group. In the case of amino-arabinose 2, the 
OH group from one of the FA chains establishes a hydrogen bond 
with Lys122 CO group, whereas OH-3 and ammonium groups, 
although out of the H-bond distance range (4.5 Å), are well 
oriented towards carbonyl groups from Lys122 and Gly123, maybe 
enabling a putative H-bond networking at this site. These 
interactions could also be identified in the complex with the murine 
MD-2. This putative binding mode of BCLA could thus explain the 
high level of activation in the biological assays. The lack of some 
lipophilic interactions arising from the absent sixth fatty acid chain, 
in comparison to E. coli lipid A, could also be compensated by 
these extra polar interactions from the amino-arabinoses. It is worth 
noting that the Ara4N moieties are playing also a major role in the 
full complex architecture (see below), justifying biological 
activation responses. 
  
Chapter 8 
The activation of TLR4/MD-2 by LPS from Burkholderia cenocepacia 
 
 
171 
 
                      
Figure 8.8 Superimposition of best docked results of B. cenocepacia LOS core. The docking 
was obtained using AutoDock Vina (depicted in red) and E. coli LPS core from PDB 3fxi 
(depicted in green). TLR4 is not shown for the sake of clarity. 
 
Figure 8.9 Detail of Tyr102. Docked pose of B. cenocepacia WT LOS in MD-2. Detail of 
some H-bond interactions involving Tyr102.                                                     
Chapter 8 
The activation of TLR4/MD-2 by LPS from Burkholderia cenocepacia 
 
 
172 
 
8.4.2  3D model for the human TLR4/MD-2 dimer in complex 
with B. cenocepacia LPS 
First, docking of the core oligosaccharide moiety was performed 
on human TLR4, focusing on the region where E. coli LPS core 
binds. The best binding pose was selected (theoretical binding free 
energy of -2.8 kcal/mol, by AutoDock Vina), taking also into 
account a proper orientation for the building of the full complex. 
Docked pose, superimposed with E. coli LPS core from PDB 3fxi, 
is shown in Figure 8.8. The human TLR4/core complex was then 
assembled to the MD-2/BCLA complex (best result from 
AutoDock Vina calculations), leading to a full hTLR4/MD-2/BC-
LOS complex, which was submitted to molecular dynamics (MD) 
simulations. Receptor dimer building was performed by using PDB 
3fxi as template. The full 3D structure of the dimer complex was 
submitted to MD simulations and is shown in Figure 8.9. MD 
simulations did not show meaningful differences with the docked 
complexes (data not shown).              
Building of a 3D model of the full complex may allow the 
identification of key interactions for the molecular recognition 
mediated by BCLA. Apart from the already mentioned 
participation in MD-2 anchoring, BCLA amino-arabinoses are 
playing a fundamental role in complex formation as they 
participate in H-bond networking in the dimerization interfaces as 
follows: both ammonium groups from Ara4Ns 2 and 3, are 
establishing hydrogen bonds with residues belonging to TLR4: 
with the Arg264 CO group, and with Asp294 carboxylate groups 
respectively; ammonium group of arabinose 1 is close to Asp395 
carboxylate and Ser416 OH group, both residues belonging to the 
opposite TLR4* and OH-3 from amino-arabinose 1 is establishing 
a H bond with Ser 415 CO group (TLR4*) (Figure 8.10). The 3D 
models from docking could suggest higher activation for BC-LOS 
Chapter 8 
The activation of TLR4/MD-2 by LPS from Burkholderia cenocepacia 
 
 
173 
 
vs MUT-LOS, arising from the extra anchorage points from 
arabinoses, in agreement with the biological results, which showed 
weaker activation for both LOSs, BC-LOS and MUT-LOS.                                        
8.4.3  Conclusions on molecular modeling experiments 
The structural peculiarities of B. cenocepacia core and the 
presence of two amino-arabinoses in the lipid A region provide 
relevant hints at an atomic level for the binding to and activation 
ability of TLR4/MD-2 receptor complex. Actually, the network of 
hydrogen bonds and polar interactions contributing to the 
anchorage of the lipid A into the TLR4/MD-2 involves not only the 
sugars from the core oligosaccharide (for example, hydrogen bonds 
involving with Arg322 (Figure 8.10), but also the three amino-
arabinoses. Reported mutagenesis studies demonstrate that several 
Lys residues involved in LPS binding play indispensable roles 
through the polar interactions with the phosphate groups (Griber et 
al., 2004; Re and Strominger, 2003). In the present dimer model, 
Lys122 is involved in binding the BCLA through polar interactions 
with the core; as for Val82Phe, it has been already mentioned its 
role in building the groove that accommodates the acyl chain from 
lipid A, completing the interaction surface required for 
dimerization. The replacement of Val82 by Phe involves changes 
of van der Waals interactions into CH-π interactions, which may 
favor the binding of this chain, longer than the corresponding one 
on E. coli LPS. Thus, the biological results on mutants support our 
3D models and open new insights into the molecular recognition of 
LPS by TLR4/MD-2.   
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      Figure 8.10 Details of some interactions between the B. cenocepacia LOS and TLR4/MD-
2 from the 3D model. 
 
              
Figure 8.11 Left panel) 3D Model of the dimer of B. cenocepacia LOS in   complex with 
TLR4/MD-2. Right panel) Detail of the dimer of B. cenocepacia LOS in complex with 
TLR4/MD-2.                                                                   
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8.5 Discussion 
Opportunistic bacterial infections normally rapidly cleared from 
the airway of healthy individuals, cause persistent inflammation in 
individuals with impaired immune defences such as patients 
affected by cystic fibrosis (CF). Indeed, beyond the genetic defect, 
CF may be considered as an inflammatory disorder with 
neutrophilic airway wall inflammation, bronchiectasis and mucus 
retention (De Soyza et al., 2012); this latter provides a niche for 
bacteria that would normally try to evade immune system 
recognition. In this scenario, Burkholderia cenocepacia has been 
recognised as one of the CF pathogens with the greatest 
proinflammatory potential (and capacity for harm), particularly in 
patients undergoing lung transplantation (De Soyza et al., 2001; 
Aris et al., 2001). The pro-inflammatory capability is mainly 
attributed to the lipopolysaccharide, able to stimulate a nine-fold 
higher release of cytokines compared with that of P. aeruginosa 
(Shaw et al., 1995), the most common CF opportunistic pathogen. 
Several experiments (Rallabhandi et al., 2008)
 
demonstrate that the 
highest immunostimulatory activity correlates with the higher 
degrees of lipid A acylation and to the asymmetrical distribution of 
the acyl chains with respect to the glucosamine disaccharide 
backbone (De soyza et al., 2012). Indeed, whether the synthetic 
tetra-acylated lipid IVA antagonizes the elicitation of the 
inflammatory response, on the contrary, the hexa-acylated lipid A 
of E. coli has been shown to exhibit the highest agonistic activity 
on human cells. Likewise, it has previously been shown that P. 
aeruginosa, synthesizes hexa-acylated LPS during the adaptation 
step of the chronic infections seen in CF. On the other hand penta-
acylated LPS from P.aeruginosa does not activate human 
TLR4/MD-2 complex (Hajjar et al., 2002). Therefore the current 
dogma of LPS detection considers the hexa-acylated lipid A as the 
typical agonist for the TLR4/MD-2 complex whereas 
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underacylated LPSs have been shown to be less or not sensed by 
the PRR complex. Interestingly, as shown herein through a plethora 
of biological assays, B. cenocepacia penta-acylated lipid A can 
elicit a significant inflammatory response activating the human 
MD-2/TLR4 complex despite the relative underacylated structure 
as compared to P. aeruginosa, suggesting a different model of 
TLR4/MD-2 activation.  
In this frame, the present work highlights the ability of penta-
acylated LPS to strongly activate TLR4 . Furthermore, the role of 
amino-arabinose has been investigated using Ara4N modified 
chemotype. Results, using point mutants of MD-2 and molecular 
modeling, indicate that the increased length of acyl chains of the 
lipid A moiety and the presence of the amino-arabinose residues 
are synergistically working for the activation and dimerization of 
LPS receptors. Modeling experiments show that both amino-
arabinoses contribute to the dense network of interactions involving 
sugars of core region providing additional anchorage points of the 
lipid A moiety into the receptor complex; indeed the absence of 
amino-arabinoses in LAMUT is responsible for its lower 
immunostimulatory activity with respect to BCLA, as observed in 
Figure 8.2, Bottom. Interestingly, the observation of the increased 
agonistic activity of LAMUT when tested on human mutant MD-2 
K122E (Figure 8.5, Bottom) suggests a further potential role for 
amino-arabinoses consisting in masking the negative charges of 
phosphate groups of lipid A backbone; this hypothesis could be 
explained considering the repulsive charges between the LA 
phosphate groups and the Glu122 on MD-2 surface that might be 
responsible to relocate the disaccharide backbone so that it is able 
to expose the acyl chain required for activation/dimerization of the 
receptorial complex. Although LAMUT lacks the additional 
“points of anchorage” to the MD-2 represented by amino-
arabinoses, in any case exerts a consistent agonist activity on 
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human cells. In this work it is showed that this behavior is due to 
the increased length of the acyl chains of the BCLA with respect to 
E.coli lipid A, in particular due to the one of the 16:0 (3-OH) fatty 
acids not present in the E.coli lipid A acylation pattern. Therefore, 
the presence of longer acyl chains is responsible for the fulfillment 
of the MD-2 binding pocket by the hypo-acylated lipid A from B. 
cenocepacia thus allowing the exposition of the acyl chain 
responsible for the TLR4 activation, as it could be assumed by 
observing our computational models and experimental results from 
luciferase assays executed on human mutant MD-2 V82F (Figure 
8.4). Indeed, computational analyses suggest that the higher 
immunostimulatory activity observed for BCLA and LAMUT  
when tested on hMD-2 V82F is due to the capacity of the longer 
acyl chains to establish lipophilic interactions with higher 
efficiency arising from the change of van der Waals interactions 
(valine) into CH-π interactions (phenylalanine).    
        In summary, it can be stated that the “uncommon” model of 
TLR4/MD-2 activation by BCLA is due to a combination of two 
pivotal features: i) the amino-arabinoses that provide extra polar 
interactions facilitating the BCLA binding to the TLR4/MD-2 
multimer, and ii) the length of the two primary 16:0 (3-OH) acyl 
chains compared to those possessed by the prototype E.coli lipid A, 
that compensates the minor number of fatty acids filling the 
hydrophobic binding pocket of MD-2 protein, allowing  the 
exposition of the acyl chain responsible for the TLR4 dimerization. 
Taking into account the role of the BCLA structure in promoting 
the inflammatory response of human innate immunity and the high 
social impact of inflammation-related pathogenicity of B. 
cenocepacia in cystic fibrosis, the present work results of great 
interest since it opens new insights into the molecular recognition 
of B. cenocepacia LPS by the TLR4/MD-2 complex, a key events 
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of the pathophysiology of the inflammatory responses in cystic 
fibrosis.   
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9.1 Extremophiles: an overview 
Belonging to both two Dominia of Archaea and Bacteria, and to 
either Gram-positive and Gram-negative family, extremophiles are 
life-forms capable to live and thrive in inhospitable, from a human 
viewpoint, environments such as alkaline and acidic waters, boiling 
hot springs, high pressure waters, ultra saline brines, without 
excluding a combination of aforesaid chemical and physical 
extremes which is typical of polyestremophilic microbes (Mesbah 
and Wiegel, 2008). On the basis of the physical or chemical 
parameters these microrganisms can be distinguished in: 
acidophiles and alkalophiles that live at extreme pH values; 
thermophiles that are able to live in extremely high temperatures, 
ranging from 40°C up to 100°C; psycrophiles able to survive in 
frozen habitats, i.e. glaciers or polar seas; halophiles that live in 
extreme salt concentrations from 3 M to saturation of NaCl; 
barophiles that require elevated pressure for proliferation and 
xerophiles that can be isolated from extremely anhydrous 
environments (Figure 9.2). Several studies of extremophiles have 
helped redraw the three-domain system of life. Indeed, the typical 
dogma held that living organisms could be grouped into two 
domains: Bacteria, with a simple structural architecture, and 
Eukarya, whose cells are more complex (see also Section I). The 
discovery of microorganisms in environments that were assumed to 
be sterile supported to the once heretical proposal that yet a third 
group, the Archaea, exists (Figure 9.1).  Many microbiologists 
believe that ancestors of today’s archeal species might represent a 
type of organism that first inhabited Earth when it was a young and 
hot planet. These unique features led the American microbiologist 
Carl Woese to propose these microorganisms be lumped together 
and called Archeabacteria, as already described in Section I, 
Chapter 1. Anatomically, archaeans differ from bacteria since their 
Chapter 9 
Elucidation of the Structure and Biological Acitivity of Endotoxins isolated 
from the thermophilic bacteria Thermomonas hydrothermalis 
 
 
185 
 
cell membrane is composed by isoprenoid and isoprenyl glycerol 
ether-linked lipids, with fully saturated acyl chains (Gulik et al., 
1985). The presence of these lipids and the production of 
exopolysaccharides allowing the formation of biofilms, are 
responsible for the extraordinary stability shown by extremophiles. 
The notable resistance offered by these components to hydrolysis at 
acidic and alkaline pHs and at high temperature, have been 
proposed as the feature that allowed the development of archaeal 
extremophile strains. Noticeable, recently researchers have focused 
on DNA and have completely sequenced a number of bacterial and 
archaeal genomes; these studies have demonstrated that some genes 
of archaea are similar to bacterial genes and others to eukaryotic 
genes. On the other hand, a large fraction of archaeal genes appear 
to be unique. These unshared genes establish archaea’s separate 
identity.    
        
 
                  Figure 9.1. Evolutionary tree of the three domains system.  
                                                                                                    
Owing to their unique features, estremophiles have attracted 
much interest since they showed to possess a high biotechnological 
potential with a number of important industrial applications 
comprising bioremediation and biomining processes (Taylor et al., 
2012). Of particular interest are the enzymes that help 
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extremophiles to function in hostile circumstances such as synthetic 
catalysts that speed up chemical reactions without being altered 
themselves. The common used enzymes degrade or stop working 
when exposed to heat or other extreme conditions, and so 
manufacturers that rely on them must take specific steps to protect 
the molecules during reactions or storage. Since enzymes from 
extremophiles – termed “extremozymes” – remain active when 
other enzymes would fail, they can potentially remove the need for 
those steps, thereby increasing efficiency and reducing costs 
(Madigan and Marrs, 1997). Furthermore, they can form the basis 
of entirely new enzyme-based processes (Madigan and Marrs, 
1997).  
 
             
               Figure 9.2 Classification and examples of extremophiles. 
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9.2 Thermophiles: an overview 
Among all environmental factors, temperature is considered one of 
the most important variable controlling the viability and activities 
of microorganisms as well as the parameter that can be easily 
measured (Brock, 1970). In this context, thermophiles represent a 
class of microorganisms, including Archaea, Bacteria and Eukarya, 
that can live and reproduce at relatively high temperatures, between 
50° and 60°C (Stetter, 1999), but also microbes living at 
temperatures above 80°C, termed hyperthermophiles, were found 
(Stetter, 1999). Some hyperthermophiles even thrive in 
environments hotter than 100°C (Madigan and Marrs, 1997).
 
Hot 
habitats are encountered in correspondence of volcanic areas above 
and below the sea level, where mineralised water comes to the 
surface, and in the deep rock formations heated by the Earth’s 
interior. All thermophiles require hot water but differ in other 
habitat needs. Some thrive in only acidic water, others require 
calcium or sulphur carbonate, still others live in alkaline springs. 
Depending on these other features, thermophiles are described 
more specifically with terms such as thermoacidophile that live in 
heat and acid environments or halophilic alkalithermophiles that 
grow optimally at or above Na
+
 concentrations of 1.7 M, pH 
greater than or equal to 8.5, and temperatures greater than or equal 
to 50°C (Bowers and Wiegel, 2011).
 
The first extremophile capable 
of growth at temperatures greater than 70°C was Thermus 
aquaticus, that has become famous as the source of the heat-
resistant enzyme Taq DNA polymerase, one of the most used 
enzymes in the molecular biology field (Brock, 1986).  
approximately at same time the first hyperthermophile in an 
extremely hot and acidic spring was isolated. This organism, the 
archaean Sulfolobus acidocaldarius, grows at temperatures as high 
as 85°C. Thermophiles grow in communities composed of billions 
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of individuals and often dozens of species. Some communities form 
long, flexible structures called streamers in fast-flowing water of 
runoff channels (Figure 9.3). The thermophilic species in these 
streamers are direct descendants of early bacteria. Many other 
bacteria communities grow in columns or pedestals termed mats 
(Figure 9.3). The thermophilic mat community can be compared to 
a forest community. Its superficial species either need or can 
withstand abundant light, while its understory species live with less 
or no light and may metabolize chemicals such as hydrogen and 
iron.
 
    
 
       
                Figure 9.3 Thermophilic streamers (left) and mats (right).     
 
In case of mesophilic organisms, exposure to heat shock conditions 
induces the transiently synthesis of the Heat Shock Proteins 
(HSPs). The synthesis of HSPs is triggered by the accumulation, 
within the cell, of misfolded proteins, as a consequence of the 
stress condition as in case of drastical changes in pH, UV 
irradiation, osmolarity and the presence of variously toxic 
substances such as antibiotics, ethanol, aromatic compounds or 
heavy metals (Ramos et al., 2001). These proteins act like 
chaperones for the other biomolecules, assuring their correct 
folding and translocating them into the right cell compartments, 
even in case of altered functionality of the cell itself.  
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   Changes in temperature result in alterations of the cell membrane 
lipid composition, in order to retain the fluidity of the membrane. 
In Bacteria, this can be obtained by increasing the length of the 
acyl chains, the ratio of iso to ante-iso branching and/or the degree 
of saturation (Prado et al., 1988). The growth temperature-
dependent alterations in fatty acids composition seem to be aimed 
to maintaining the proton permeability of the plasmatic membrane 
at a rather constant level (van de Vossenberg et al., 1998). 
 
  
In Archaea, the acyl chains undergo cyclisation or transition from 
the diether to tetraether. These latter show lowered proton 
permeability due to the hindrance brought to the lipid layer of the 
membrane. Moreover, ether linkages are far more resistant to 
oxidation and to high temperature  than ester linkages, as well as to 
enzymatic degradation by phospholipases (Choquet et al., 1994). 
Consequently, membranes composed by tetraether lipids result 
more termostable.  
Premise  
Thermomonas hydrothermalis is a newly identified, rod-shaped, 
non-motile, strictly aerobic Gram-negative bacterium with the 
optimum temperature for growth of about 50°C (Alves et al., 
2003). It was isolated for the first time from the hot spring at São 
Gemil in Central Portugal and, on the basis of the phylogenetic 
analysis of the 16S rRNA gene sequence, it was considered to be 
closely related to another slightly thermophilic bacterium named 
Thermomonas haemolytica that, nevertheless, has a lower growth 
temperature range than T. hydrothermalis (Alves et al., 2003). The 
knowledge that these microorganisms have developed peculiar 
chemical modifications in their cell wall components to survive at 
high temperatures, makes Thermomonas hydrothermalis a 
fascinating group of bacteria to be studied in order to verify which 
alterations can occur in their membrane constituents that can be 
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associated to their extreme lifestyle. Owing to their location, 
lipopolysaccharides are permanently exposed to environmental 
stresses that likely affect their general structure; indeed LPSs 
isolated from extremophilic bacteria frequently show unusual 
chemical characteristics that influence their biological effects on 
the innate immune system. Interestingly, previous studies 
demonstrated that LPSs or LOSs belonging to non-pathogenic 
bacteria exert an antagonist or partial antagonist activity towards 
toxic LPSs both in vivo and in vitro experiments (Rose et al., 
1995). Nevertheless, despite their key role in viability of Gram-
negative bacteria and their potential “beneficial effects” on innate 
immune system, very little is known about structure and biological 
activity of lipopolysaccharides isolated from extremophilic 
bacteria. Given these premises, the elucidation of the structure 
together with the study of the biological activity of the 
lipopolysaccharide molecule isolated from the slightly thermophilic 
bacteria Thermomonas hydrothermalis become a fascinating target 
to pursue. The present paper is consistent with this objective and, 
therefore, it reports the complete structure of the 
lipooligosaccharide extracted from T. hydrothermalis, that is the 
first LOS that has been characterised among the genus 
Thermomonas. The overall structure was obtained by a 
combination of chemical, NMR spectroscopic and mass 
spectrometric analyses executed on the entire molecule and on its 
partially deacylated and fully deacylated forms. Moreover, a 
meticulous study on T. hydrothermalis LOS bioactivity was 
performed by testing it on important innate immune system 
components. 
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9.3 Extraction, Purification and Compositional 
Analyses of LOS from Thermomonas 
hydrothermalis 
Crude LOS (R-LPS) was isolated from lyophilised cells of T. 
hydrothermalis strain SGM-6
T
using the phenol/chloroform/light 
petroleum extraction protocol (Galanos et al., 1969). The presence 
of a rough-type LPS was confirmed by the SDS-PAGE 
(Kittelberger and Hilbink, 1993) after silver nitrate gel staining 
(Kittelberger and Hilbink, 1993) that showed a run to the bottom of 
the gel due to the low molecular mass of the LOS form; the 
material was purified from other cell contaminants by enzymatic 
digestion with RNase, DNase, and proteases followed by dialysis 
and Sephacryl HR-300 chromatography.  
Structural analyses (Leontein and Lönngren, 1978; De Castro et al., 
1964)
 
on pure LOS revealed the following monosaccaride 
composition: D-GalA, D-Man, D-Gal, D-GlcN (2-amino-2-deoxy-D-
glucose) and 3-deoxy-D-manno-oct-2-ulopyranosonic acid (D-
Kdo). Methylation analysis (Hakomori, 1964) of the intact LOS 
indicated the presence of 6-substituted galactofuranose, terminal 
galactopyranose, terminal galactopyranuronic acid, 3-substituted 
galactopyranose, 6-substituted aminoglucopyranose, 4,6-
disubstituted mannopyranose and 4,5-disubstituted Kdo. Fatty 
acids composition, obtained by using GC-MS, showed the 
occurrence of (R)-3-hydroxyundecanoic acid [C11:0 (3-OH)] in 
amide and in ester linkages and undecanoic acid (C11:0) 
exclusively in ester linkage. 
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9.4 Isolation and structural characterisation of core 
oligosaccharide by NMR spectroscopy 
The complete structure of the core oligosaccharide moiety was 
achieved by NMR spectroscopy and MALDI MS analyses executed 
both on the de-O-acylated LOS and on its fully deacylated form. 
Combination of data belonging to these products was pivotal to 
obtain clear information regarding the peculiar structure of 
Thermomonas hydrothermalis LOS.  The de-O-acylation was 
executed using anhydrous hydrazine (Holst, 2000). The 
1
H NMR 
spectrum of the de-O-acylated product, showed in Figure 9.4, 
highlighted the presence of nine anomeric signals (A-I) between δ 
= 5.80 and 4.40 ppm (Table 9.1) relative to nine distinct spin 
systems. It is worth to note that NMR analysis performed on 
partially deacylated LOS did not show the presence of the signals 
typically assigned to the H-3 methylene protons of the Kdo residue.  
 
Figure 9.4 1H NMR spectrum of  de-O-acylation product with zoom of anomeric 
region (top-right). 
4.64.74.84.95.05.15.25.35.45.55.65.75.85.9 ppm
H1 A
H1 D
H1 F
H1 G
H1 H
H1 I
H1 B H1 C
H1 E
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All residues, except residue D, were present as pyranose rings as 
proven by the 
13
C chemical shift values and by the intra-residual 
long-range correlations between C-1/H-1 and H-5/C-5 observed in 
the 
1
H,
13
C-HMBC spectrum, whereas the observation of 
correlations between protons of residue D and down-field shifted 
carbon signals, around 83.0 ppm suggested the occurrence of a 
furanose ring, as confirmed by the intra-residual H-1/C-4 and C-
1/H-4 correlations in the 
1
H,
13
C-HMBC spectrum.  Residue C (H-
1/C-1 signals at δ = 5.54/94.3 ppm, Table 9.1) and G (H-1/C-1 
signals at δ = 4.63/101.3 ppm, Table 9.1) were assigned to the lipid 
A GlcNp1P and GlcNp4P on the basis of their H-2 protons that 
showed a correlation with two nitrogen-bearing carbon atoms at 
δ=53.7 and δ=55.3 ppm respectively. Moreover, the multiplicity of 
the anomeric proton signal (
3
JH-1,P = 8.0 Hz) of residue C and the 
downfield shifts of H-4 and C-4 (3.95 ppm and 76.5 ppm 
respectively) of residue G were diagnostic of the presence of a 
phosphate group linked at position O-1 C and O-4 G. The 
occurrence of an inter-residue connectivity between H-1 of G and 
H-6a,b of C, identified in the NOESY and HMBC spectra, 
corroborated the assignment of residues C and G to the lipid A 
backbone. Spin systems A (H-1/C-1 at δ=5.79/95.4 ppm, Table 9.1) 
and B (H-1/C-1 at δ=5.70/95.0 ppm, Table 9.1) were identified as 
α-GalA residues due to the presence of a correlation of H-5 A and 
H-5 B  (4.54 ppm and 4.51 ppm respectively) with two carboxyl 
groups (175.8 ppm and 176.2 ppm respectively), that allowed us to 
recognise spin systems A and B as uronic acid residues. The α-
anomeric configuration was attributed on the basis of the intra-
residual NOE contact of H-1 with H-2 and the 
1
JC1,H1 and 
3
JH1,H2 
values (172.3 and 3.4 Hz, respectively) whereas the 
3
JH3,H4 and 
3
JH4,H5 values (3 and 1 Hz, respectively) were diagnostic of a 
galacto configuration. Furthermore, spin systems A and B, as 
residue C, showed the typical multiplicity of a phosphorylated α-
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anomeric proton signal (
3
JH-1,H-2= 3.2 Hz, 
3
J H-1,P= 7.6 Hz); both 
residues were terminal galacturonic acids since none of their 
carbon atoms was shifted by glycosilation. Residue E (H-1/C-1 at 
δ=5.18/100.7 ppm, Table 9.1) was recognised as a β-mannose, as 
shown by its 
3
JH1,H2 and 
3
JH2,H3 low values (3 Hz) and by the intra-
residual NOE correlation of H-1 only with H-2 (diagnostic of a 
manno-configured residue); the β-anomeric configuration was 
assigned on the basis of the strong intra-residue NOE contacts of 
H-1 with H-3 and H-5, together with the 
3
JH1,H2 coupling constant 
(7.8 Hz). Substitution was observed at position O-6, as testified by 
the glycosylation shift for C-6 (66.7 ppm, Table 9.1).  
 
 
Table 9.1 1H and 13C NMR chemical shifts of the product oligosaccharide 
derived from the de-O-acylated  (top) and the fully de-acylated  (bottom) LOS 
from Thermomonas hydrothermalis. N.d. is not determined.   
Chemical shift (1H/13C) of the de-O-acylated LOS
Unit 1 2 3 4 5 6 7 8
A 
t-α-GalAp
5.79
95.4
3.92
67.5
3.99
69.1
4.37
70.3
4.54
73.3 175.8
B 
t-α-GalAp
5.70
95.0
3.90
67.5
4.01
69.2
4.29
70.3
4.51
73.2 176.2
C
6-α-GlcNp1P
5.54
94.3
3.97
53.7
3.72
70.2
3.57
69.5
4.01
71.5
4.16/3.82
68.2
D 
6-α-Galf
5.23
109.2
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Spin systems D, F, H and I were all attributed to galactose 
residues. In details, residue D (H-1/C-1 at δ=5.23/109.2 ppm, Table 
9.1), as described above, showed to be a α-galactofuranose (α-Galf) 
due to the 
1
JC,H  coupling constant value of 174.0 Hz together with 
the 
13
C chemical shift of the anomeric carbon signal and the intra-
residual NOE connectivities; furthermore, residue D was found to 
be substituted at position O-6 due to the downfield shift of its C-6 
(71.0 ppm, Table 9.1). Spin system F (H-1/C-1 at δ=5.07/99.6 
ppm, Table 9.1) was identified as a terminal α-galactose residue 
about which the α-anomeric configuration and the galacto 
configuration were assigned as described above for residues A and 
B. Eventually, both residues H and I (H-1/C-1 at δ=4.50/102.9 ppm 
and 4.44/103.8 ppm, respectively, Table 9.1) were attributed to β-
galacto-configured sugar residues, as proven by the chemical shift 
values of carbinolic protons and the 
3
JH,H ring coupling constants; 
moreover, as delineated for residue E, the large 
3
JH-1,H-2 values and 
the NOE contacts of H-1 with H-3 and H-5, were diagnostic of the 
β-anomeric configurations. Residue H showed to be substituted at 
position O-3, whereas residue I was identified as a terminal glucose 
residue.        
 
Figure 9.5 Section of 1H NMR and 1H, 31P HSQC spectra of the de-O-acylated 
LOS from T. hydrothermalis. The localization of the phosphate groups is 
indicated. 
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 The 
31
P NMR spectrum of de-O-acylated product confirmed 
the presence of four phosphate signals that can be distinguished in 
three groups present in different regions of the spectrum, at –2.08 
ppm, –2.11 ppm and –1.73 ppm. A 31P, 1H HSQC experiment 
(Figure 9.5) was executed in order to identify and localise 
abovementioned phosphate groups. The phosphorous signal at–2.08 
ppm showed to be related to a double correlation with two different 
proton signals at 5.70 ppm (H-1 B) and 3.95 ppm (H-4 G). Above 
double correlation was attributed to H-1 B of the α-GalA residue 
attached to C-4 of β-GlcN II G of lipid A backbone via 
phosphodiester bond. Signal at –2,11 ppm in the 31P-1H HSQC 
spectrum (Figure 9.5) was connected to the proton signal at 5.54 
ppm (H-1 C). Finally, signal at –1.73 ppm showed to have a double 
correlation with two anomeric proton signals at 5.79 ppm (H-1 A) 
and 5.54 ppm (H-1 C), underlining a further phosphodiester bond 
involving, in this case, the α-GlcN I C of lipid A backbone and the 
α-GalA residue A. Therefore, summarising all results belonging to 
the 
31
P, 
1
H HSQC experiment it was found that T. hydrothermalis 
LOS possess a peculiar lipid A carbohydrate backbone 
characterized by the presence of the disaccharide [P→4-β-D-
GlcpN-(1→6)-α-D-GlcpN1→P] carrying one galacturonic acid on 
each phosphate group.  
Owing to the absence of the signals relative to the Kdo residue, 
whose presence was detected in chemical analyses (see above), it 
was decided to perform 1D and 2D NMR experiments also on the 
fully deacylated lipooligosaccharide molecule. The complete 
deacylation was executed, after a mild hydrazinolysis, by a strong 
alkaline hydrolysis with KOH 4M; sample was desalted on a 
Sephadex G-10 column and then lyophilised to give the core 
oligosaccharide backbone. The 
1
H NMR spectrum of the fully 
deacylated product (Figure 9.6) showed the presence of the 
diasterotopic methylene signals of the Kdo residue (H-3ax/H-3eq 
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1.97/1.72 ppm, Figure 9.6); moreover it showed the occurrence of 
an additional anomeric signal (H-1/C-1 at δ= 5.46/93.4 ppm, Table 
9.1), not detected in the NMR analysis on the de-O-acylated LOS, 
whose presence, on the contrary, was evaluated in the mass 
spectrometric analysis on the de-O-acylated product (see below). 
The additional spin system, labeled as L (Table 9.1), was attributed 
to a phosphorylated α-GalA unit. The 31P NMR and the 31P, 1H 
HSQC spectra of the totally deacylated LOS confirmed the peculiar 
structure of the lipid A backbone; furthermore both spectra 
highlighted the occurrence of another double correlation between 
the anomeric proton signal of residue L (H-1 at δ=5.46 ppm) and 
the H-4 of the core oligosaccharide mannose residue E (H-4/C-4 at 
δ=4.13/75.9 ppm, Table 9.1) allowing to identify a further 
phosphodiester linkage involving, in this case, two sugar residues 
of the core oligosaccharide moiety. All 
31
P NMR spectroscopy 
experiments were confirmed through MALDI mass spectrometry 
performed on both de-O-acylated and fully deacylated LOS from T. 
hydrothermalis (see below).    
 
 
 
            Figure 9.6  
1H NMR spectrum of  the fully deacylated product.   
 
Rationalising all NMR results, NOESY and ROESY spectra and 
scalar long-range correlations observed in the 
1
H,
13
C-HMBC 
spectrum allowed to define the saccharide sequence. In details, 
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starting from the Kdo unit K, it was observed a substitution at its 
O-4 by mannose E, as suggested by the NOE correlation between 
H-1 E and H-4 K (Figure 9.8), and a substitution at O-5 by the β-
galactose residue H, underlined by the occurrence of a NOE 
contact (Figure 9.8) and a long-range correlation between H-1 H 
and H-5 K. Mannose E was, in turn, substituted at position O-6 by 
residue F, the terminal α-galactose unit, as attested by the long-
range correlation between H-1 F and H-6a,b E and the relative NOE 
connectivity (Figures 9.7 and 9.8); taking in account the double 
correlation between H-1 L and H-4 E, earned from the 
31
P, 
1
H 
HSQC spectrum of the fully deacylated LOS, mannose E is also 
 
   
Figure 9.7 Section of the TOCSY (black) and NOESY (gray) spectra of  the de-O-
acylated LOS from T. hydrothermalis. The relevant inter-residue NOE cross-peaks are 
shown. 
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Figure 9.8 Section of the TOCSY (black) and NOESY (gray) spectra of  the fully 
deacylated LOS from T. hydrothermalis. The relevant inter-residue NOE cross-peaks are 
shown. 
 
substituted at position O-4 by galacturonic acid L via 
phosphodiester linkage. Furthermore, a strong NOE contact 
between H-1 D and H-3 H (Figures 9.7 and 9.8) attested that 
residue H was further substituted at position O-3 by 
galactofuranose D. This latter was, in turn, substituted at its O-6 by 
the terminal β-galactose unit I, highlighted by the NOE contact 
between H-1 I and H-6a,b D (Figures 9.7 and 9.8). In conclusion, 
the structure of core oligosaccharide moiety of LOS from 
Thermomonas hydrothermalis can be described as it follows: 
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9.5 Structural analyses of lipid A and core 
oligosaccharide by MALDI mass spectrometry 
In order to unveil the primary structure of lipid A from 
Thermomonas hydrothermalis LOS, an aliquot of intact LOS was 
analysed by MALDI MS spectrometry. The spectrum relative to the 
intact LOS (Figure 9.9) showed, at lower mass range, three ion 
peaks related to the lipid A moiety raising from the typical 
fragmentation between the lipid A portion and the Kdo-containing 
oligosaccharide domain (Sturiale et al., 2005). In particular, the 
main ion peak at m/z 1925.3 (Figure 9.9) was identified as a hexa-
acylated bis-phosphorylated lipid A, carrying a galacturonic acid 
residue on both phosphate groups. The hexa-acylated lipid A was 
found to be characterized by the presence of two C11:0 (3-OH) in 
ester linkage and two C11:0 (3-OH) in amide linkage as primary 
fatty acids and two C11:0 as secondary fatty acids, in agreement 
with compositional analyses. The other two ion peaks related to the 
lipid A species were relative to lipid A species without one (m/z 
1749.4) or two (m/z 1572.7) galacturonic acid residues (Figure 9.9). 
The nature and the positions of secondary acyl chains were also 
assessed analysing MALDI mass spectrum executed on the entire 
LOS after treatment with NH4OH (Figure 9.10A), as previously 
described (Silipo et al., 2002). Thus, on the basis of mass 
spectrometry, chemical analyses and NMR spectroscopy data, the 
main lipid A species was depicted as reported in Figure 9.14.   
I                     D                    H K
β-Gal-(1→6)- -Galf-(1→3)-β-Gal-(1 5)- -Kdo
4         
F E ↑          
α-Gal-(1→6)-β-Man         
4                                                                              
↑
P         
L   ↑
α-GalA
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Figure 9.9 Negative-ion MALDI TOF mass spectrum of intact LOS of Thermomonas 
hydrothermalis recorded in linear mode. Assignment of the main ion peaks is shown. The 
main lipid A specie structure is sketched in the spectrum. 
 
In Figure 9.9 it was also detectable the ion peak related to the core 
oligosaccharide moiety at m/z 1285.3 relative to a hexa-saccharide 
carrying an additional sugar residue, namely, the galacturonic acid 
linked to the core oligosaccharide via phosphodiester bridge, in 
agreement with the results by NMR analyses. At higher molecular 
masses (Figure 9.9), in the range 2800–3400Da, a cluster of ion 
peaks was detected corresponding to LOS species, given by the 
combination of core oligosaccharide and lipid A moieties. In 
particular main signal at m/z 3211.6 matched with a LOS 
characterized by a hexa-acylated bis-phosphorylated lipid A, 
carrying two galacturonic acids, covalently linked to a 
phosphorylated hepta-saccharide core moiety. Two minor peaks, at 
m/z 3035.5 and m/z 2938.1 (Figure 9.9) relative to LOS species 
without one or two galacturonic acid residues respectively, were 
also found. Further on, MALDI mass spectrometric analyses on the 
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de-O-acylated (Figure 9.10B) and fully deacylated LOS were 
undertaken. Spectrum inherent about the hydrazinolysis product 
(Figure 9.10B) showed the presence of an ion peak at m/z 1220.0 
matching with a lipid A structure lacking in O-acyl chains, as 
expected, but lipid A species without one or two GalA residues 
were not present, in agreement with NMR data. Moreover, it was 
identified a cluster of peaks related to LOS species whose main 
signal (m/z 2505.5, Figure 9.10B) was consistent with the 
combination of the abovementioned lipid A (m/z 1220.0, Figure 
9.10B) and the already described core oligosaccharide (m/z 1285.3, 
Figures 9.9 and 9.10A), further confirming NMR analyses. MALDI 
mass spectrum performed on fully deacylated LOS (not shown) 
corroborated all results about the core oligosaccharide structure 
reported above. In conclusion, all mentioned data allowed to define 
the complete structure of LOS from Thermomonas hydrothermalis, 
that is sketched in Figure 9.14. 
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Figure 9.10 A) Negative-ion MALDI TOF mass spectrum of intact LOS of Thermomonas 
hydrothermalis after treatment with  NH4OH. Lipid A structure deprived of  primary fatty 
acids in ester linkage to the diglucosamine backbone is shown. Assignment of the main 
ion peaks is indicated. B) Negative-ion MALDI TOF mass spectrum of purified LOS of 
Thermomonas hydrothermalis after de-O-acylation  performed by using anhydrous 
hydrazine. Lipid A structure deprived of ester-linked acyl chains  is sketched in figure. 
Assignment of the main ion peaks is shown. 
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9.6 Biological activity of isolated T. hydrothermalis LOS 
To confirm the absence of contamination, the purified LOS of T. 
hydrothermalis was analysed for the presence of bacterial 
lipoproteins (BLPs) in HEK 293 cells expressing TLR2 (Nigro et 
al., 2008), which is the PRR agonist of bacterial lipoprotein (BLP) 
(Figure 9.11A). NF-κB activation constituted the read out of this 
experiment. No activation of NF-κB was recorded, in agreement 
with the chemical data that confirm the absence of BLP in our 
sample (Figure 9.11A). Therefore, the biological activity of LOS 
was assessed in the model of HEK293 cells, which stably express 
human CD14, MD-2 and TLR4. HEK 293 hTLR4 were exposed to 
different LOS concentrations (1, 10 and 100 ng/ml). The 
Escherichia coli LPS, which possess a fully hexa-acylated lipid A 
structure, acts as a potent agonist for TLR4-MD2-CD14 receptors 
(see also Section III). This LPS was used as a positive control at the 
same concentrations as before. NF- B activation was evaluated 
through the assessment of luciferase activity after 4 h stimulation. 
Likewise, IL-8 release was recorded via enzyme-linked 
immunosorbent assay (ELISA) after 4 h stimulation. The results 
showed that the T. hydrothermalis LOS induced a significantly 
lower NF-κB activation with respect to cells exposed to LPS of E. 
coli (LOS of T. hydrothermalis vs LPS of E.coli p<0.01 at 1 ng/ml, 
p<0.001 at 10 ng/ml and 100 ng/ml). In accordance with NF-κB 
activity, the level of IL-8 expression is lower after stimulation with 
T. hydrothermalis LOS with respect to LPS from E. coli LPS (LOS 
T. hydrothermalis vs LPS E. coli p<0.001 at 10 ng/ml and 100 
ng/ml) (Figure 9.11B). It was then assessed whether T. 
hydrothermalis LOS could interfere with the TLR4-mediated 
signaling induced by hexa-acylated lipid A. HEK 293 hTLR4 cells 
were pre-incubated 1 h with different amounts (1, 10 and 100 
ng/ml) of LOS and then exposed to 10 ng/ml of hexa-acyl E. coli 
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LPS for 4 h.  T. hydrothermalis LOS significantly antagonized 
hexa-acyl LPS-dependent TLR4-mediated NF- B activation and 
IL-8 release at the concentrations of 1 ng/ml (LOS T. 
hydrothermalis vs LPS E.coli P<0.05) (Figure 9.12).  
      
 
Figure 9.11 A) Assessment  of contaminations in LOS. Fold of NF- B activation upon 
stimulation of HEK 293 hTLR2 with 1,10 and 100 ng/ml of T. hydrothermalis LOS  for 
6h. Hexa-acylated E. coli LPS and Pam3CSK4 were used as controls.  *p,0.05, **p,0.01, 
***p,0.001 in the Student’s t-test (T. hydrothermalis LOS  vs E. coli LPS).  B) 
Stimulation of HEK 293-hTLR4/MD2-CD14 with LOS derived from T. hydrothermalis. 
Fold of activation of NF-κB and IL-8 release after 4 h of stimulation with 1, 10 and 100 
ng/ml of LOS; commercial LPS of E. coli was used as a control. Significant difference 
between T. hydrothermalis LOS  generated values and the corresponding E. coli LPS  
values are indicated (T. hydrothermalis LOS  vs E. coli LPS) (*P<0.05; **P <0.01; ***P 
<0.001). 
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Figure 9.12 Competition assay. Fold of NF-κB activation and IL-8 release in HEK 293 
hTLR4/MD2-CD14 stimulated with different concentrations (1, 10 and 100 ng/ml) of T. 
hydrothermalis LOS for 1 h  and then re-stimulated with 10 ng/ml of E. coli LPS (LPS-
EB ultrapure, InvivoGen) for 4 h. Significant difference between T. hydrothermalis LOS  
generated values and the corresponding E. coli LPS  values are indicated (T. 
hydrothermalis LOS  vs E. coli LPS) (*P<0.05; **P <0.01; ***P <0.001). 
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hydrothermalis to activate Bone Marrow-Derived Macrophages 
(BMDMs) for cytokine production (TNF- , KC). BMDMs were 
treated with 1, 10 and 100 ng/ml of the T. hydrothermalis LOS, as 
above, and cytokine release was recorded after 18 h (Figure 9.13). 
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elicited significantly lower amounts of TNF-α release (LOS T. 
hydrothermalis vs LPS E.coli  p<0.05 at 1 and 10 ng/ml, p<0,01 for 
100ng/ml) and significantly lower amounts of KC release (LOS T. 
hydrothermalis vs LPS E.coli  p<0.05 at 1 and 100 ng/ml, p<0,01 
for 10 ng/ml) than E. coli LPS (Figure 9.13).  
 
 
Figure 9.13 Cytokine release in BMDMs stimulated with T. hydrothermalis LOS. TNF-α 
and KC released by BMDMs after stimulation with 1, 10 and 100 ng/ml of LOS derived 
from T. hydrothermalis and E. coli LPS, measured by ELISA at 18 h. Significant 
difference between T. hydrothermalis LOS  generated values and the corresponding E. 
coli LPS  values are indicated (T. hydrothermalis LOS  vs E. coli LPS) (*P<0.05; **P 
<0.01; ***P <0.001). 
 
9.7 Discussion 
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microbial cells. Since lipopolysaccharides are the main components 
of the outer leaflet of the external membrane of Gram-negative 
bacteria, it is reasonable to assume that some structural changes 
should also characterise LPSs isolated from thermophiles as 
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the molecular mechanisms underlying their essential role in the 
adaptation of T. hydrothermalis to the peculiar external 
temperatures and also to define their activity on the components of 
the innate immunity system. In this context, it was determined the 
complete structure of T. hydrothermalis R-LPS enriching structural 
data with important results regarding the bioactivity of purified 
LOS tested on innate immune system cells. Structural elucidation 
of LOS was achieved by a multi-techniques approach comprising 
compositional analyses, 1D and 2D NMR spectroscopy and 
MALDI-MS spectrometry experiments. In details, the lipid A 
structure was carried out by mass spectrometric analysis executed 
on the intact LOS and all results were corroborated by fatty acids 
analysis and by further MALDI-MS experiments performed on 
partially deacylated lipooligosaccharide; whereas the elucidation of 
the core oligosaccharide skeleton was achieved by a combination 
of NMR experiments executed on the de-O-acylated and on the 
fully deacylated LOS but also by MALDI-MS experiments 
performed on the intact LOS and on its deacylated forms. 
Thermomonas hydrothermalis LOS was found to be characterised 
by a unique structure (Figure 9.14), lacking in heptose residues, 
composed of a hexa-saccharide skeleton in which the 
phosphorylated mannose residue (Figure 9.14) carries an additional 
sugar unit, a galacturonic acid, via phosphodiester linkage. 
Moreover, also lipid A turned out to have a peculiar backbone 
structure:[α-D-GalAp1→P→4-β-D-GlcpN-(1→6)-α-D-
GlcpN1→P←1-α-D-GalAp] acylated by two C11:0 (3-OH) in ester 
linkage and two C11:0 (3-OH) in amide linkage as primary fatty 
acids and two C11:0 as secondary fatty acids (Figure 9.14). Thus, 
the overall structure of T. hydrothermalis LOS showed to be, at 
physiological pH, highly negatively charged since it possesses 
three phosphate groups and four sugar residues bearing carboxyl 
groups represented by Kdo unit and galacturonic acid residues. 
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This peculiarity confers to the entire macromolecule the ability to 
interact with divalent cations normally present on the surface of the 
outer membrane; these interactions between LOS-negative charges 
and aforesaid cations contribute to the rigidity and to the tightness 
of the outer membrane, resulting in bacterial high resistance to 
external stresses (Alexander and Rietschel, 2001).
 
These findings 
concerning LOS structure might explain the Thermomonas 
hydrothermalis capability to survive in a hot spring at the 
uncommon temperature of 50°C, giving further confirmations to 
the key role of lipopoly/lipooligosaccharides on extremophilic 
bacterial outer membrane. Furthermore, since LPS/LOS is involved 
in immune system elicitation, it was mandatory to investigate the 
immunostimulatory activity of T. hydrothermalis LOS. This latter 
showed a lower ability to engage the TLR4-MD2-CD14 pathway 
with respect to the hexa-acylated LPS of E.coli. This is a 
fascinating result as the T. hydrothermalis lipid A is hexa-acylated 
like the E. coli lipid A, which is considered, as mentioned above, 
the prototype of the agonist of the TLR4 complex (Park et al., 
2009) (see also Section III). However, several differences could 
underline the low immunopotential of this LOS: (i) the presence in 
T. hydrothermalis lipid A of acyl chains shorter than those of E. 
coli (11 carbon atoms vs 14 carbon and 12 carbon atoms); (ii) the 
symmetry of lipid A which is decorated by 3 acyl residues on each 
glucosamine molecule and, finally, (iii) the presence of 
galacturonic acid on both phosphate groups. Even if the addition of 
these residues should not influence the negative charge of the two 
phosphate groups, the change of the binding of the two decorated 
phosphates with the MD2-TLR4 complex is supposed to modulate 
the activation of the down-stream signaling. Interestingly, the T. 
hydrothermalis lipid A also displayed an antagonistic activity vs 
the hexa-acylated E. coli LPS at low dose; this property has been 
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extensively reported for tetra-acylated lipid A, such as eritoran and 
lipid IVA (Kim et al., 2007; Ohto et al., 2007) (see also Section III).  
                       
                       Figure 9.14 LOS from Thermomonas hydrothermalis. 
 
Several models support the antagonistic activity of these molecules 
by disturbing the binding of the fully potent LPS and preventing 
the TLR4 dimerization (Saitoh et al., 2004). Nevertheless, the 
structures and activity of the molecular complexes, especially the 
intermediate forms, resulting upon LPS TLR4-MD2 binding are 
not fully understood. In this sense, it was not possible to identify 
the mechanism allowing the T. hydrothermalis lipid A to 
successfully compete with E. coli LPS in TLR4 binding. 
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Consistently with data of TLR4 activation, in BMDM the T. 
hydrothermalis LOS elicits a low amount of inflammatory 
cytokine, such as TNF-α and KC, thus confirming the low 
biological activity of this molecule. 
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10.1 Growth of Burkholderia dolosa cells for LOS 
extraction 
Burkholderia dolosa IST4208 isolate was obtained from the 
respiratory secretions of a CF patient under surveillance at the 
Hospital de Santa Maria CF Center, in Lisbon. Isolate B. dolosa 
IST4208 was obtained in 2005 from a CF patient who passed away. 
Consent was obtained from the patient, and the isolate was 
provided by the hospital for this particular study; the patient’s 
anonymity was preserved. This isolate was identified based on the 
polymorphisms of the recA gene (Vermis et al., 2004), followed by 
multilocus sequence typing (MLST) analysis. The MLST 
sequences of the allelic type of seven loci were assigned and 
submitted to the B. cepacia complex MLST database 
(http://pubmlst.org/bcc/) under the designation ST-668; the 
obtained profile confirmed the identification as B. dolosa.                                                                          
Cells of B. dolosa IST4208 were grown overnight in lysogeny 
broth (LB; Difco, Sparks, MD), then inoculated into LB (initial 
OD640nm 0.05) and grown in shake flasks with orbital agitation (250 
rpm, 37°C) until mid-exponential phase. The cell culture was 
diluted (standardized OD640nm 0.2±0.02), and a sample (100 mL) 
was plated onto LB agar (Difco) plates. These plates were 
incubated (37°C, 24 h) to allow cells to grow on the agar surface, to 
mimic bacterial growth in CF lungs. Cells were scraped, collected, 
autoclaved, and lyophilised. 
10.2 Isolation of Pseudomonas aeruginosa strain RP73 
The P. aeruginosa clinical isolate RP73 was isolated after 17 
years of chronic lung infection in a CF patient (Jeukens et al., 
2013). The strain was kindly provided by Prof. Burkhard Tummler  
(Klinische Forschergruppe, Medizinische Hochschule, Germany). 
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The strain was plated on trypticase soy agar (TSA) plates and 
cultured in trypticase soy broth (TSB) at 37°C. 
10.3 Bacterial growth conditions for Burkholderia 
cenocepacia ΔarnBC and ΔarnT-arnBC
+
 strains 
Bacterial strains were grown in LB medium at 37°C. Bacterial 
were grown in LB medium at 37°C. When required, antibiotics 
were added as follows: trimethoprim, 50 mg ml
-1
 for E. coli and 
100 mg ml
-1
 for B. cenocepacia; tetracycline 20 mg ml
-1
 for E. coli 
and 100 mg ml
-1
 for B. cenocepacia; and kanamycin 40 mg ml
-1
 for 
E. coli. Gentamicin at 10 mg ml
-1
 and ampicillin at 100 mg ml
-1
 
were used for triparental mating to select against donor and helper 
E. coli strains. Rhamnose was added to a final concentration of 
0.4% as needed. Antibiotics and chemicals were purchased from 
Sigma Chemical (St Louis, MO, USA). 
10.4 Growth of Thermomonas hydrothermalis cells 
Strains SGM-6
T 
were isolated from the hot spring at São Gemil in 
Central Portugal. Water samples were transported at ambient 
temperature and filtered through membrane filters (Gelman type 
GN-6; pore size 0.45 μm, diameter 47 mm) within 12 hours, which 
were placed on the surface of Thermus agar plates. These 
preparations were wrapped in plastic bags and incubated at 50 °C 
for up 7 days. Cultures were purified by sub-culturing and were 
preserved at –80 °C in Thermus medium containing 15% glycerol 
(Alves et al., 2003).
 
Growth of the organisms was examined in 
several media but was consistently better with Thermus medium, 
which was adopted to grow the organisms, unless otherwise stated. 
Cell morphology, dimensions and motility were examined by 
phasecontrast microscopy during exponential growth in liquid 
medium. The number and position of flagella were determined by 
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light microscopy after staining of the cells with the Ryu stain 
(Heimbrook et al., 1989; Alves et al., 2003). 
10.5 Chemical Analyses 
Determination of monosaccharides and of their absolute 
configuration through GC-MS analysis, were all carried out as 
described (Leontein and Lönngren, 1978). Sugar residues were 
identified as acetylated O-methyl glycosides derivatives. After 
methanolysis (1.25M HCl/MeOH, 85°C, 16 h) and acetylation with 
acetic anhydride in pyridine (85°C, 30 min) the sample was 
analysed by GC-MS. The absolute configuration of 
monosaccharides has been elucidated by GC-MS analysis of the 
acetylated O-(+)-Oct-2yl glycosides derivatives and comparison 
with standards. Linkage analysis was carried out by methylation of 
both complete core region and complete O-chain region as 
described (Hakomori, 1964): the sample was methylated with 
iodomethane, hydrolysed with 2 M trifluoroacetic acid (100°C, 2 
h), carbonyl-reduced with NaBD4, acetylated with acetic anhydride 
and pyridine, and analyzed by GC-MS. Total fatty acid content was 
determined by acid hydrolysis. LOS was first treated with HCl 4M 
(4h, 100°C) and then neutralised with NaOH 5M (30 min, 100°C). 
Fatty acids were then extracted in CHCl3, methylated with 
diazomethane and analysed by GC-MS. The ester bound fatty acids 
were selectively released by base-catalysed hydrolysis with NaOH 
0.5M/MeOH (1:1 v/v, 85°C, 2h), then the product was acidified, 
extracted in CHCl3, methylated with diazomethane and analysed by 
GC-MS. The absolute configuration of fatty acids was determined 
as described (Rietschel, 1976) 
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10.6  Isolation of oligosaccharide (OS) from B. dolosa, 
B. cenocepacia IST and K56-2 strains   
   Isolation of OS was obtained by mild acid hydrolysis. Purified 
LOS (~10 mg) was dissolved in acetate buffer (1 mL, pH 4.4). SDS 
(1 mg/mL) was added, and hydrolysis proceeded (100°C, 3 h). 
After lipid A removal by centrifugation (10 000g, 30 min), the 
water-soluble product was purified by gel filtration 
chromatography on a Bio-Gel P-6 column (Bio-Rad, Hercules, 
CA). 
10.7 Isolation of polysaccharide portion from 
Padoraea pulmonicola 
   The O-chain moiety was isolated by performing a mild acid 
hydrolysis. The purified LPS (~7 mg) was dissolved in acetate 
buffer (1 mL, pH = 4.4), SDS (1 mg/mL) was added, and the 
hydrolysis was carried out at 100°C for 3 h. After lipid A removal 
by centrifugation, the water-soluble product was then purified by 
gel filtration chromatography on a Sephacryl S-100 column. 
 
10.8 Isolation of oligosaccharide moiety from  
Pseudomonas aeruginosa RP73 and 
Thermomonas hydrothermalis 
 
   LOS was treated with anhydrous hydrazine (1 mL), stirred at 37 
°C for 90 min, cooled, poured into ice-cold acetone (20 mL) to 
allow its precipitation. Precipitated LOS was centrifuged (3000 g, 
30 min), washed with ice-cold acetone, dried, dissolved in water, 
and lyophilized. The O-deacylated LOS product was N-deacylated 
with 4M hot KOH as described (Silipo et al., 2012). After removal 
of salts by gel permeation chromatography with Sephadex G-10 
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(Pharmacia) column, the resulting oligosaccharide OS was 
lyophilized. 
10.9 Isolation lipid As from all bacterial strains 
analysed 
   Free lipid A was obtained by hydrolysis (100°C, 3 h) of LOS in 
sodium acetate buffer (100 mM, pH 4.4). The solution was 
extracted three times with CHCl3/MeOH/H2O (100:100:30, v/v/v) 
and centrifuged (10000g, 30 min). The obtained precipitate (free 
lipid A) was washed with water. 
 
10.10 NMR Analyses 
   All the structural assignments of core oligosaccharides moieties 
characterised (chapters 3,5-7,9) and of O-chain portion isolated 
from P. pulmonicola (chapter 4) were carried as follows. 1D and 
2D 
1
H NMR spectra were recorded in D2O (300 K, pD 7) with a 
600 DRX spectrometer (Bruker) equipped with a cryoprobe. The 
spectrometer was internally calibrated with acetone (δH=2.225 
ppm; δC=31.45 ppm). 
31
P NMR experiments were carried out with 
a Bruker DRX-400 spectrometer; aqueous 85% phosphoric acid 
was used as external reference (δ = 0.00 ppm). Rotating frame 
Overhauser enhancement spectroscopy (ROESY) and nuclear 
Overhauser enhancement spectroscopy (NOESY) experiments 
were performed using data sets (t1×t2) of 4096×256 points with 
mixing times between 100 and 400 ms. Double quantum-filtered 
phase-sensitive COSY experiments were executed with sets of 
4096×512 points. Total correlation spectroscopy (TOCSY) 
experiments were performed with spinlock times of 100 ms with 
data sets (t1×t2) of 4096×256 points. The data matrix in all the 
homonuclear experiments was zero-filled in both dimensions to 
give a matrix of 4 K×2 K points, and was resolution-enhanced in 
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both dimensions using a cosine-bell function before Fourier 
transformation. Coupling constants were determined by 2D phase-
sensitive DQF-COSY (Piantini et al., 1982; Rance et al., 1983). 
Heteronuclear single quantum coherence (HSQC) and 
heteronuclear multiple bond correlation (HMBC) experiments were 
performed in 
1
H-detection mode by single-quantum coherence with 
proton decoupling in the 
13
C domain using data sets of 2048×256 
points. Experiments were carried out in the phase-sensitive mode. 
(States et al., 1982) A 60 ms delay was used for the evolution of 
long-range correlations in the HMBC experiment. The data matrix 
in all the heteronuclear experiments was extended to 2048×1024 
points by using forward linear prediction extrapolation. 
10.11 MALDI TOF mass spectrometry analysis 
   MALDI-TOF mass spectra were recorded in the negative and 
positive polarity in linear mode on a Perseptive (Framingham, MA, 
USA) Voyager STR equipped with delayed extraction technology.  
High resolution mass spectra were acquired in reflector mode on a 
4800 Proteomics analyzer MALDI TOF/TOF mass spectrometer 
(Applied Biosystems, Framingham, MA, USA). In this case mass 
spectra, resulting from the sum of 1250 laser shots, were obtained 
with a resolution higher than 10000 (as the ratio between the mass 
of the peak and its full width at half maximum intensity) and with 
mass accuracy below 100 ppm. 
Lipid A samples were dissolved in CHCl3/CH3OH (50:50, v/v) at a 
concentration of about 25 pmol/μL. Matrix solution was prepared 
by dissolving 2,4,6-trihydroxyacetophenone (THAP) in 
CH3OH/0.1% trifluoroacetic acid/CH3CN (7:2:1, v/v) at a 
concentration of 75 mg/mL. A 1:1, v/v sample/matrix solution 
mixture (<1μl) was deposited onto a stainless-steel MALDI sample 
plate , and left to dry at room temperature. 
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LOS sample required a more laborious preparation as recently 
reported (Sturiale et al., 2005). Briefly, a small amount of the intact 
LOS was first suspended in a mixture of methanol/water (1:1) 
containing 5mM ethylenediaminetetraacetic acid (EDTA) and 
allowed to dissolve by a brief ultrasonication. A few microliters of 
the obtained mixture were then desalted on a small piece of 
ParafilmTM with some grains of cation-exchange beads (Dowex 
50WX8-200, Sigma–Aldrich), previously converted into the 
ammonium form; 0.3 μL of this sample solution was finally 
deposited, together with the same volume of 20 mM dibasic 
ammonium citrate, in a thin layer of homogeneous matrix film 
obtained from a solution whose components were 2,4,6-
trihydroxyacetophenone (THAP), 200 mg/mL in methanol, and 
nitrocellulose (Trans-blot membrane, BioRad), 15 mg/mL in 
acetone/propan-2-ol (1:1 v/v), mixed in a 4:1 v/v ratio. MS analysis 
of the oligosaccharide sample was performed utilising a matrix 
solution of dihydroxybenzoic acid (DHB) 50 mg/ml in TFA 0.1% 
ACN 80/20, by the classic dried drop method: 1 μl of a 
sample/matrix solution mixture (1:1, v/v) was deposited onto the 
MALDI sample plate and left to dry at room temperature. 
 
10.12 HEK293 hTLR4/CD14/MD-2 cell culture, 
transfection, and stimulation of B. dolosa 
   Stably transfected HEK cell line 293-hTLR4-MD2-CD14 
(Invivo-Gen, San Diego, CA) was cultured in DMEM (Lonza, 
Basel, Switzerland) with 10% FBS (Euroclone, Pero, Italy). 
Blasticidin-S (10 mg/mL; InvivoGen) and HygroGold (50 mg/mL; 
InvivoGen) were added to cell cultures according to the 
manufacturer’s instructions. The cells were transiently transfected 
by using PolyFect Transfection Reagent (Qiagen) according to the 
manufacturer’s instructions. For NF-kB studies, the cells were 
seeded into 96-well plates at a concentration of 3×10
5
 cells per mL, 
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then transfected overnight with a reaction mixture of PolyFect 
transfection reagent (1 mL, Qiagen), and plasmids pGL3.ELAM.tk 
(150 ng; Promega), pRLTK (15 ng; Promega) (Silipo et al., 2004). 
pGL3.ELAM.tk encodes Firefly luciferase under control of the NF-
kB promoter; pRLTK encodes Renilla luciferase, and was used as a 
control. HEK 293 hTLR4/MD2/CD14 cells were exposed to 
different concentrations of B. dolosa LOS or E. coli LPS (1, 10, or 
100 ng/mL; Ultra-pure LPS-EB, InvivoGen), and stimulation was 
for 4 h. 
10.13 Bone marrow-derived macrophages (BMDMs)  
culture and stimulation assay with B. dolosa 
LOS 
   Bone marrow-derived macrophages (BMDMs) were derived 
from bone marrow cells collected from five-week-old wildtype 
C57BL/6 female mice (Charles River Laboratories; all animals 
were maintained in a specific pathogen-free animal facility at the 
Sapienza University of Rome (Italy)). BMDMs were differentiated 
over 7 days in RPMI 1640 medium (Lonza), supplemented with 
heat-inactivated FBS (10%, Euroclone), L-glutamine (2 mM), 
sodium pyruvate (5 %), non-essential amino acids (NEAA 100×; 
100 mm, Euroclone), β-mercaptoethanol (0.5%, Gibco), and 
macrophage colony-stimulating factor (30 ng/mL; Miltenyi Biotec, 
Calderara di Reno, Italy). At 7 days, BMDMs were characterized 
by immunostaining with FITC-F4/80 and Mac-1/CD11b (clone 
M1/70) monoclonal antibodies (Abcam, catalogue number 
ab105155 and BD Pharmingen, catalogue number 557397, 
respectively) by flow cytometric analysis in a FACSCalibur 
cytometer (BD Biosciences). 
For stimulation assays, BMDMs were seeded in 24-well plates 
(5×105 cells per well), exposed to different concentrations of B. 
dolosa LOS or E. coli LPS (1, 10, or 100 ng/mL) and incubated for 
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12 h. Cell suspension supernatants were recovered and processed to 
measure TNF-α (R&D Systems, catalogue number DY410), IL-10 
(R&D Systems, catalogue number DY417), and IL-6 (R&D 
Systems, catalogue number DY406) production by DuoSet ELISA 
assay according to manufacturer’s instructions. 
In the competition assays, BMDMs were primed with B. dolosa 
LOS (1, 10, or 100 ng/mL) for 1 h and then re-stimulated with of E. 
coli LPS (10 ng/mL). After 12 h of re-stimulation, TNF-α, IL-10, 
and IL-6 production was quantified by ELISA assay (DuoSet) 
according to manufacturer’s instructions. 
10.14 Mice treatment in P. aeruginosa LOS analysis 
   C57Bl/6NCrlBR mice (20–22 gr) were purchased by Charles 
River. Mice were housed in filtered cages under specific-pathogen 
free conditions and permitted unlimited access to food and water. 
Mice were exposed to intranasal injection of LOS (15 μg/mouse) 
derived from P. aeruginosa RP73 clinical isolate. Commercial LPS 
derived from PAO1 strain (Sigma-Aldrich) was used as reference. 
Control animals were exposed to phosphate buffered saline (PBS). 
Sixteen hours after exposure, mice were sacrificed and 
bronchoalveolar lavage fluid (BALF) was performed by washing 
the lungs three times with 1 ml of RPMI (Euroclone) with 
proteinase inhibitors. Lungs were removed and homogenised in 1 
ml of PBS with ions containing proteinase inhibitors. Total cells 
present in the BALF were counted, and a differential cell count was 
performed on cytospins stained with Diff Quick (Dade, Biomap, 
Italy). Erythrocyte present in the BALF were lysed with ACK lysis 
solution (Sigma Aldrich), cells were then resuspended in 
cetyltrimethylammonium chloride 0.5% (Sigma Aldrich) and 
centrifuged. Supernatants were used to analyze the 
myeloperoxidase (MPO) activity by ELISA assay (Moalli et al., 
2011).
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10.15 HEK293 cell activation assay-luciferase reporter 
assay in chapter 8 
   HEK293 cells were seeded in 96-well plates at 3x10
4
 cells/well 
and incubated overnight in a humidified atmosphere (5% CO2) at 
37°C. The next day, when cells were 60-80 % confluent, they were 
co-transfected with the plasmids for MD-2 (10 ng), TLR4 (1 ng), 
NF-κB-dependent luciferase (50 ng) and constitutive Renilla (10 
ng) expression using JetPEI transfection reagent (all amounts are in 
ng/well). Cells were stimulated 6 hours after transfection with 
endotoxin preparations. Cells were lysed after 16 hours of 
stimulation in 1x reporter assay lysis buffer (Promega, USA) and 
analysed for reporter gene activities using a dual-luciferase reporter 
assay system. Relative luciferase units (RLU) were calculated by 
normalizing each sample’s luciferase activity for constitutive 
Renilla activity measured within the same sample.  
 
10.16 HEK293 hTLR4/CD14/MD-2 cell culture, 
transfection, and stimulation in T. 
hydrothermalis analysis 
 
   HEK 293 hTLR4/MD2/CD14 were exposed to different 
concentrations of T. hydrothermalis LOS or E. coli LPS (LPS-EB 
ultrapure, InvivoGen) at different concentrations (1, 10, 100 ng/ml) 
and stimulation was prolonged for 4 h. For the competition assay, 
cells were primed with T. hydrothermalis  LOS (1, 10 and 100 
ng/ml) for 1 h and then re-stimulated with 10 ng/ml of E. coli LPS 
(LPS-EB ultrapure, InvivoGen) for 4 h. To assess the absence of  
contamination in LPS preparations HEK 293 hTLR2 were 
stimulated with LOS derived from T. hydrothermalis  or  E. coli 
LPS. Pam3CSK4 (invivoGen) was used with HEK 293 hTLR2. 
NF- B-dependent luciferase activity was measured using the Dual-
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Luciferase® Reporter Assay System (Promega, Milan, Italy), as 
reported (Nigro et al., 2008). Cell supernatants were recovered and 
IL-8 release in cell culture supernatants were measured using 
DuoSet R&D System. 
 
10.17 BMDMs culture and stimulation assays in T. 
hydrothermalis analysis 
   Bone marrow-derived macrophages (BMDMs) were derived 
from bone marrow cells collected from five-week old wild-type 
C57BL/6 (Charles River Laboratories). For stimulation assays, 
BMDMs were seeded into 24-well plates (5x10
5
 cells/ml) and were 
exposed to different concentrations of T. hydrothermalis LOS or  E. 
coli LPS (1, 10, 100 ng/ml) for 18 h. Cell supernatants were 
recovered and cytokine levels in cell culture supernatants were 
measured through ELISA using DuoSet R&D System, following 
manufacturer suggestions. 
10.18 Molecular modeling on B. cenocepacia LOS and 
lipid A 
 
10.18.1 Docking studies of LAMUT-and BCLA on MD-2  
 
   Each ligand, LAMUT and BCLA, was docked into human and 
murine MD-2 protein using AutoDock 4.2, and separately using 
AutoDock Vina 1.1.2. For human MD-2 (from PDB 3fxi), the 
Autogrid grid point spacing was set at 0.375 Å, center coordinates 
of the grid box were 29.00, -7.00, 17.875(x, y, z), and number of 
grid points in xyz was 41, 53, 83. For murine MD-2 (from PDB 
3vq2), the Autogrid grid point spacing was set at 0.375 Å, center 
coordinates of the grid box were -27.50, -15.50, 22.00 (x, y, z), 
leading to with 75 x 40 x 60 (x, y, z) grid points. Best result from 
each docking job with BCLA was used as starting geometry for 
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subsequent docking calculations. Different combinations of 
allowed rotatable bonds were also considered for the ligands. 
Docking calculations with AutoDock were performed using 
Genetic Algorithm (number of individuals in population 150, 
maximum number of energy evaluations 2500000-5000000, 
maximum number of generations 27000, number of top individuals 
to survive to next generation 1, rate of gene mutation 0.02, rate of 
crossover 0.8, window size 10, Alpha parameter of Cauchy 
distribution 0.0, Beta parameter Cauchy distribution 1.0). When 
docking BC-LOS, flexible docking was also performed considering 
Asp101, Glu120 and Glu122 as flexible residues. 
Docking calculations with AutoDock Vina were also performed. 
Coordinates and dimensions of grid boxes, starting geometries and 
general methodology were the same as for AutoDock. When 
docking BC-LOS, flexible docking was also performed considering 
Asp101 as flexible residue. 3D structures of the docked complexes 
were optimized by performing MD simulations with Impact 
(implicit water, and AMBER* force field). 
 
10.18.2 Docking studies of BC-LOS core on TLR4  
 
   The core moiety of BC-LOS was docked into human TLR4 
protein using AutoDock Vina 1.1.2. All torsional bonds from the 
ligand were allowed to rotate. Ammonium groups were considered 
as ionized. Grid box was built on TLR4 from PDB 3fxi with grid 
center at 26.00, -22.00, 11.50 (x, y, z), number of grid points of 41 
x 41 x 43 (x, y, z), and spacing of 0.375 Å. Final optimization of 
the 3D structure of the docked complex was carried out by MD 
simulation with Impact (implicit water, and AMBER* force field). 
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10.18.3 Building of the full complex of human MD-2/TLR4 with 
BC-LOS 
   Docked MD-2/BC-LOS complex was merged to docked BC-LOS 
core/TLR4 using PDB 3fxi as template. The resulting structure was 
optimized by MD simulations with implicit water (AMBER* force 
field). Coupling of two TLR4/MD-2/BC-LOS complexes was 
finally performed also using PDB 3fxi as template. The full 3D 
structure of the dimer complex was submitted to MD simulations 
with implicit water and AMBER* force field (charges from: 
forcefield, cutoff: extended, method: PRCG, maximum iterations: 
500, converge on: gradient, convergence threshold: 0.05). 
10.19 Genetic manipulation on B. cenocepacia K56-2 
   PCR reactions were done with Taq DNA polymerase or HotStar 
HiFidelity DNA Polymerase (Qiagen, Mississauga, ON, Canada). 
Plasmid DNA was isolated using QiaPrep Spin kit (Qiagen). PCR 
products were purified using a QIAquick PCR purification kit or a 
QIAquick gel extraction kit (Qiagen). Plasmids were transformed 
into E. coli strains by the classical calcium chloride method or 
mobilized into B. cenocepacia by triparental mating as described 
(Flannagan et al., 2008). Gene deletions or insertions were 
performed by allelic exchange as described previously (Flannagan 
et al., 2008).
 
This system relies on a suicide vector that contains an 
I-SceI restriction site (pGPI-SceI) and the replicative vector 
encoding the I-SceI endonuclease (pDAI-SceI-SacB). Two new 
derivatives of pGPI-SceI, pGPISceI-X and pGPI-SceI-2 were used. 
To create pGPI-SceI-X, the xylE gene was PCR-amplified from 
pMo130 using primers 3925 and 3929. This PCR product was 
digested with EcoRI and XbaI and ligated to pGPI-SceI digested 
with the same enzymes to create pGPI-SceI-X. pGPI-SceI-2 was 
created by cutting pGPI-SceI-X with EcoRV and SmaI, removal of 
the xylE gene, and self-ligation. pGPISceI-X and pGPI-SceI-2 were 
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created from pGPI-SceI in order to add new restriction sites at the 
multiple cloning sites. 
10.19.1 Construction of an unmarked L-Ara4N conditional 
   B. cenocepacia strain Prha-arn was constructed by allelic 
exchange using pMH396, which was obtained by cloning two DNA 
fragments into pGPI-SceI-2. One DNA fragment, spanning about 
~300 bp of the 5′-end of arnT coding region along with Prha and 
rhaRS genes, was PCR-amplified from pXO38 using primers 4993 
and 2282. The second DNA fragment comprised a ~300 bp 
fragment upstream arnT, which was PCR-amplified from genomic 
B. cenocepacia DNA using primer number 4994 and 4486. The 
upstream fragment was digested with NotI and SpeI, the 
downstream fragment was digested with SpeI and XbaI and both 
fragments were ligated to pGPI-SceI-2 digested with NotI and XbaI 
to create pMH396. This plasmid was used to insert the Prha and 
rhamnose control elements by allelic exchange as previously 
described with the exception of including rhamnose at a 
concentration of 0.4% (w/v) in all media used throughout the allelic 
exchange process. 
10.19.2 Construction of a suppressor strain that is viable in the 
absence of L-Ara4N synthesis 
   Strain ΔarnBC was derived from Prha-arn by deleting the L-
Ara4N synthesis genes arnB (BCAL1931) and arnC (BCAL1932) 
using pMH407. To construct pMH407, an internal fragment of 
arnC was PCR amplified using genomic B. cenocepacia DNA and 
primers 5115 and 5116. The PCR product was digested with NotI 
and XbaI and ligated to pGP-SceI-2 to create pMH406. Next, an 
internal fragment of arnB was PCR-amplified using primer 5117 
and 5118 and genomic B. cenocepacia DNA as a template. This 
fragment was digested with NheI and NotI and ligated into 
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pMH406 digested with the same enzymes to create pMH407. Next, 
an overnight culture of Prha-arn grown in LB broth and 0.4% 
rhamnose was washed twice with PBS to remove rhamnose and the 
plated onto 10 LB agar plates [~5×10
5
 cfu (colony-forming units) 
per plate] to enrich for suppressor colonies. After 3 days incubation 
at 37°C, colonies were pooled and the suicide vector pMH407 was 
introduced into pooled cells by triparental mating. To isolate 
colonies where homologues recombination between pMH407 and 
arnBC genes took place, exconjugants were screened for 
polymyxin B sensitivity in the presence of rhamnose. Colonies that 
failed to grow on LB agar containing polymyxin B (100 mg/ml) 
and rhamnose (0.4%) were used to resolve pMH407 using I-SceI 
endonuclease-encoding plasmid, and the deletion of arnBC was 
confirmed by PCR using the flanking primers 4778 and 4940. 
10.19.3 Construction of a suppressor strain that can synthesize 
L-Ara4N but lacks arnT 
   The suppressor strain ΔarnT-arnBC+ was constructed in two 
steps by first deleting arnT from the ΔarnBC strain and next, 
reintroducing arnBC into their native genomic loci. arnT was 
deleted by allelic exchange using the plasmid pMH414, which was 
created by cloning two DNA fragments flanking arnT into 
pGpSceI-2. The upstream fragment was PCRamplified from 
pXO38 using the primer 4867 and 4206. The downstream fragment 
was PCR-amplified using genomic B. cenocepacia DNA as 
template and primer 4840 and 4841. The upstream fragment was 
digested with NotI and BglII, while the downstream fragment was 
digested with BglII and XbaI and both fragments were ligated into 
pGpSceI-2 digested with NotI and XbaI to create pMH414. This 
plasmid was used to delete arnT resulting in strain ΔarnBC ΔarnT. 
pMH415 was subsequently used to reintroduce functional arnBC 
genes by allelic exchange into their genomic locus in ΔarnBC 
ΔarnT strain, resulting in the strain ΔarnT-arnBC+. 
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10.19.4 Single copy gene replacement of lpt genes into Prha-arn 
   Single copy, unmarked gene replacement was performed in Prha-
arn by allelic exchange using the plasmid pMH447. pMH447 was 
created to replace the genes amrAB genes (BCAL1674–
BCAL1675), which encodes aminoglycoside efflux pump, with any 
gene of interes. Successful replacement of the gene of interest with 
amrAB renders B. cenocepacia sensitive to gentamicin and allows 
for easy screen for single copy unmarked gene replacement. 
pMH447 was created by cloning two DNAfragments upstream and 
downstream BCAL1674–BCAL1675 into pGPI-SceI-2. The 
upstream fragment was PCR amplified using B. cenocepacia 
genomic DNA and primer 5386 and 5387. The downstream 
fragment was PCR amplified using B. cenocepacia genomic DNA 
and primer 5388 and 5389. PCR product of upstream fragment was 
digested with EcoRI and NdeI and the PCR product of downstream 
fragment was digested with NdeI and NheI, and both fragments 
ligated to pGPI-SceI-2 digested with XbaI and EcoRI. The ligation 
between the compatible cohesive ends of NheI and XbaI destroys 
both sites thus creating unique NdeI and XbaI sites suitable for 
cloning into pMH447. pMH447 was used to delete amrAB from 
Prha-arn creating the gentamicin sensitive strain Prha-arn 
ΔamrAB. lptFG (BCAL2677–BCAL2678) were PCR amplified 
using wild-type B. cenocepacia DNA and primers 5165 and 5166. 
PCR product was digested with NdeI and XbaI and cloned into 
pMH447 cut with the same enzymes to create pMH448. pMH448 
was then used to replace amrAB with wild-type lptFG in Prha-arn 
background thus creating the strain Prha-arn ΔamrAB::lptFGWT. 
lptFG (BCAL2677–BCAL2678) genes were PCR amplified using 
genomic DNA from suppressor strain ΔarnBC and primers 5165 
and 5166. PCR product was digested with NdeI and XbaI and 
cloned into pMH447 cut with the same enzymes to create pMH449. 
pMH449 was then used to replace amrAB with suppressor lptFG in 
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Prha-arn background thus creating the strain Prha-arn 
ΔamrAB::lptFGS. lptG was PCR amplified using genomic DNA 
from suppressor strain ΔarnBC and primers 5256 and 5166. PCR 
product was digested with NdeI and XbaI and cloned into pMH447 
cut with the same enzymes to create pMH451. pMH451 was then 
used to replace amrAB with suppressor lptFG in Prha-arn 
background thus creating the strain Prha-arn DamrAB::lptGS. To 
test for the ability lptGF genes to suppress Ara4N lethality, 
overnight cultures of each strain, grown in LB broth plus rhamnose 
were washed twice with PBS to remove residual rhamnose, serially 
diluted, and 5 ml drops of each dilution were plated onto LB agar 
with or without 0.4% rhamnose. 
10.19.5 Site direct mutagenesis and replacement of wild-type 
lptG with lptGD31H 
   lptGF was PCR amplified using wild-type genomic B. 
cenocepacia DNA and primer 5449 and 5166. PCR product was 
then cut with NotI and XbaI and ligated to pGPI-SceI-2 cut with 
the same enzymes to create pMH461. Aspartic acid at position 31 
was changed to histidine using pMH461 as template and primer 
5436 and 5437 by site direct mutagenesis as previously described 
(Hamad and Nilles, 2007) pMH461 was then introduced into Prha-
arn and then resolved which resulted in either reversion to wild-
type lptG or lptGD31H replacement. To screen for successful 
lptGD31H replacement colonies where patched onto LB agar with or 
without rhamnose and colonies that grew in absence of rhamnose 
indicated replacement of wild-type lptG with lptGD31H. The 
resulting strain was named Prha-arn lptGD31H and lptGD31H 
replacement was confirmed by DNA sequencing of the lptG gene. 
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10.19.6 Antimicrobial peptide sensitivity testing and MIC 
determination 
   The MIC values to polymyxin B were determined as previously 
described (Loutet et al., 2009) with a few modifications. Overnight 
cultures, grown in LB broth supplemented with 0.4% rhamnose, 
were adjusted to an optical density at 600 nm (OD600) of 0.002 in 
LB broth plus 0.4% rhamnose, and polymyxin B was added to 
samples at twofold dilutions. Samples were then aliquoted into 
100-well plates and incubated at 37°C with constant shaking for 24 
h in a Bioscreen C automated growth curve analyser (MTX Lab 
Systems, Vienna, VA, USA). The MIC values were determined as 
the lowest concentration of antibiotic that inhibited visible growth 
after 24 h of incubation.  
10.19.7 Transmission electron microscopy 
   Cultures we depleted of L-Ara4N by growing bacteria in M9 
minimal media supplemented with 5% yeast extract and 0.5% 
glucose for 8 h. Cells were fixed with 2.5% glutaraldehyde and 
stained with 2% uranyl acetate and lead citrate. Grids were 
visualized using a Philips 410 transmission electron microscope 
operating at 60 kV. 
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Conclusions 
The present PhD project has been entirely focused on the 
relationship between the structure and the biological activity of 
endotoxins isolated from cystic fibrosis opportunistic pathogens.  
The first chapters are dedicated to the structural characterisation of 
LOS and O-chain moiety from Burkholderia dolosa and Pandoraea 
pulmonicola respectively. Both elucidated structures have revealed 
peculiar features that can be correlated to the high virulence of 
these cystic fibrosis pathogen bacteria. In particular, B. dolosa was 
found to be characterised by a LOS possessing a novel core 
oligosaccharide structure with no negative charges at the outer core 
conferring on the LPS an overall neutral characteristic that renders 
it resistant to cationic antimicrobial peptides. Moreover, biological 
assays highlighted a notable pro-inflammatory activity exerted by 
isolated B. dolosa LOS thus confirming the important role of LOS 
in pathogenicity of this cystic fibrosis pathogen. Similarly, 
structural determination of the antigenic determinant of the LPS 
molecule from the newly identified Pandoraea pulmonicola 
revealed the occurrence of a trisaccharide repeating unit bearing an 
uncommon non-sugar substituent. Since the O-chain moiety is 
known to elicit the host adaptive immune response, it is possible to 
assume that its novel structure and, in particular, the aglycon 
substituent, might be involved in the high virulence of P. 
pulmonicola in CF patients which was observed to be related to a 
remarkable production of cytokines in lung epithelial cells leading 
to a potent inflammatory process responsible for patient’s death.                                                                                               
Interesting insights were also obtained from data belonging to the 
structural analysis of endotoxins isolated from chronic strains of 
both Pseudomonas aeruginosa RP73 and Burkholderia 
cenocepacia. The former was isolated after 17 years of colonisation 
and its LOS structure was completely elucidated together with the 
assessment of the pro-inflammatory activity. The results have 
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demonstrated that P. aeruginosa can undergoes changes in its 
endotoxin structure, both the O-chain and lipid A moieties, to 
generate strains with a low immunostimulant activity in order to 
escape from host immune activity. Indeed, the absence of the 
antigenic determinant and the presence of an underacylated lipid A 
found in P. aeruginosa RP73, were related to an endotoxin with a 
very low inflammatory power as shown by the poor recruitment of 
neutrophils in bronchoalveolar lavage fluid of mice used in in vivo 
experiments. The analysis of the endotoxin structure isolated from 
B. cenocepacia strains isolated at different stages of chronic 
colonisation further confirmed that an important phenotypic change 
in CF pathogens is the loss of the LPS O-chain moiety to reduce 
their detectability by host immune defenses. 
A second part of this thesis is dedicated to the role of amino-
arabinoses in several biological activities exerted by Burkholderia 
cenocepacia. Through a plethora of genetic and biochemistry 
experiments it was possible to assign several fundamental roles to 
the amino-arabinoses: i) they were found to be involved in B. 
cenocepacia high resistance to the most common used antibiotics 
in treatment of CF; ii) their presence is required for viability of this 
opportunistic pathogen since they represent an important signal for 
the export of the LPS to the outer membrane. Furthermore, through 
a meticulous study of the binding mechanisms of the B. 
cenocepacia lipid A to its physiological receptor, the TLR4/MD-2 
complex, two further roles were attributed to amino-arabinoses: i) 
they act as a mask of the negative charged phosphate groups of the 
lipid A leading to a fine orientation of this latter into the MD-2 
binding pocket; ii) their presence gives additional polar interactions 
to the binding of B. cenocepacia lipid A to the receptorial complex 
thus providing additional points of anchorage that favor the 
interaction and the immunostimulant activity of the B. cenocepacia 
lipid A. The study of the interaction between B. cenocepacia lipid 
A and the TLR4/MD-2 complex demonstrated that the typical 
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paradigm that asserts that underacylated lipid As have no or low 
inflammatory power, can not be applied to the B. cenocepacia lipid 
A. Indeed, the analysis have showed that this latter exerts its 
immunostimulant activity through a sinergistical effect given by the 
presence of amino-arabinoses and by the presence of long fatty acid 
chains; in particular these latter are responsible for the complete 
fulfillment of the MD-2 binding pocket, leading to the exposition 
of one acyl chain that is required for the elicitation of the 
inflammatory process. 
The last part of this PhD thesis has been focused on 
characterisation of endotoxins isolated from a thermophilic 
bacteria. The importance to insert this study in the present thesis is 
consistent with the discovery of LPSs from non-pathogenic bacteria 
exerting antagonist or partial antagonist activity towards toxic 
LPSs. Thus, by isolating and characterising the structure and 
biological activity of endotoxins from extremophilic bacteria it is 
possible to offer new perspectives for treatment of pathologies 
caused or exacerbated by bacterial LPS, such as in case of cystic 
fibrosis. In this context, the elucidated structure and biological 
activity of Thermomonas hydrothermalis LOS is of great interest 
since the determined novel structure was found to exert a very low 
immunostimulant activity and, more important, to antagonize the 
toxic activity of the high inflammatory E. coli lipid A. 
The overall results obtained from the projects reported in this 
thesis work, further confirmed the importance of LPS in bacterial 
life and pathogenesis mechanisms. Furthermore, structural analyses 
and biological tests conducted showed which molecular 
components are mostly involved in LPS endotoxicity. The 
knowledge of molecular structures involved in elicitation of the 
inflammatory process or the comprehension of mechanisms 
adopted by bacteria to escape host immune defenses during its 
adaptation to host environment, as well as the isolation and study of 
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macromolecules from non-pathogenic bacteria, as microorganism 
living in extreme environments, can offer novel pharmacological 
targets for the development of new aimed biomedical therapies.
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